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Summary 
Traumatic spinal cord injury (SCI) imposes major life changes affecting mostly the young and is more 
prevalent in men than in women. Worldwide, about 170’000 new cases occur annually. The majority 
of patients are left with profound and persistent functional impairments such as paralysis, sensory 
deficiencies, chronic pain, and bladder and bowel problems. At the injury site, the primary impact 
leads to tissue destruction including damage of blood vessels, neurons and glial cells, and disruption 
of axons. This creates an excitotoxic environment in the penumbra, which sets adjacent, non-injured 
cells, including neurons, at risk. A complex secondary cascade follows where astrocytes form a 
persistent dense scar to separate, and therefore also protect, the intact neurons from the toxic 
environment of the injury site. This physical barrier, together with the limited regenerative capability 
of injured axons, is one of the main reasons for the limited degree of recovery following SCI. 
Experimental evidence suggests that these processes can be influenced by the application of 
targeted drugs. Therefore, several clinical trials have been undertaken during the last years. Although 
no standard treatment evolved worldwide from these trials, they have improved our understanding 
of the difficulties faced in such trials. In particular, they struggle in adequately identifying treatment 
effects vs. spontaneous improvements. This might be partly due to our current clinical assessments, 
which lack sensitivity to minimal changes in sensorimotor functions, making reliable stratification of 
homogenous sub-groups and prediction of outcome still challenging. To enable efficient translation 
from bench to bedside, these interventions require biomarkers that can be used as surrogate makers 
to early test safety and efficacy of new drugs applied within clinical trials. 
Such biomarkers need to be able to capture biological processes of recovery like neuronal and myelin 
repair. Today, structural magnetic resonance imaging (MRI) is one of the few tools able to capture 
such structural changes in-vivo and might therefore be a promising method to close this knowledge 
gap. As a first step towards the development of neuroimaging biomarkers, recent studies have 
focused on characterizing spontaneous trauma-induced structural changes after SCI in the spinal cord 
and brain. At the spinal cord level, remote cervical atrophy of up to 30% was evident in chronic SCI 
patients. Supraspinally, degeneration and reorganization was present within the sensorimotor and 
limbic system. In this thesis, the main aim was to further improve our understanding of trauma-
induced structural changes by applying conventional and advanced MRI protocols. This enabled us to 
quantitatively analyze changes at different levels of the neuraxis (at and above the level of injury). 
Further, this thesis explores the relationships between quantitative MRI readouts, and 
electrophysiological and functional outcome. 
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In the first study, we investigated the spatial and temporal evolution of the lesion and adjacent tissue 
bridges after SCI using a clinically established imaging protocol. At 1-month post injury, the lesion 
was well demarcated and allowed reliable identification of midsagittal lesion extent and tissue 
bridges. The lesion width decreased within the first year after injury, suggesting removal of axonal 
and myelin debris. In contrast, the size of total tissue bridges remained stable within the first year 
after injury, and these tissue bridges were transmissible for electrophysiological information flow. 
Importantly, the size of tissue bridges and the extent of damage are predictive of outcome at 1 year 
follow-up. 
Next we moved on to explore underlying tissue-specific structural, microstructural and molecular 
changes within areas of cervical atrophy occurring in chronic SCI patients.   
In the second study, we investigated whether grey matter pathology, alongside white matter 
changes, also contributes to clinical impairment. We therefore took advantage of recent 
improvements in diffusion-weighted imaging and spinal anatomical MRI sequences with higher in-
plane resolution. Besides white matter atrophy and evidence for neurodegeneration and 
demyelination within the major sensorimotor tracts, we found marked atrophy within ventral and 
dorsal horns which related to lesion severity. Tissue-specific neurodegeneration was associated with 
appropriate clinical and neurophysiological impairment. Next to antero- and retrograde degeneration 
of sensorimotor tracts, this study provides evidence that neuronal circuits within the spinal cord 
undergo trans-synaptic neurodegeneration, leading to grey matter changes above the level of injury.  
In the third study, we identified underlying molecular changes in areas of cervical atrophy by using a 
novel spinal magnetic resonance spectroscopy protocol. This study showed lesion level dependent 
metabolic alterations related to chronic neuroinflammation, neurodegeneration and demyelination 
above the level of injury. Lesion severity was driving the amount of metabolic changes relating to 
neuroinflammation. Greater signs of neuroinflammation were associated with more cervical atrophy 
and greater clinical impairment. Our data suggest that the SCI results in chronic neuroinflammation, 
in addition to ongoing neurodegeneration and demyelination, which might drive or contribute to 
cervical atrophy. 
In the fourth and last study in this thesis, we investigated the temporal and spatial evolution of the 
extrapyramidal system after SCI. We analyzed surface area changes as well as underlying 
microstructural changes within the thalamus, striatum and globus pallidus. Whereas recent 
neuroimaging studies focused on changes within the sensorimotor and limbic system after SCI, the 
involvement of basal ganglia structures in recovery from a SCI has been suggested by animal studies. 
We revealed that within the first 2 years after SCI, patients showed contractions of surface area in 
the motor thalamus within regions representing lower limbs, within the pulvinar and the striatum 
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compared to controls. In addition, surface area expansions were evident in the sensorimotor 
thalamus within regions that represent the upper limbs, and in the striatum. In parallel, 
microstructural parameters also changed over time, suggesting degeneration, demyelination and 
probably inflammation in the sensorimotor thalamus, striatum and globus pallidus. At 1 month post 
injury, increased surface area changes within the motor striatum predicted lower extremity motor 
score at 2-year follow-up and increased signs of iron accumulation within the pulvinar nuclei were 
predictive of 2-year pin-prick score. This study provides evidence for progressive basal ganglia 
changes after SCI related to clinical readouts. 
In conclusion, this thesis expands previous knowledge and shows transneuronal reorganization of 
primarily unaffected spinal and brain regions after SCI, in addition to degenerative changes occurring 
at the lesion site and in directly injured white matter tracts above the level of injury. Moreover next 
to degeneration and demyelination, the findings within this thesis indicate that chronic 
neuroinflammation might be present after SCI. This biological response might relate or contribute to 
degenerative changes within the central nervous system, and therefore is also possibly associated to 
clinical outcome. Thus, quantitatively analyzed conventional as well as innovative new multimodal 
MRI protocols allow for the quantification of trauma-induced spinal and supraspinal changes and 
might serve as biomarkers to assess the efficacy of new treatment interventions. Towards this goal, 
next steps involve the combination of structural and functional MRI in longitudinal multicenter 
assessments in acute SCI to simultaneously measure spinal and supraspinal changes and their impact 
on reorganization as SCI patients recover. This will not only increase our understanding of the 
temporal sequence of structural changes and their relationship to each other, but allow the 
identification of the most sensitive biomarkers for different experimental approaches focusing on the 
treatment of SCI patients.  
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Zusammenfassung 
Eine traumatische Rückenmarksverletzung verändert das Leben der Betroffenen nachhaltig. Jedes 
Jahr treten weltweit ungefähr 23 neue Fälle pro Million Einwohner auf. Insgesamt handelt es sich 
also um jährlich mehr als 170'000 Fälle, was die grosse Bedeutung dieses Themas hervorhebt. In den 
meisten Fällen verbleiben die Patienten mit tiefgreifenden und persistierenden Einschränkungen wie 
motorischen Dysfunktionen, sensorischen Störungen, chronischen Schmerzen und Blasen- und 
Darmprobleme. Die primäre Verletzung im Rückenmark führt zum Untergang des betroffenen 
Gewebes, zur Unterbrechung von Axonen und zur Schädigung von Blutgefässen und Gliazellen. 
Dadurch entsteht eine toxische Umgebung für die angrenzenden, nicht verletzten Zellen in der 
Penumbra, welche dadurch sekundär auch zu Schaden kommen können. Um das zu verhindern, setzt 
eine komplexe, sekundäre Kaskade ein, in der Astrozyten aktiviert werden und eine dichte, bleibende 
Barriere bilden, um so die intakten Neuronen vor der toxischen Umgebung der primären Verletzung 
zu schützen. Zusammen mit der begrenzten Regenerationsfähigkeit von verletzten Neuronen ist 
diese physische Barriere eine der Hauptgründe für die limitierte Erholung von rückenmarksverletzten 
Patienten. 
Tierstudien haben gezeigt, dass die limitierte Erholung mittels der Anwendung von Wirkstoffen 
beeinflusst werden kann, was zur Realisierung von verschiedenen klinischen Studien an Menschen 
geführt hat. Obwohl keine dieser Studien in neue Behandlungsstandards von rückenmarksverletzten 
Patienten resultierte, haben wir viel über die Planung und Durchführung solcher Studien gelernt. 
Eines der Hauptprobleme bleibt jedoch bestehen – nämlich die adäquate Identifizierung von 
Behandlungseffekten im Unterschied zu spontaner Erholung. Ein Grund dafür ist, dass unsere 
momentanen klinischen Messungen nicht sensitiv genug sind, um minimale Verbesserungen in 
sensomotorischen Funktionen zu erfassen. Dies macht die  zuverlässige Stratifizierung von 
homogenen Subgruppen innerhalb von klinischen Studien und die Vorhersage von funktionellen 
Verbesserungen zu einer echten Herausforderung. Um einen effizienten Transfer von präklinischen 
zu klinischen Studien zu ermöglichen, sind Biomarker notwendig, welche als Surrogatmarker benutzt 
werden können, um Sicherheit und Wirksamkeit von neuen Medikamenten innerhalb klinischen 
Studien zu testen. 
Solche Biomarker müssen im Stande sein, biologische Prozesse der Erholung zu erfassen, wie zum 
Beispiel Reymelinisierung oder neuronale Plastizität. Heutzutage ist Magnetresonanztomographie 
(MRT) eine der wenigen nicht-invaisven Methoden, welche in-vivo strukturelle Änderungen des 
Zentralnervensystems darstellen kann. Dies macht MRT zu einer vielversprechenden Technik, um als 
Biomarker dienen zu können. Um solche MRT Biomarker zu entwickeln, haben verschiedene Studien 
in einem ersten Schritt versucht, spontan auftretende strukturelle Änderungen im Rückenmark und 
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Hirn zu charakterisieren. Diese Studien haben gezeigt, dass eine Rückenmarksverletzung oberhalb 
der Läsion zu zervikaler Atrophie von bis zu 30% führt und dass degenerative und reorganisierende 
Prozesse im Hirn, vor allem innerhalb des sensomotorischen und limbischen Systems, auftreten. Ziel 
dieser Dissertation war es deshalb, unser Verständnis von trauma-induzierten, strukturellen 
Änderungen auf verschiedenen Ebenen der Neuroachse, das heisst auf und oberhalb der Läsion, 
besser zu verstehen. Dabei haben wir sowohl klinische MRT-Sequenzen als auch weiterentwickelte, 
hochmoderne Sequenzen und Post-Processing-Methoden verwendet, um Veränderungen quantitativ 
analysieren zu können. Ein weiteres Ziel dieser Arbeit umfasste ein besseres Verständnis von 
Zusammenhängen zwischen solchen quantitativen MRT Parametern und klinischer Erholung, um die 
bestehende Prognostik zu verbessern. 
Innerhalb der ersten Studie haben wir die zeitliche und räumliche Entwicklung der Läsion sowie der 
angrenzenden Gewebebrücken mittels konventionellen MRT-Sequenzen charakterisiert. Nach einem 
Monat nach der Verletzung war die Läsion gut genug abgegrenzt, so dass eine zuverlässige 
Identifizierung des Läsionsausmasses und der Grösse von midsagittalen Gewebebrücken gemacht 
werden konnte. Die Läsionsbreite nahm innerhalb des ersten Jahres ab, was für eine Beseitigung von 
Axon- und Myelin-Fragmenten innerhalb der Läsion spricht. Die Gewebebrücken hingegen blieben 
unverändert, und ihre Grösse wiederspiegelte ihre Fähigkeit für elektrophysiologischen 
Informationsfluss. Grössere Gewebebrücken und kleinere Läsionen, gemessen einen Monat nach der 
Verletzung, korrelierten mit besserer Erholung nach einem Jahr. 
Als nächstes haben wir die darunterliegenden strukturellen, mikrostrukturellen und molekularen 
Prozesse  von zervikaler Atrophie oberhalb der Läsion nach einer traumatischen 
Rückenmarksverletzung untersucht.  
In der zweiten Studie erforschten wir, ob die graue Substanz des Rückenmarks oberhalb der Läsion, 
neben Änderungen der weissen Substanz, auch zu Einschränkungen des Patienten beiträgt. Dabei 
machten wir uns neuste Verbesserungen in Diffusions-gewichteter Bildgebung und spinale, 
hochaufgelösten MRT-Sequenzen zu Nutze. Neben Atrophie der weissen Substanz und Evidenz für 
Neurodegeneration und Demyelinisierung der sensomotorischen Hauptleitungsbahnen, stellten wir 
auch eine ausgeprägte Atrophie der Vorder- und Hinterhörner der grauen Substanz oberhalb der 
Läsion fest, deren Grösse mit dem Läsionsausmass zusammenhing. Gewebsspezifische 
Neurodegeneration war mit entsprechender klinischer und neurophysiologischer Beeinträchtigung 
assoziiert. Diese Studie zeigt antero- und retrograde Degeneration der sensomotorischen 
Leitungsbahnen und liefert Hinweise dafür, dass neuronale Schaltkreise innerhalb des Rückenmarks 
von transsynaptischer Neurodegeneration betroffen sind, was zu Änderungen innerhalb der grauen 
Substanz oberhalb der Läsion führt.  
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In der dritten Studie untersuchten wir zelluläre Änderungen innerhalb der atrophierten Region 
oberhalb der Läsion mittels neuartiger, spinaler MR Spektroskopie. Diese Studie zeigt läsionhöhen-
abhängige metabolische Veränderungen oberhalb der Läsion, welche mit chronischer 
Neuroinflammation, Neurodegeneration und Demyelinisierung zusammenhängen. Die Stärke der 
chronischen Neuroinflammation hing mit der Grösse der initialen Läsion, der Stärke der zervikalen 
Atrophie und dem klinischen Status des Patienten zusammen. Diese Studie suggeriert, dass eine 
Rückenmarksverletzung nicht nur zur Neurodegeneration und Demyelinisierung oberhalb der Läsion 
führt, sondern dass chronische Neuroinflammation zur zervikalen Atrophie und dadurch auch zum 
klinischen Status des Patienten beitragen könnte. 
In der vierten und letzten Studie haben wir die zeitliche und räumliche Entwicklung der Basalganglien 
nach einer Rückenmarksverletzung untersucht, in dem wir Änderung der Oberfläche und der 
Mikrostruktur innerhalb des Thalamus, des Striatums und des Globus Pallidus analysierten. Die 
meisten neueren Studien in rückenmarksverletzten Patienten, welche strukturelle Bildgebung 
benutzten, zeigten kortikale Änderungen des sensomotorischen und limbischen Systems. Tierstudien 
deuten jedoch darauf hin, dass die Basalganglien eine wichtige Rolle in der Erholung nach einer 
Rückenmarkverletzung spielen. Im Vergleich zur Kontrollgruppe haben Patienten in dieser Studie 
innerhalb den ersten zwei Jahren nach der Verletzung im motorischen Thalamus sowie im pulvinaren 
Kern und im Striatum Abnahmen der Oberflächen gezeigt. Die Abnahmen innerhalb des motorischen 
Thalamus sind dabei in Regionen aufgetreten, welche die unteren Extremitäten abbilden. Im gleichen 
Zeitraum zeigten Patienten zudem kompensatorische Zunahmen der Oberflächen im 
sensomotorischen Thalamus in Regionen der oberen Extremitäten und im Striatum. Parallel dazu 
änderten auch die mikrostrukturellen Parameter, welche zeigen, dass im Thalamus, im Striatum und 
im Globus Pallidus Degeneration, Demyelinisierung und möglicherweise neuroinflammatorische 
Prozesse stattfinden. Einen Monat nach der Verletzung korrelierte die Grösse der 
Oberflächenänderungen innerhalb des motorischen Striatums mit dem motorischen Status der 
unteren Extremitäten nach zwei Jahren. Ebenfalls einen Monat nach der Verletzung waren Zeichen 
von erhöhter Eisenansammlung innerhalb des pulvinaren Kern mit dem sensorischen Status des 
spinothalamischen Trakts nach zwei Jahren assoziiert. Diese Studie zeigt als erstes, dass eine 
Rückenmarksverletzung zu progressiven Änderungen der Basalganglien führt, welche mit dem 
klinischen Status des Patienten zusammenhängen. 
Zusammenfassend zeigt diese Dissertation, dass eine traumatische Rückenmarksverletzung zum 
einen zu degenerativen Veränderungen auf Höhe der Läsionsstelle und den direkt verletzten 
Leitungsbahnen führt, aber auch transneuronale Änderungen im grossen Umfang in primär nicht 
betroffenen Regionen im Rückenmark und Hirn stattfinden. Neben den bekannten Mechanismen wie 
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Demyelinisierung und Neurodegeneration deuten die Resultate innerhalb dieser Arbeit darauf hin, 
dass anhaltende Neuroinflammation ebenfalls eine wichtige Rolle spielen könnte, die mit den 
degenerativen Änderungen und dadurch auch mit der Erholung der Funktion des Patienten in 
Zusammenhang steht. Konventionelle und innovative, neue MRT-Sequenzen erlauben eine 
Quantifizierung von trauma-induzierten Veränderungen im Rückenmark und im Gehirn. Diese 
könnten deshalb in Zukunft als Biomarker in klinischen Studien gebraucht werden, um die 
Wirksamkeit neuer Interventionen zu testen. Um dies zu erreichen, braucht es weitere Schritte wie 
zum Beispiel die Kombination von funktionellem und strukturellem MRT in longitudinalen Multi-
Center Studien in akuten aber auch chronischen Patienten mit Rückenmarksverletztung. Dies erlaubt 
das zeitgleiche Messen von Änderungen im Rückenmark und Hirn, sowie das Erfassen der 
Auswirkungen der Erholung auf die Reorganisation des Zentralnervensystems.  
Zum einen wird dies unser Verständnis des zeitlichen Musters von strukturellen Änderungen und des 
Zusammenhangs von strukturellen Änderungen zueinander, verbessern. Zum anderen ermöglichen 
uns solche Studien, die sensitivsten Biomarker zu identifizieren, welche dann für unterschiedliche 
pharmakologische und neurorehabilitative Interventionen genutzt werden können, welche zum Ziel 
haben, den klinischen Status des Patienten zu verbessern. 
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1 General Introduction 
My research is a response to the urgent need to improve the validation of new interventions after 
spinal cord injury (SCI). To date, the only effective treatment leading to a limited extent of functional 
recovery is by means of intensive neurorehabilitation, highlighting the need for new therapeutical 
approaches. Although many clinical trials have emerged within the last years trying to overcome the 
limited recovery present after SCI, they are often unable to prove adequate efficacy. This is because 
SCI is a heterogeneous disorder in terms of primary and secondary damage, neurological deficits and 
subsequent spontaneous recovery (Bracken and Holford , 2002, Fawcett et al. , 2006). Neuroimaging 
biomarkers possess the potential to improve treatment validation, as they are able to measure 
structural changes associated with biological processes of recovery. As the spinal cord is inherently 
connected with the brain via axons of major pathways, it is assumed that a focal damage to the 
spinal cord will lead to tract-specific widespread changes within the whole central nervous system 
(CNS), measurable by means of magnetic resonance imaging (MRI). Such biomarkers have the 
potential to provide novel insights into structural changes specifically where clinical assessments are 
insensitive to unravel small alterations. The scope of the present thesis is therefore to better 
understand trauma-induced structural changes at different levels of the neuraxis after traumatic SCI, 
and explore the predictive ability of such neuroimaging biomarkers. 
To better understand the context of the findings presented in this thesis, I will first outline the 
structure of the healthy spinal cord and then elucidate on pathophysiological mechanisms present 
after SCI. Next, studies using advanced imaging techniques to visualize remote changes above the 
level of injury are briefly summarized. Last, starting points for future therapies and ways to improve 
the validation of such interventions are presented, together with the specific aims of this thesis. 
1.1 The spinal cord in healthy humans 
The spinal cord is part of the central nervous system (CNS), connecting the brain to the peripheral 
nervous system and vice versa. It consists of about 10 billion neurons (Kalat, 1998) and is 
approximately 1cm in diameter. The spinal cord comprises two functionally and anatomically distinct 
compartments, the white and grey matter (Goshgarian, 2010).  
The white matter is somatotopically organized in functional distinct columns (Fig. 1), with descending 
tracts mainly specific for motor function and ascending tracts mainly transmitting sensory function. 
Descending tracts are grouped into the pyramidal system, compromising of the lateral and anterior 
corticospinal tract, and the extrapyramidal system, consisting of the rubrospinal, reticulospinal, 
vestibulospinal and olivospinal tracts (Kuypers, 1964, Lemon, 2008). The lateral corticospinal tract 
controls fine movement of the limbs, whereas the anterior corticospinal tract contributes to 
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movement control of axial and trunk muscles (Nathan et al. , 1990). The rubrospinal tract influences 
the tonus of distal muscles, whereas the reticulospinal, vestibulospinal and olivospinal tracts affect 
the tonus of motoneurons of proximal or trunk muscles (Orlovsky, 1972, Nathan et al. , 1982, Nathan 
et al. , 1990). Ascending tracts consist of the dorsal column (transmitting information of light-touch 
and proprioception), the anterior and lateral spinothalamic tract (transmitting pain and 
temperature), and of the anterior and posterior spinocerebellar tracts (transmitting proprioceptive 
information to coordinate movement) (Tracey, 2004). 
The butterfly-shaped grey matter consists primarily of cell bodies of sensory, motor and 
interneurons, as well neuropil (dendrites, mainly unmyelinated axons and their terminals) (Brown, 
2012). In addition, it is highly vascularized, and embedded with glial cells (Brown, 2012). Primarily, 
the grey matter serves as the site of transmission of neuronal impulses between neurons (Brown, 
2012). Similar as Brodman areas in the brain, which are regions with identical cytoarchitecture 
(Brodmann, 1912), the grey matter is also organized in anatomically distinct cell layers, so called 
Rexed laminae (Rexed, 1952, Rexed, 1954). In addition, single nuclei can be delineated from each 
other, which are partially overlapping with the laminae. Laminae I-VII are located within the dorsal 
horns, which is present at all spinal levels, and receive and transmit incoming somatosensory 
information. In particular, laminae I and II contain cells responding mainly to noxious and thermal 
stimuli arising from the dorsal root ganglion or the Lissauer tract. Their axons join the contralateral 
spinothalamic tract. Laminae III and IV include Aβ fibers arising from the dorsal root ganglion. These 
cells either (1) connect to cells from laminae IV, V and VI, and serve as propriospinal neurons and 
interneurons, (2) project to the contra- and ipsilateral spinothalamic tract, or (3) respond to light 
touch (Rexed, 1952, Rexed 1954, Brown, 2012). Lamina V and VI receive proprioceptive afferents 
from muscle spindles, joint and tendon receptors, and send information of body and limb position to 
the posterior spinocerebellar tract (Rexed, 1952, Rexed, 1954, Brown, 2012). Lamina VII receives 
information from lamina II-VI, and from visceral fibers and project to (1) visceral motor neurons, (2) 
ipsilateral posterior spinocerebellar tract, (3) ipsilateral anterior spinocerebellar tract or (4) 
sympathetic (T1-L3) or parasympathetic fibers (S2-S4) (Rexed, 1952, Rexed, 1954, Brown, 2012). The 
ventral horns involve Lamina VIII and IX and are present throughout the cord. They comprise mainly 
α-motor neurons, but also smaller β- and γ-motor neurons are present projecting to skeletal muscle 
(α), respectively to muscle spindles (γ), or both (β). The ventral horns possess a somatotopic 
organization with proximal motoneurons located in the medial part of the horns, and distal 
motoneurons located in the lateral part of the horns (Lamb, 1976). Lamina X connects the left and 
right grey matter and contains decussating commisural axons. 
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Figure 1: Cross-section of the spinal cord with whiter matter tracts (left) and grey matter columns 
(right).  
1.2 Dysfunction of the spinal cord: Traumatic spinal cord injury 
1.2.1 Epidemiology of spinal cord injury 
SCI results from damage to the spinal cord and is a devastating event impacting the life of patients 
permanently. SCI is typically classified in traumatic and non-traumatic injuries. Causes of non-
traumatic SCI include spinal ischemia, compression by tumors or degenerative diseases (e.g. 
osteoarthritis) (Kakulas, 1999). In contrast, causes of traumatic SCI vary depending on the country, 
but include motor vehicle accidents, falls, sports accidents and violence (Wyndaele and Wyndaele, 
2006). 
Worldwide, numbers of people suffering from SCI are estimated to be between 2 and 6 millions, 
mostly affecting young men (mean age: 33 years, prevalence: 3.8 times higher in men) (Wyndaele 
and Wyndaele, 2006). Although two thirds of all SCI are attributed to young people, the numbers of 
elderly people (> 60 years) suffering from a SCI has doubled in the last 10 years (Sekhon and Fehlings, 
2001). Despite extensive rehabilitation programs, most patients are left with profound and persistent 
functional impairments such as motor deficits, sensory dysfunction, urological problems, and the 
emergence of neuropathic pain as a secondary complication (Siddall et al. , 1999, Siddall et al. , 2003, 
Cruz-Almeida et al. , 2005, Finnerup et al. , 2014). Patients being admitted without any function 
below the level of lesion usually show no or limited recovery, whereas patients with partially 
preserved sensorimotor function are able to undergo a more significant recovery like regaining hand 
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function or walking skills (Curt, 2008). Up to the present day, no treatment is available ameliorating 
neurological dysfunction. However, as the quality of emergency and primary care has improved over 
the last decades, life expectancy of SCI patients is similar to non-injured population (Fawcett et al. , 
2006). Consequently, even after rehabilitation, most patients need regular medical checkups as they 
suffer from secondary health challenges, therapy to maintain their functional status, and/ or 
assistance in daily aspects of life (Kennedy et al. , 2006). Given the young average age of patients and 
the long-term consequences, SCI leads to a tremendous socio-economical impact with high costs 
arising from acute hospitalization, rehabilitation and on- going treatment and assistance (Dryden et 
al. , 2005). Novel therapeutical and pharmacological approaches are therefore highly needed to 
improve patients’ quality of life and reduce health costs. 
1.2.2 Classification and assessments of spinal cord injury 
There are different ways to assess neurological and functional deficits after SCI. Here, the main 
methods are elucidated, which are routinely used in a clinical setting. 
1.2.2.1 Clinical Assessments 
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) 
The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) is used as a 
gold standard for assessing motor and sensory deficits, the level injury and completeness as 
measured by the American Spinal Injury Association (ASIA) Impairment Scale (AIS) (Kirshblum et al. , 
2011).  
Crucially, to assess motor deficits, five key muscles representing spinal segments of the upper and 
lower extremities are tested and graded from zero (total paralysis) to five (active movement against 
full resistance). Sensory deficits are assessed by using light-touch and pin-prick on each dermatome 
to test dorsal column and spinothalamic tract function, graded from zero (absent sensation) to two 
(normal sensation). Depending on the extent of spared sensorimotor function below the level of 
lesion, the neurological completeness is classified in categories from A to E (Table 1). 
Although this assessment is considered to be the gold standard, this clinical test depends on the 
patient’s subjective perception, suffers from a rather high inter-rater variability and lacks sensitivity 
to minimal changes in motor and sensory functions (Ellaway et al. , 2011). The ISNCSCI classification 
and its associated scoring system is therefore insufficient to accurately predict a patient’s outcome.  
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AIS  Functional complet-
ness of injury  
Motor function below level of injury  Sensory function 
below level of injury  
A  Complete  No  No  
B  Incomplete  No  Yes  
C  Incomplete  Yes, and more than half of the key 
muscles below the neurological level 
show a muscle grad less than 3 (grade 
0-2)  
Yes  
D  Incomplete  Yes, and more than half of the key 
muscles below the neurological level 
show a muscle grad equal or greater 
than 3 (grade 3-5)  
Yes  
E  Restutio ad integrum  Yes  Yes  
Table 1: Classification of spinal cord injury according to the American Spinal Injury Association (ASIA) 
Impairment Scale (AIS). 
GRASSP 
The Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP) was developed 
to reliably evaluate changes in upper limb impairment/function (Kalsi-Ryan et al. , 2012ab). In 
particular, this multimodal test includes (1) dorsal und (2) palmar sensation tested with Semmes-
Weinstein monofilaments, graded from zero to two according to the ISNCSCI, (3) strength of 10 
upper limb key muscles, graded from zero to five according to the ISNCSCI, (4) qualitative grasping, 
and (5) quantitative grasping involving different tasks of daily life. 
SCIM 
The Spinal Cord Independence Measure (SCIM) is a disability scale to define daily-life independence 
of patients after SCI. It involves questions about (1) self-care, (2) respiration and sphincter 
management, and (3) mobility (Itzkovich et al. , 2007). 
1.2.2.2 Neurophysiological assessments 
Neurophysiological assessments complement clinical assessments by supplementing them with 
information about the integrity of different tracts. This involves primarily the assessment of motor 
tracts by transcranial magnetic stimulation (TMS), somatosensory evoked potentials (SSEPs) to assess 
the integrity of large diameter fibers within the dorsal columns (Dawson, 1947, Kramer et al. , 2008), 
and contact heat evoked potentials (CHEPs) to assess integrity of small diameter fibers within the 
spinothalamic tracts (Chen et al. , 2001, Kramer et al. , 2012). In addition, nerve conduction 
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assessments provide information about the central and peripheral conduction of sensory and motor 
neurons (Kimura, 1984), and sympathetic skin assessments provide information about the 
autonomous nervous system (Kucera et al. , 2004). 
1.2.2.3 Neuroimaging 
After SCI, structural T1- and T2-weighted MRI is the gold standard to determine the level and extent 
of the injury. Standard clinical sequences provide insights into vertebral injury, ligamentous 
disruption, disc protrusion, site of maximal spinal cord compression and type of cord injury, and is 
clinically used to define whether decompressive or reconstructive surgery is needed (Chandra et al. , 
2012). Additionally, such sequences can depict macro-structural intramedullary changes such as the 
evolution of hemorrhage, edema, cord swelling, and dynamics of lesions. 
When applying spinal MRI in a clinical setting, an important criterion for feasibility of sequences is 
time. Unfortunately, advanced, time-saving imaging techniques rely on fast gradient-echo sequences 
such as echo-planar imaging, which come with major technical challenges. Specifically, the spinal 
cord is (1) surrounded by many different tissue types, resulting in susceptibility artefacts (Posse and 
Aue, 1990), (2) affected by physiological motion leading to the generation of artefacts (Zaitsev et al. , 
2015), and (3) a small structure which needs high resolution to be properly imaged (Stroman et al. , 
2014). Despite these challenges, novel innovative spinal structural sequences have recently advanced 
the neuroimaging field. This includes for example structural sequences providing higher in-plane 
resolution and optimized contrast (e.g. multiple echo data image combination (MEDIC) (Schmid et al. 
, 2005)) allowing disentangling effects within white and grey matter (Martin et al. , 2016). In addition, 
technical advances in spinal diffusion-weighted imaging (DWI) include a reduced field of view (FOV) 
which allows for higher in-plane resolution, and reduced acquisition time and artefacts. This enables 
improved mapping of diffusion processes capable of revealing changes within white matter tracts, 
which are related to axonal integrity and myelin content (Schmierer et al. , 2004, Schmierer et al. , 
2008). Recent developments in spinal magnetic resonance spectroscopy (MRS) included the usage of 
saturation pulses (Edden et al. , 2006), higher order shimming (Hock et al. , 2013a) and non-water 
suppressed spectroscopy (Hock et al. , 2013b) with B0 frequency alignment, allowing to detect 
metabolic alterations within the tiny spinal cord. 
At the brain level, clinically feasible quantitative imaging has recently become available and has the 
potential to measure neuronal changes at the microstructural level by applying physical models 
(Weiskopf et al. , 2013, Callaghan et al. , 2014). This is because the amount of myelination, iron 
content and neuronal microstructure is reflected in MR relaxation times, proton density and 
magnetization transfer (Stüber et al. , 2014). Quantitative imaging protocols usually consists of 
multiple images with varied acquisition parameters like magnetization transfer saturation (MT), 
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longitudinal relaxation rate (R1=1/T1) and effective transverse relaxation rate (R2*). In particular, it 
was shown that R1 relates to myelination/ demyelination (Mottershead et al. , 2003, Schmierer et al. 
, 2008 , Lutti et al. , 2014), proton density (Gelman et al. , 2001, Rooney et al. , 2007, Harkins et al., 
2016), and lipid content (Stanisz et al. , 2005). MT is sensitive for myelination/ demyelination 
(Schmierer et al. , 2004, Dula et al. , 2010, Turati et al. , 2015) and R2* is sensitive to iron (Hankins et 
al. , 2009, Lemasson et al. , 2013). Such measures are unbiased and independent of the scanner used, 
which might facilitate multicenter studies (Weiskopf et al. , 2013). 
1.3 Pathophysiology of traumatic spinal cord injury 
The pathophysiology of acute traumatic SCI consists of a primary injury mechanism, which is caused 
by the initial trauma, and a secondary injury mechanism, followed with a time lag, which is 
characterized by additional processes further exacerbating and manifesting the initial functional 
deficits. 
1.3.1 Primary injury 
In traumatic SCI, the mechanical impact causes cell damage to neurons and glial cells, leads to blood 
vessel disruption and interruption of axons within the spinal cord (Dumon et al. , 2001). Additionally, 
SCI can also harm the surrounding structures resulting in bone fracture, ligamentous injuries and 
dislocation of fragments or disc material which can also harm the spinal cord (McDonald and 
Sadowsky, 2002). Depending on the injury morphology, neurons and their axons may only show signs 
of transection or in addition also be compressed, stretched and dislocated (Bunge et al. , 1993) . This 
primary injury largely determines the clinical status of the patient at admission (Dumont et al. , 
2001). 
At the molecular level, different cascades are triggered as a response to the mechanical insult that 
occur within minutes to days after injury. Within minutes, TNF-α gets upregulated and acts as a 
proinflammatory cytokine (Yang et al. , 2004). Together with the release of erythrocytes and serum 
constituents from damaged blood vessels, this leads to an edematous swelling of the spinal cord 
(Kakulas, 1984). Depending on the venous blood pressure, the swelling of the cord can result in 
secondary ischemia (McDonald and Sadowsky, 2002). Apart from TNF-α, many other inflammatory 
molecules get activated within the first 24 hours after injury which subsequently leads to the 
activation of neutrophils and macrophages. Neutrophils activation then primarily results in additional 
cord swelling (McDonald and Sadowsky, 2002), whereas macrophages are involved in coagulate 
necrosis with prominent ischemic cell change (Buss et al. , 2004). Later on, astrocytes invade the 
epicenter of the lesion (Nagamoto-Combs et al. , 2007), and eventually become reactive in the 
secondary injury cascade.   
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1.3.2 Secondary damage 
The primary SCI is followed by a second phase which can exacerbate the primary damage and 
therefore additionally limit regeneration. In our current understanding, one of the main factors 
triggering the secondary injury cascade involves the local disturbance of blood supply (Schwab and 
Bartholdi , 1996; Lee et al. , 1999; Dumont et al. , 2001). Most important, the damage of cells, myelin 
and blood vessels leads to a toxic microenvironment, setting adjacent neurons in the penumbra at 
risk (for a review see Rolls et al. , 2009). To prevent further damage, reactive astrocytes form a 
persistent dense scar tissue around the lesion (Faulkner et al. , 2004). The downside of this process is 
that the glial scar itself acts as a physiological barrier, and in addition contains extracellular matrix 
molecules including chondroitin sulphate proteoglycans which inhibit axonal regrowth (Fawcett and 
Asher , 1999). 
1.4 Using advanced structural MRI to track pathophysiological events after 
spinal cord injury 
As described in chapter 1.2.2.3, several new MRI sequences emerged within the last years which are 
clinically applicable and provide information on tissue microstructure. Because the injury site 
contains the primary information about the recovery potential (chapter 1.3), most preclinical MR 
studies focused on identifying changes at the lesion site (Sundberg et al. , 2010, Li et al. , 2015). 
Unfortunately, the application of such sequences at the lesion site in humans is hampered by metal 
artefacts induced by vertebral fixations. Because the CNS is organized in hierarchical levels, which 
depend on each other (Freund et al. , 2016), it is assumed that a SCI leads to changes within 
damaged networks. Specifically, changes at the cord level can lead to appropriate spinal circuit 
remodeling (Filli et al. , 2015), which may also lead to changes in cortical networks, trackable by 
means of MRI. Based on this concept, MRI studies have started to elucidate remote changes above 
the level of injury by taking advantage of advanced imaging techniques. These studies are briefly 
summarized in this chapter. 
1.4.1.1 Remote spinal changes 
Two months after injury, decreases of spinal cord area above the level of injury are already evident in 
patients (Freund et al. , 2013a, Hou et al. , 2016). This decrease linearly progressed over the first year 
after injury, resulting in spinal atrophy of about 7% (Freund et al. , 2013a). In chronic SCI patients, 
spinal cord atrophy of up to 30% was observed (Cohen-Adad et al. , 2011, Freund et al. , 2011a, 
Lundell et al. , 2011) which presumably represents the endpoint of neurodegenerative events 
including demyelination and neuronal degeneration. In line, white matter integrity within the 
sensorimotor tracts were altered in chronic SCI patients, as assessed by means of diffusion and 
magnetization transfer imaging (Cohen-Adad et al. , 2011, Freund et al. , 2011a, Petersen et al. , 
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2012, Koskinen et al. , 2013). Recent longitudinal MRI studies in animals showed that transected 
axons caused subsequent disintegration of the spinal cord, with demyelination spreading rostrally 
and caudally, resulting in spinal atrophy (Rao et al. , 2013). Crucially, the amount of atrophy was 
related to the sensorimotor outcome (Cohen-Adad et al. , 2011, Lundell et al. , 2011, Freund et al. , 
2012ab, Freund et al. , 2013a, Grabher et al. , 2015, Ziegler et al. , 2018). 
1.4.1.2 Remote supraspinal changes 
Further upstream, chronic SCI patients exhibit atrophy of primary sensorimotor cortex (Freund et al. , 
2011a, Jurkiewicz et al. , 2006, Wrigley et al. , 2009a, Jutzeler et al. , 2016), decreased volumes in the 
pyramids (Freund et al. , 2013, Jutzeler et al. , 2016), in sensorimotor brainstem pathways (Grabher 
et al. , 2017), and in the limbic system (Jutzeler et al. , 2016). In line, studies in rats showed altered 
tract integrity of the internal capsule and the pyramids (Guleria et al. , 2008, Jirjis et al. , 2016) 
suggestive of Wallerian degeneration and demyelination. In recent longitudinal studies, the temporal 
evolution of these changes was addressed in subacute SCI patients. Specifically, such changes 
occurred within the first month after SCI, and were paralleled by microstructural changes indicative 
of demyelination, iron accumulation and neuronal degeneration (Freund et al. , 2013a, Grabher et al. 
, 2015, Grabher et al. , 2017, Ziegler et al. , 2018). Importantly, the amount of structural brain 
changes were associated to sensorimotor outcome (Jurkiewicz et al. , 2006, Freund et al. , 2013a, 
Grabher et al. , 2015, Grabher et al. , 2017, Ziegler et al. , 2018). 
1.5 Starting points for future therapies 
To overcome the limited capacity for recovery, several new therapeutical approaches emerged 
within the last years, which can be attributed to four main mechanisms (Schwab, 2002). These 
approaches will be briefly explained, and the current status of such applications in humans will be 
discussed. 
1.5.1 Enhancing regenerative sprouting 
Although peripheral nerves are capable of reinitiating axonal growth after damage (Fawcett and 
Keynes, 1990), sprouting of transected axons in the CNS is limited as different inhibitory proteins 
block neurite outgrowth (Caroni and Schwab, 1988). The main neurite outgrowth inhibitor is Nogo-A, 
whose blocking with Anti-Nogo A antibody has been extensively investigated in different preclinical 
models over the last two decades (Merkler et al. , 2001, Foud et al. , 2004, Liebscher et al. , 2005, 
Freund et al. , 2007). Neutralizing Nogo-A leads to greater axonal sprouting which results in a 
meaningful rewiring and therefore enhances functional recovery (Liebscher et al. , 2005, Freund et al. 
, 2006). The first clinical trial in humans was conducted between 2006 and 2011 (NCT00406016 
identified in clinicaltrials.gov), and showed that Anti-Nogo A antibodies are safe and well tolerable. 
Next steps include a placebo-controlled phase II clinical trial to proof efficacy of the drug. 
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1.5.2 Crossing the glial scar 
The glial scar serves as a physical barrier to axonal regrowth, and in addition, contains neurite-growth 
inhibitory molecules like chondroitin sulphate proteoglycans (CSGPs) acting as a chemical barrier to 
the process of neuroregeneration (McKeon et al. , 1991, Fawcett and Asher, 1999, Roitbak and 
Syková, 1999). To enable fibers to cross the lesion site, different approaches have been suggested 
and tested in preclinical models: (1) inhibition of CSGP using chondroitinase ABC (Bradbury et al. , 
2002), (2) applying neurite growth-promoting molecules by either a pump or modified gene (Bunge, 
2001) and (3) implantation of scaffolds into the lesion site (Tsintou et al. , 2015). Of these, only 
scaffolds have so far made it to the application in human clinical trials (NCT02688049, NCT02510365, 
NCT02352077, NCT02138110, NCT02688062, NCT03105882, NCT02326662 identified in 
clinicaltrials.gov), which are partially seeded with stem cells (NCT02688049, NCT02352077, 
NCT02326662 identified in clinicaltrials.gov). 
1.5.3 Repairing myelin 
SCI does not only lead to demyelination of directly injured axons, also surviving bundles of nerve 
fibers often lose their myelin after injury (Schwab, 1996; Kakulas, 1999, Norenberg et al. , 2004, 
Guest et al. , 2005). This loss of myelin leads to an abnormal or absent conduction of action 
potentials, which is not restored in the adult nervous system (Schwab, 2002, Guest et al. , 2005). 
Therefore, strategies aiming at myelin repair, like the Schwann cell autotransplantation (Evercooren 
et al. , 1997), or the transplantation of embryonic stem cells which subsequently develop to myelin-
producing oligodendrocytes (Liu et al. , 2000), have shown to be successful approaches for 
remyelination. Autologous human Schwann cells (NCT01739023, NCT02354625 identified in 
clinicaltrials.gov) and oligodendrocytes progenitor cells (NCT02302157 identified in clinicaltrials.gov) 
are currently being tested in phase I clinical trials.  
1.5.4 Enhancing central neuroplasticity 
The forth approach relies on central neuroplastictity, which might account for spontaneous recovery 
occurring in SCI patients. Such neuroplasticity includes the formation of new circuits through 
collateral sprouting of damaged and undamaged tracts, and synaptic plasticity in unaffected 
pathways (Raintenau and Schwab, 2001, Bareyre et al. , 2004, Ballermann and Fouad, 2006, Courtine 
et al. , 2008, Rosenzweig et al. , 2010). In contrast to regenerative sprouting, this mechanism 
presents not a “true” repair strategy, but the usage of alternative or detour pathways. Most 
therapeutical interventions aiming at regeneration are not specific to this process, and will likely also 
enhance compensatory growth (Schwab, 2002). Inter alia, such processes can be enhanced by 
applying neurotrophic factors (Bregman et al. 1997, Grill et al. , 1997, Bregman et al. , 2002). 
However, as such treatments have the highest chance to succeed in incomplete patients, who have 
anyway high rates of spontaneous recovery, it will be very challenging and difficult to detect 
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treatment effects (Blesch and Tuszynksi, 2009). So far, no clinical trial has started which specifically 
targets neuroplasticity. 
1.5.5 Issues in validating future therapies 
Due to the complexity of different mechanisms occurring after SCI, it is very likely that only a 
combination of treatment approaches will lead to the amelioration of functional  impairments 
(Bunge, 2001). To identify most promising therapies or combination of therapies, the field urgently 
needs biomarkers to stratify patients into homogenous subgroups within clinical trials, and 
subsequently delineate treatment effects from spontaneous recovery. 
1.6 Improving the validation of future therapies by the use of 
neuroimaging biomarkers 
1.6.1 Motivation for biomarker development 
Although several new clinical trials within the SCI field have emerged in recent years, it should be 
considered that less than 10% of all Phase I trials actually succeed to the make it on the market (CMR 
International, 2006), resulting in unsustainable increase in research and development cost. The main 
reason for this early drugs failure is the inability to show adequate efficacy or poor safety (Kola and 
Landis, 2004). As SCI is a heterogeneous disease, we need on one hand an increased understanding 
of SCI pathophysiology to identify potential responders to existing treatments; on the other hand it is 
essential to confirm drug pharmacology in initial human studies and terminate them if they show 
inadequate pharmacology (Peck, 2007). Unfortunately our current assessments, mostly rely on 
patient’s subjective perception and are insensitive to minimal changes, making prediction of 
outcome still challenging (Wilson et al. , 2012; Tanadini et al. , 2014). Finding biomarkers, defined as 
markers of pharmacologic responses to a therapeutic intervention (Biomarkers Definitions Working 
Group, 2001), which are predictive of safety or efficacy in Phase I and II clinical trials would allow 
better determining potential success of a treatment. In addition, such biomarkers would drastically 
decrease persisting developmental, but also socio-economical costs. 
1.6.2 Biomarkers as surrogate endpoints  
In a clinical study, primary endpoints are defined to identify treatment effects and are characterized 
by measures which consider a patient’s subjective feelings and functions (Biomarkers Definition 
Working Group, 2001). There is broad agreement that the patient’s subjective perception of his or 
her current status is the most relevant goal, and therefore should be the primary endpoint in all 
biomedical research (De Gruttola, 2001). On the other hand, a biomarker is an objective, quantifiable 
characteristics of a biological process, but does not necessarily correlate with a patient’s perception 
of his or her status (Strimbu and Tavel, 2010). Therefore, when biomarkers are used within clinical 
trials, they are considered as a substitute or “surrogate” for a clinical endpoint, which are expected 
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to predict clinical benefit or harm (Biomarkers Definitions Working Group, 2001). This means, that 
not all biomarkers are surrogate markers – they are rather a small subgroup of well-characterized 
biomarkers with well-defined clinical relevance and related to the pathophysiology of the disease 
(Strimbu and Tavel, 2010). 
1.6.3 Biomarker identification: When a biomarker becomes a surrogate marker 
Finding reliable surrogate markers usable within clinical trials is a time-consuming process, with 
phases comparable to a clinical trial itself (Fig. 2). Similar to preclinical phases in clinical trials, we first 
need to understand the natural history of SCI, the degree and time course of spontaneous recovery 
(Lammertse, 2007) and develop quantitative MRI sequences which are sensitive and comparable 
across different sites. Then, here called phase I, quantitative MRI sequences are applied in chronic 
and acute SCI patients and their proximity to clinical outcome (i.e. measures which serve as a primary 
endpoint in clinical trials) is examined. To reduce false positive results, it is important to base analysis 
on plausible biological hypotheses, which have the potential to pick up changes of the disease 
process (e.g. demyelination, degeneration). In phase II, the biomarker’s effectiveness or utility as a 
surrogate marker is investigated. This is achieved by longitudinally assessing the sensitivity and 
specificity of the biomarker on interventions. Last, in phase III/IV, surrogate markers need to be 
evaluated in prospective cohort, which could be within a clinical trial. Please note that these stages 
are not stringently in order, they can and need to overlap with each other. 
 
Figure 2: Stages of MR biomarker/ surrogate marker development 
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1.7 Aims 
The overall objective of this thesis was to better understand trauma-induced structural changes at 
different levels of the neuraxis (at and above the level of injury), and to explore the relationships 
between MRI readouts, and electrophysiological and functional outcome. In particular, this thesis 
investigates new imaging methods which can assess microstructural changes not visible on 
conventional diagnostic imaging methods. For this goal, following aims were specifically addressed: 
At the lesion site: 
1) Treatments of the injured cord will likely depend on the existence of tissue bridges. We 
therefore wanted to characterize temporal changes at the lesion site and investigate their 
predictive capability of outcome after cervical SCI. 
At the cervical cord above the level of lesion: 
2) Previous studies have shown cervical cord atrophy of up to 30%. Here we assessed 
underlying tissue-specific grey and white matter changes using high-resolution structural and 
diffusion-weighted sequences, and investigated their relationship to lesion severity and 
outcome. 
3) Following up on question 2), we investigated in a further study underlying molecular changes 
that may subtend the development of atrophy using spinal MRS, and investigated their 
relationship to atrophy, lesion severity and outcome. 
At the brain level: 
4) Structural changes of the pyramidal, sensory and limbic system have already been 
characterized after SCI. Animal models suggest that the extrapyramidal system, like the basal 
ganglia, plays a role in recovering motor function. We therefore investigated the spatial and 
temporal evolution of structural and microstructural changes and their association to 
outcome after SCI. 
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2.1 Abstract 
T2-weighted scans provided data on the extent and dynamics of neuronal tissue damage and 
midsagittal tissue bridges at the epicenter of traumatic cervical spinal cord lesions in 24 subacute 
tetraplegic patients. At 1 month post injury, smaller lesion area and midsagittal tissue bridges 
identified those patients with lower extremity evoked potentials and better clinical recovery. Wider 
midsagittal tissue bridges and smaller lesions at 1 month post-injury were associated with 
neurological and functional recovery at 1-year follow-up. Neuroimaging biomarkers of lesion size and 
midsagittal tissue bridges are potential outcome predictors and patient stratifiers in both subacute 
and chronic clinical trials.  
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2.2 Introduction 
In spinal cord injury (SCI), magnetic resonance imaging (MRI) is the most sensitive imaging modality 
to uncover the level and extent of spinal cord damage. Relationships exist between clinical 
impairment at admission (Miyanji et al. , 2007, Le et al. , 2015) and discharge (Mabray et al. , 2016) 
and acute (<48 hours) MRI biomarkers (hemorrhage (Miyanji et al. , 2007), lesion length (Le et al. , 
2015), spinal canal compression (Miyanji et al. , 2007, Mabray et al. , 2016). However, these acute 
biomarkers have limited prognostic value for late outcome (Miyanji et al. , 2007). Signal alterations 
attributed to edema and hemorrhage, which resolve only after weeks (Shimada et al. , 1999), hinder 
the accurate assessment of neuronal tissue damage and the amount of tissue sparing at the earliest 
stages post-injury. 
Moreover, the sequela of tissue damage at the lesion epicenter and the optimal time points for 
characterization of neuronal tissue damage are unknown, because longitudinal MRI assessments are 
not standard care in SCI. Whereas post-traumatic cyst development is common in SCI (Wang et al. , 
1996), its incidence and pathophysiology are incompletely understood. Residual tissue bridges 
spanning the lesion has been less studied, although these tissue bridges may be associated with 
improved recovery (Metz et al. , 2000). Treatments aiming at the repair of the injured spinal cord 
(Guest et al. , 1997, Silver and Miller , 2004, Freund et al. , 2006) will likely depend on such tissue 
bridges (Krishna et al. , 2014). 
Identifying the extent of tissue damage and bridges post-SCI might be useful for prognostication, 
evaluating treatment efficacy, and stratifying patient cohorts in clinical trials (Wang et al. , 2011, 
Nagoshi et al. , 2015). Here, we report on detailed insights into structural cord damage using 
longitudinal MRI with specific emphasis on the presence and persistence of midsagittal tissue 
bridges, their electrophysiological conductivity, and predictive value for clinical recovery in sub-acute 
cervical SCI patients. 
2.3 Materials and Methods 
2.3.1 Experimental Design 
Twenty-four patients with acute cervical traumatic SCI, admitted consecutively to University Hospital 
Balgrist (Zurich, Switzerland) between December 2005, and July 2014, were included in this study 
(Freund et al. , 2013a, Grabher et al. , 2015). The local ethics committee approved the study protocol 
and all patients gave informed, written consent. 
In all patients, MRI data were acquired at approximately 1 month post-injury. Thirteen patients were 
additionally followed up with 100% compliance at 3, 6, and 12 months postinjury. At all time points, 
all patients were clinically assessed using the international standards for the neurological 
Study I 
 
Tracking structural changes in spinal cord and brain after SCI 33 
classification of SCI protocol (ie, upper (UEMS) and lower (LEMS) extremity motor scores and light-
touch and pin-prick scores), the Spinal Cord Independence Measure (SCIM) and the Graded 
Redefined Assessment of Strength, Sensibility and Prehension (GRASSP). SCIM data were missing for 
2 patients (1 at 3 and 1 at 6 months) whereas GRASSP data were missing from 1 patient at 3 months. 
The GRASSP test was not available for 8 patients because their injuries date back before the 
introduction of this test. 
2.3.2 Electrophysiological recordings 
We obtained motor (MEPs) and sensory (SEPs) evoked potentials at 3 months post-injury according 
to standard protocols (Curt et al. , 2008). MEPs were recorded bilaterally over the tibialis anterior 
(TA) and abductor hallucis (AH). Bilateral tibialis nerves were stimulated for the SEP recordings. For 
MEPs and SEPs, amplitudes and latencies were calculated. 
2.3.3 MRI 
From the 24 patients, 14 were scanned with a 3 Tesla (T) MRI scanner and 10 with a 1.5T MRI 
scanner. From the 14 patients scanned at 3T, 8 were scanned with a 3T Magnetom Verio MRI 
scanner and 6 with the updated 3T Magnetom Skyrafit scanner (Siemens Healthcare, Erlangen, 
Germany). From the 10 patients scanned at the 1.5T scanner system, 4 were scanned with a 
Magnetom Symphony, 3 with a Magnetom Espree, 2 with Magnetom Avanto (all Siemens 
Healthcare), and 1 with Signa HDx (GE Medical Systems, Waukesha, WI). All scanners were operated 
with a 16-channel receive head and neck coil. A standardized imaging protocol was used, based on 
product sequences including a sagittal T1-weighted (for 1.5T: repetition time [TR] = 561ms; echo time 
[TE] = 11ms; flip angle = 150 degrees; for 3T: TR = 540ms; TE = 10ms; flip angle = 150 degrees), a 
sagittal T2-weighted (T2w; for 1.5T: TR = 4,188ms; TE = 113ms; flip angle = 150 degrees; for 3T: 
TR = 3,430ms; TE = 90ms; flip angle = 150 degrees), and an axial T2w image (for 1.5T: TR = 5,170ms; 
TE = 100ms; flip angle = 150 degrees; for 3T: TR = 4,190ms; TE = 100ms; flip angle = 150 degrees). 
Axial and sagittal images were acquired using the same coordinate system in order to accurately 
identify the mid-sagittal slice. For the qualitative analysis, all sequences were considered. The sagittal 
T2-weighted images were used for quantitative analysis (for 1.5T: 0.55 × 0.55 × 2.75mm; for 3T: 
0.57 × 0.57 × 2.75mm) of lesion size and midsagittal tissue bridges. 
2.3.4 Image Analysis 
Imaging at 1 month was used to classify whether a lesion (high-intense signal change on T2-weighted 
image), edema, and/or hemorrhage were present. Two raters, blinded to patient identity and scan 
time point, assessed the anterior-posterior width, rostrocaudal length, and total area of the lesion, 
and the width of tissue bridges on the midsagittal slice using Jim6.0 (Xinapse Systems, Aldwincle, UK) 
at all time points (Fig. 3). Inter- and intraobserver reliability was assessed for all quantitative MR 
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parameters in 10 randomly selected scans, by calculating the coefficient of variation (COV). Mean 
intra- and interobserver COV for all measures was remarkably low, with 4.3% and 5.2%, respectively. 
Figure 3: (A–C) Overview of quantitative magnetic resonance imaging (MRI) indices (LW, LL, LA, DB, 
and VB) assessed at the lesion site within the cervical cord using the midsagittal slice. (A) Typical T2-
weigthed MRI of the lesion epicenter from 1 spinal cord injury patient. (B) Schematic drawing of the 
MRI parameters analyzed. (C) T2-weigthed midsagittal slice overlaid with the MRI lesion parameters 
in 1 patient. (D) Evolution of a post-traumatic cyst with persisting midsagittal tissue bridges shown 
over the course of the first year postinjury. DB = dorsal midsagittal tissue bridges; LA = lesion area; 
LL = lesion length; LW = lesion width; VB = ventral midsagittal tissue bridges. 
2.3.5 Statistical Analysis 
Stata software (version 13; StataCorp LP, College Station, TX) was used for statistical analysis. Rates 
of change of MRI readouts and clinical recovery were estimated with linear mixed-effects models 
with the MRI parameter or clinical measure as response variable and time as predictor. For clinical 
measures, time post-injury was modeled on a log scale to account for nonlinear recovery patterns, 
whereas a quadratic term in time was added to model nonlinear changes for all MRI measures 
(Freund et al. , 2013a). Linear regression models identified associations between the 1-month 
quantitative MRI parameters and clinical outcomes at 12 months, adjusted for age. For associations 
between midsagittal tissue bridges and clinical outcomes, only those patients with tissue bridges 
(mid- or parasagittal) entered the regression analysis. 
2.4 Results 
Twenty-four patients had acute traumatic cervical SCI (20 men, age [mean ± standard deviation] 
46.58 ± 18.96 years). The interval between baseline and 1-month scan was 38.13 ± 16.71 days 
(n = 24), 3 months 95.1 ± 38.0 days (n = 13), 6 months 198.1 ± 39.3 (n = 13), and 12 months 
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390.2 ± 66.8 days (n = 13). Electrophysiological recordings were acquired at 87.92 ± 5.96 days post-
injury (n = 24). After surgical decompression, 6 were classified as complete (American Spinal Injury 
Association Impairment Scale [AIS] A) and 18 as incomplete (AIS B–D; Table 2). 
Within the first year, patients recovered, on average, 3.8 points/log-month on the UEMS (p < 0.001; 
95% confidence interval [CI]: 2.620, 4.897; n = 24), 2.6 points/log-month on the LEMS (p < 0.001; CI: 
1.339, 3.840; n = 24), 12.9 points/log-month in the SCIM (p < 0.001; CI: 8.218, 17.547; n = 24), 10.5 
points/log-month in the GRASSP (p = 0.001; CI: 4.158, 16.872; n = 16), and 2.5 points/log-month in 
the light-touch score (p = 0.030; CI: 0.236, 4.661; n = 24). Pin-prick score showed no significant 
recovery over time (p = 0.119; CI: −0.64, 5.62; n = 24). 
2.4.1 Lesion Characteristics and Changes Over Time 
At 1 month, a lesion (ie, high-intense signal on the sagittal T2-weighted image) was visible in all 
patients and a subset of patients showed hemorrhage (n = 5) and edema (n = 15). In 23 of 24 
patients, tissue bridges (midsagittal and/or parasagittal) were identified whereas the cord was 
completely transected in 1 patient who was classified as AIS A (Table 3). Of the 20 patients with 
midsagittal tissue bridges, 14 had both ventral and dorsal tissue bridges, whereas the remaining 
patients had only a dorsal (n = 3) or ventral (n = 3) tissue bridge. 
In the 13 patients with serial MRI, lesion area declined by 6.73mm2/month (p = 0.027; CI: –12.671, 
−0.781) over time. The rate of decline decelerated (ie, a negative quadratic term) by 0.39mm2/month 
(p = 0.035; CI: 0.026, 0.742). Lesion width decreased by 0.40mm/month (p = 0.001; CI: −0.642, 
−0.159) with rate of decline decelerating at 0.02mm/month (p = 0.014; CI: 0.004, 0.034). Lesion 
length (p = 0.779) and the width of midsagittal tissue bridges (p = 0.425) remained essentially 
unchanged over time. 
2.4.2 Electrophysiological Conductivity Across the Lesion 
Lower extremity evoked potentials were abolished in all complete patients (AIS A; n = 6), although 
midsagittal tissue bridges were present in 2 of 6. Thickness of the midsaggital tissue bridges in the 2 
AIS A patients was thinner than the overall average of those found in 18 incomplete patients (AIS B–
E; Fig. 4AB). In these 18 incomplete patients, MEP and tibialis SEP latencies were recordable; the 
latencies prolonged (MEP: TA, 34.76 ± 6.84ms; AH, 44.22 ± 5.46ms; tibialis SEP: P40, 47.97 ± 4.44ms; 
N50, 56.06 ± 4.53ms) and the amplitudes reduced (MEP: TA, 0.45 ± 0.33mV; AH, 0.80 ± 0.90mV; 
tibialis SEP: 1.28 ± 1.09mV).  
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   ISNCSCI Outcome measures at 12-month 
ID Age at 
injury 
sex AIS at 
1-/ 12-
month  
Initial site of 
impairment 
(motor/ 
sensory) 
LEMS UEMS GRASSP SCIM Pin-
prick 
Light-
Touch 
1 41 m A/A C5/ C5 0 25 80 37 18 20 
2 32 m A/A C5/ C3 0 35 137 26 29 32 
3 30 m A/A C4/ C4 0 26 87 30 16 32 
4 27 m A/A C2/ C3 0 14 20 19 13 16 
5 17 m A/A C5/ C4 0 23 90 37 33 33 
6 29 m A/B C5/ C5 0 23 77 34 26 53 
7 30 m B/B C7/ C8 0 48 208 38 46 68 
8 51 m B/C C6/ C6 12 32 116 31 44 67 
9 70 m C/C C7/ C8 41 48 188 36 41 112 
10 65 m C/C C4/C3 23 16 NA 10 61 61 
11 53 f C/D C4/ C5 49 42 177 84 94 62 
12 22 m C/D C7/ C6 19 48 205 70 37 72 
13 59 m C/D C4/C4 32 38 NA 73 60 60 
14 41 m D/D C5/C6 47 44 NA 100 70 95 
15 30 m D/D C6/C6 46 45 NA 100 84 94 
16 65 m D/D C4/C3 40 34 NA 32 64 60 
17 63 f D/D C5/C5 49 47 NA 91 108 111 
18 65 f D/D C4/C5 50 36 172 99 58 64 
19 21 m D/D C5/C3 49 42 219 99 95 96 
20 62 m D/D C4/C4 47 41 NA 92 112 112 
21 66 f D/D C4/C4 50 45 129 98 70 60 
22 75 m D/D C4/C2 49 43 NA 79 112 112 
23 47 m D/D C5/ C4 47 35 130 98 97 98 
24 67 m D/E C3/ C3 50 50 227 100 102 107 
Table 2: Clinical and epidemiological data for all patients included in the study.  
Abbreviations: AIS = American Spinal Injury Association Impairment Scale, GRASSP = Graded and 
Redefined Assessment of Strength, Sensibility and Prehension; ISNCSCI = International Standards for 
Neurological Classification of Spinal Cord Injury; LEMS = Lower Extremity Motor Score; NA= not 
available; SCIM = Spinal Cord Independence Measure; UEMS = Upper Extremity Motor Score. 
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   Electro-
physiology 
MRI parameters 
ID Age at 
injury 
se
x 
Evoked 
potentials  
Magnetic 
field 
strength 
Size of midsagittal 
tissue bridges 
[mm] 
Para-sagittal 
tissue 
bridges 
Lesion size (area 
[mm2]/ length 
[mm]) 
1 41 m No 3T 0 No 33/ 18.6 
2 32 m No 3T 0 Yes 54.3/ 10.4 
3 30 m No 3T 0 Yes 123.9/ 18.4 
4 27 m No 3T 0 Yes 131.6/ 20.4 
5 17 m No 3T 1.5 Yes 256.4/ 32.3 
6 29 m No 3T 1.5 Yes 156.4/ 28.9 
7 30 m Yes 3T 0.6 Yes 35.5/ 7.2 
8 51 m Yes 3T 1.3 Yes 50.7/ 11.7 
9 70 m Yes 3T 0.5 Yes 55/ 10.5 
10 65 m Yes 1.5T 2.5 Yes 21.5/ 9.4 
11 53 f Yes 3T 2.2 Yes 18.6/ 8.1 
12 22 m Yes 3T 3.2 Yes 30.2/ 11.7 
13 59 m Yes 1.5T 3.4 Yes 4.5/ 3.3 
14 41 m Yes 1.5T 1.5 Yes 15.0/ 6.2 
15 30 m Yes 1.5T 2.1 Yes 11.3/ 4.7 
16 65 m Yes 1.5T 2.7 Yes 34.4/ 7.8 
17 63 f Yes 1.5T 2.8 Yes 30.5/ 7.8 
18 65 f Yes 3T 3.2 Yes 18.2/ 6.4 
19 21 m Yes 1.5T 3.3 Yes 21.0/ 5.3 
20 62 m Yes 1.5T 3.5 Yes 9.7/ 3.5 
21 66 f Yes 1.5T 3.7 Yes 21.3/ 8.7 
22 75 m Yes 1.5T 5.6 Yes 63.7/ 18.6 
23 47 m Yes 3T 5.9 Yes 4.5/ 3.3 
24 67 m Yes 3T 1.5 Yes 21.5/ 9.4 
Table 3: Electrophysiological and MRI data for all patients included in the study. 
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Figure 4: (A,B) Electrophysiological recordings across the tissue bridges. (A) Patients were grouped into two 
cohorts with (i./ ii.) and without (iii.) persisting tissue bridges. From most patients with tissue bridges, 
electrophysiological transmission was crossing the lesion and these patients showed better recovery of motor 
function below the level of lesion (i.). In patients without tissue bridges, no EPs and no recovery of motor 
function below the level of lesion was present (iii.). (B) Patients with midsagittal tissue bridges and recordable 
EPs (i.) showed a tendency toward wider tissue bridges than those with tissue bridges but without recordable 
EPs (ii.). (C) Correlations illustrating the relationship between magnetic resonance imaging (MRI) indices at 1 
month and clinical recovery at 1 year.  
EP = Evoked Potentials; GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension; 
LEMS = Lower Extremity Motor Score; MEPs = Motor-evoked Potentials; SCIM = Spinal Cord Independence 
Measure; SEPs = Sensory-evoked Potentials; UEMS = Upper Extremity Motor Score. 
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2.4.3 Clinical Associations 
Wider midsagittal tissue bridges at 1 month were associated with better LEMS (p = 0.008; R2 = 0.593), 
SCIM scores (p = 0.002; R2 = 0.365), pin-prick (p < 0.001; R2 = 0.475) and light-touch scores (p = 0.014; 
R2 = 0.255) at 1 year (Table 4). Smaller lesion area at 1 month was associated with better LEMS 
(p = 0.001; R2 = 0.408), UEMS (p = 0.005; R2 = 0.305), SCIM score (p = 0.019; R2 = 0.227), GRASSP 
(p = 0.013; R2 = 0.367), pin-prick (p = 0.005; R2 = 0.301), and light-touch scores (p = 0.016; R2 = 0.237) 
at 1 year. Smaller lesion length at 1 month was associated with better LEMS (p < 0.001; R2 = 0.448), 
UEMS (p = 0.005; R2 = 0.311), SCIM score (p = 0.020; R2 = 0.222), GRASSP (p = 0.009; R2 = 0.400), pin-
prick (p = 0.004; R2=0.321), and light-touch scores (p = 0.013; R2 = ;0.249) at 1 year. Smaller lesion 
width at 1 month was related to higher pin-prick score (p = 0.013; R2 = 0.247) at 1 year (Fig. 4C). 
2.5 Discussion 
This study characterizes the natural history of structural changes at the lesion site during the first 
year after traumatic cervical SCI. We uncovered the relationship between early MRI measures of 
lesion extent and midsagittal tissue bridges, and presence of evoked potentials and clinical recovery. 
In all patients, lesions were well demarcated at 1 month. The midsagittal tissue bridges that were 
identified in the majority of patients at 1 month were permissive for electrophysiological information 
flow. In the 13 patients with serial MRI, lesion area and width declined nonlinearly over time, 
whereas the size of midsagittal tissue bridges did not change significantly. Crucially, wider midsagittal 
tissue bridges and smaller lesions at 1 month post-injury were associated with enhanced clinical 
recovery at 1 year. 
Acute spinal MRI (<48 hours) is limited in its prognostic usefulness (Miyanji et al. , 2007); however, at 
1 month (i.e., subacute), lesion borders were clearly identifiable (Shimada et al. ,1999), allowing 
precise characterization of morphometric changes. Interestingly, already at 1 month, a post-
traumatic cyst had formed in all patients with relevant cord damage. Over 1 year, both lesion area 
and width declined at a decreasing rate, whereas lesion length remained essentially unchanged. The 
removal of granular debris and axon/myelin fragments at the lesion epicenter by cerebrospinal fluid 
circulation (Noble and Wrathall, 1985) may explain decreasing lesion size. Recovery of upper limb 
function at 1 year was associated with lesion area (i.e., intramedullary damage) at 1 month post-
injury. Because biological changes at the lesion site are complex and include death of motor neurons 
(Grumbles and Thomas, 2017) as well as axonal degeneration (Buss et al. , 2005), larger lesions might 
represent greater loss of motoneurons and axons. It is therefore possible that better recovery of 
upper extremity function was attributed to smaller lesions in which motor neuron pools innervating 
arm and hand muscles were less affected by trauma (Grumbles and Thomas, 2017). 
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Clinical measure at 1-
year follow-up 
(dependent variable) 
MR parameter at 1 
month 
(independent variable) 
n p R2 Standardized 
regression 
coefficient  
(95% CI) 
LEMS Midsagittal tissue bridges 23 0.008 0.593 6.034 
(1.751 10.317) 
 Lesion area 24 0.001 0.408 -0.230 
(-0.353 -0.108) 
 Lesion length 24 <0.001 0.448 -1.797 
(-2.679 -0.916) 
UEMS Lesion area 24 0.005 0.305 -0.097 
(-0.163 -0.033) 
 Lesion length 24 0.005 0.311 -0.733 
(-1.215 -0.251) 
GRASSP Lesion area 16 0.013 0.367 -0.535 
(-0.937 -0.132) 
 Lesion length 16 0.009 0.400 -4.504 
(-7.670 -1.338) 
SCIM score Midsagittal tissue bridges 23 0.002 0.365 12.293 
(4.927 19.658) 
927 19.658) 
 Lesion area 24 0.019 0.227 -0.258  
(-0.469 -0.048) 
 Lesion length 24 0.020 0.222 -1.900 
(-3.475 -0.326) 
Pin-prick score Midsagittal tissue bridges 23 <0.001 0.475 13.499 
(7.054 19.944) 
 Lesion area 24 0.005 0.301 -0.296 
(-0.495 -0.097) 
 Lesion length 24 0.004 0.321 -2.271 
(-3.731 -0.810) 
 Lesion width 24 0.013 0.247 -5.886 
(-10.427 -1.345) 
Light-touch Midsagittal tissue bridges 23 0.014 0.255 9.151 
(2.045 16.258) 
 Lesion area 24 0.016 0.237 -0.248 
(-0.444 -0.051) 
 Lesion length 24 0.013 0.249 -1.891 
(-3.343 -0.440) 
Table 4: Regression models predicting outcome at 1-year follow-up with quantitative MR measures 
at 1 month. N indicates number of subjects included in the regression models. All models are 
adjusted for age. Please note that for all correlations with tissue bridges, only those patients without 
complete cord transection were included.  
Abbreviations: GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension; LEMS 
= Lower Extremity Motor Score; UEMS = Upper Extremity Motor Score; SCIM = Spinal Cord 
Independence Measure. 
  
Study I 
 
Tracking structural changes in spinal cord and brain after SCI 41 
All incomplete patients (AIS B–D) showed midsagittal tissue bridges, the size and location of which 
remained stable over time. The presence and size of midsagittal tissue bridges was paralleled by 
recordable electrophysiological information flow across the lesion and clinical recovery below the 
lesion (eg, LEMS). Interestingly, only in 2 of 20 patients with thinner tissue bridges were evoked 
potentials not recordable. This suggests that a crucial amount of fibers permissive for 
electrophysiological information flow is necessary to drive the complex processes of recovery of 
function below the lesion level (Kakulas et al. , 1998, Courtine et al. , 2009). This structure-function 
relationship indicates that neuronal tissue within the tissue bridges contain fibers that conduct 
afferent and efferent information of ascending and descending pathways. Plastic changes, such as 
regenerative sprouting (Freund et al. , 2006) and formation of detour circuits (Davies et al. , 1997, 
Filli et al. , 2014), likely contributed to the (re-)occurrence of information flow fostering functional 
recovery. 
2.5.1 Limitations 
This study has some limitations. First, the ratio of males to females was not balanced and therefore 
might be a limitation to its generalizability. However, the high male/female ratio is indeed 
representative in SCI and therefore our cohort reflects the inhomogeneity observed in SCI (Curt et al. 
, 2008). Second, because we intended to find a simple, clinically feasible measurement, midsagittal 
tissue bridges might not best assess tissue bridges of descending white matter tracts given that these 
would be located more laterally. Future studies should attempt to quantify also parasagittal tissue 
bridges, which, however, require more sophisticated MRI protocols with higher in-plane resolution 
and better signal-to-noise ratio. All findings should be validated with a larger sample size before 
entering clinical trials and clinical practice for stratification of study cohorts and prediction of 
individual recovery of function. 
2.6 Conclusion 
Preserved midsagittal tissue bridges may be an important diagnostic criterion for cohort selection 
and stratification for regenerative treatment trials in acute and chronic SCI (Guest et al. , 1997, Silver 
and Miller, 2004, Freund et al. , 2006) and for supraspinal control during epidural stimulation 
(Harkema et al. , 2011). This study characterized the changes occurring at the lesion epicenter in the 
first year post SCI and identified in vivo tissue bridges as a vital substrate for clinical recovery in 
cervical SCI. As early biomarkers, midsagittal tissue bridges appear to be sensitive and accurate 
predictors of clinical outcome and hold significant potential, next to clinical measures, for use in 
clinical practice and clinical trials. Directions of future studies include addressing our limited 
understanding of the importance of location and integrity of tissue bridges by using high-resolution 
sequences of the spinal cord. 
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3.1 Abstract 
Objective: This study investigates whether grey matter pathology above the level of injury, alongside 
white matter changes, also contributes to sensorimotor impairments following spinal cord injury 
(SCI). 
Methods: A 3T MRI protocol was acquired in 17 tetraplegic patients and 21 controls. A sagittal T2-
weigthed sequence was used to characterize lesion severity. At the level C2/C3, a high-resolution 
T2*-weighted sequence was used to assess cross-sectional areas of grey and white matter including 
their sub-compartments; a diffusion weighted sequence was used to compute voxel-based diffusion 
indices. Regression models determined associations between lesion severity, tissue-specific 
neurodegeneration and associations of the latter with neurophysiological and clinical outcome.  
Results: Neurodegeneration was evident within the dorsal and ventral horns and white matter above 
the level of injury. Tract-specific neurodegeneration was associated with prolonged conduction of 
appropriate electrophysiological recordings. Dorsal horn atrophy was associated with sensory 
outcome, while ventral horn atrophy was associated with motor outcome. White matter integrity of 
dorsal columns and corticospinal tracts was associated with daily-life independence.  
Conclusion: Our results suggest that, next to antero- and retrograde degeneration of white matter 
tracts, neuronal circuits within the spinal cord far above the level of injury undergo trans-synaptic 
neurodegeneration, resulting in specific grey matter changes. Such improved understanding of 
tissue-specific cord pathology offers potential biomarkers with more efficient targeting and 
monitoring of neuroregenerative (i.e. white matter) and neuroprotective (i.e. grey matter) agents. 
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3.2 Introduction 
Spinal cord injury (SCI) usually leads to sensorimotor dysfunction resulting from damage at the level 
of injury. However, a complex cascade of secondary neurodegenerative processes occurs across the 
spinal cord and brain (Huber et al. , 2015). In chronic SCI, cervical cord atrophy of up to 30% has been 
reported above the level of injury; its magnitude relating to the degree of clinical impairment (Freund 
et al. , 2011a). Recent improvements in diffusion-weighted imaging and anatomical sequences with 
higher in-plane resolution (Martin et al. , 2016), combined with advanced post-processing techniques 
(Mohammadi et al. , 2013a, David et al. , 2017) now allow assessing grey and white matter changes 
in the cervical spinal cord occurring after SCI. 
Although white matter pathology within the spinal cord contributes to sensorimotor impairments, 
the functional effects of grey matter pathology above the level of injury are uncertain. Improved 
understanding of tissue-specific cord pathology may allow more efficient targeting and monitoring of 
neuroregenerative and neuroprotective agents. This study therefore addresses (i) to what extent 
cord atrophy above the level of injury is driven by pathophysiological processes occurring in grey and 
white matter, (ii) whether lesion severity is associated with the magnitude of neurodegeneration 
above the level of injury, and (iii) whether the tissue-specific neurodegeneration is associated with 
neurophysiological and clinical outcome. 
Based on structural and diffusion MRI data we assessed tissue-specific cord pathology above the 
level of injury in chronic SCI patients when compared to healthy controls. These measures included 
the assessment of dorsal and ventral horn areas (Grabher et al. , 2017), diffusivity changes within the 
major spinal pathways, and associations between lesion severity (Huber et al. , 2017), tissue-specific 
pathology and neurophysiological changes. 
3.3 Materials and Methods 
3.3.1 Standard Protocol Approvals, Registrations, and Patient Consents 
Our study protocol was designed in accordance with the Declaration of Helsinki and was approved by 
the local Ethics Committee of Zurich (KEK-ZH-Nr. 2012-0343, PB_2016-00623). All participants gave 
their written informed consent prior to participation. 
3.3.2 Participants 
We recruited 17 SCI patients (mean age: 48.7±14.1 years, three females) between November 2014 
and May 2016, who were preciously admitted to the University Hospital Balgrist (Zurich, 
Switzerland). Twenty-one healthy controls (mean age: 41.7±11.3 years, seven females) from the local 
neighborhood served as a control data set which was acquired and used in a previous study (Grabher 
et al. , 2016).  
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Inclusion criteria for SCI patients were 1) traumatic cervical SCI, 2) no other neurological or mental 
disorders affecting clinical outcome, 2) age between 18 to 70 years, 3) MRI compatible, and 4) no 
pregnancy.  
3.3.3 Clinical Assessments 
All patients were examined with comprehensive clinical protocols to assess neurological and 
functional impairment. These included 1) the International Standards for Neurological Classification 
of Spinal Cord Injury protocol for motor, light-touch and pin-prick score and completeness of injury 
(Kirshblum et al. , 2011), 2) the Spinal Cord Independence Measure (SCIM) to measure daily life 
independence (Itzkovich et al. , 2007), 3) Graded Redefined Assessment of Strength, Sensibility and 
Prehension (GRASSP) for assessing upper limb function (Kalsi-Ryan et al. , 2012ab), and 4) the 
Walking Index for Spinal Cord Injury (WISCI) (Dittuno et al. , 2001). All patients completed the full 
protocol, except GRASSP score was not available for 1 patient. 
3.3.4 Neurophysiological Assessments 
Contact heat evoked potentials (CHEPs) and somatosensory evoked potentials (SSEPs) were acquired 
bilaterally in patients at the dermatomes C4, C6 and C8 to measure the integrity of the spinothalamic 
tract (i.e. CHEPs) and the dorsal column (i.e. SSEPs). For the acquisition of CHEPs (Kramer et al. , 
2013) and SSEPs (Kramer et al. , 2008), the same protocols were applied as previously described. 
3.3.4.1 Contact heat evoked potentials 
A contact heat stimulator (PATHWAY Pain & Sensory Evaluation System, Medoc, Israel) was used to 
deliver contact heat stimuli from a baseline temperature of 35°C to a peak temperature of 52°C with 
a heating rate of 70°C/s and a cooling rate of 40°C/s. For each dermatome, we first assessed heat 
perception and pain thresholds within two consecutive trials. For the CHEPs recording, scalp 
recording sites were prepared with Nuprep (D.O. Weaver & Co, Aurora, CO) and alcohol. Three 9mm 
Ag/AgCl surface disc electrodes were positioned according to the international 10-20 system with the 
active electrode at the Cz position and referenced to linked earlobes (A1-A2); impedances were kept 
below 5kΩ. Ten to 15 contact heat stimuli were applied (interstimulus interval=8-12seconds). Two 
seconds after each stimulus, an audio cue appeared and patients rated their perceived intensity 
according to numerical rating scale. All signals were sampled from 100ms pre-trigger to 1500ms post-
trigger at a sampling rate of 2000Hz using a preamplifier (20 000×, bandpass filter=0.25-300Hz, ALEA 
Solutions, Switzerland). Data were recorded in a LabView-based program (V1.43 CHEP, ALEA 
Solutions, Switzerland) with a 100-millisecond period pretrigger and 1-second posttrigger. Raw data 
was bandpass filtered from 0.5-30Hz.   
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3.3.4.2 Somatosensory evoked potentials 
For dermatomal SSEPs, Key Point (Medtronic, Mississauga, Canada) was used to record and deliver 
electrical stimulation of 3Hz. Stimuli were elicited by single 0.2-msec, repetitive, square wave 
electrical stimulation. We first assessed electrical perception and pain thresholds for each 
dermatome (not exceeding 40mA) within two consecutive trials. For the recording of SSEPs, surface 
gel electrodes (10mm) were used on each dermatome after having the skin prepared with Nuprep 
(D.O. Weaver & Co, Aurora, CO) and alcohol. Disposable needle electrodes (Spes Medica, S.r.l., Italy) 
were positioned according to the international 10-20 system with the active electrode positioned at 
the contralateral side for the stimulated dermatome (C3-C4) referenced to Fz; impedances were kept 
below 5kΩ. The stimulation intensity was individually set as threefold electrical perception threshold. 
Averages of two traces of 300 cortical responses were obtained for each dermatome. Raw data was 
bandpass filtered from 2-2000Hz.  
3.3.4.3 Neurophysiological Classification 
We determined amplitudes and latencies of each dermatome for each patient after averaging all 
single trial waveforms for CHEPs (i.e. N2P2, N2, P2) and SSEPs (i.e. N1P1, N1, P1). 
Furthermore, CHEPs and SSEPs were classified as normal (onset latency ≤ 2 standard deviations from 
control dermatome recording), pathological (onset latency > 2 standard deviations from control 
dermatome recording) or absent (not recordable) (Kramer et al. , 2008). The full CHEPs protocol was 
acquired in 14 patients and partially in 1 patient. For SSEPs, 12 patients received the full protocol and 
2 patients participated in part of the protocol. 
3.3.5 Image Acquisition 
All imaging was performed on a clinical 3T SkyraFit scanner (Siemens Healthcare, Erlangen, Germany) 
equipped with a 16-channel radio-frequency receive-only head and neck coil and a radio-frequency 
body transmit coil. A stiff neck (Laerdal Medicals, Stavanger, Norway) was used in all participants to 
minimize motion artefacts. Due to motion artefacts, one patient was excluded from macrostructural 
analysis, and three patients had to be excluded from microstructural analysis. 
At the lesion epicenter a sagittal T1-weighted (TR=600ms, TE=9.9ms, flip angle=150°, in-plane 
resolution=0.57mm×0.57mm, slice thickness=3.3mm), a sagittal T2-weighted (TR=3500ms, TE=84ms, 
flip angle=160°, in-plane resolution=0.34mm×0.34mm, slice thickness=2.75mm) and an axial T2-
weighted image (TR=5510ms, TE=93ms, flip angle=150°, in-plane resolution=0.5mm×0.5mm, slice 
thickness=3.6mm) were acquired to assess the lesion size.  
At the cervical cord above the level of injury (centered at C2/C3), five volumes were acquired with a 
T2*-weighted 3D multi-echo GRE sequence (multiple echo data image combination (Schmid et al. , 
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2005)) in the oblique axial plane (i.e. perpendicular to the cord) to assess grey and white matter 
atrophy. Each of the five volumes acquired, consisted of 20 partitions with a resolution of 
0.5×0.5mm2 (FOV=192×162mm2, slice thickness=2.50mm (10% gap), TR=44ms, TE=19ms, flip 
angle = 11°, readout bandwidth=260 Hz/pixel). Each volume took 2.13 minutes to acquire. 
Application of zero filling interpolation doubled the nominal in-plane resolution (0.25×0.25mm2). 
At the identical level, a high-resolution DTI dataset was acquired using a cardiac-gated reduced-FOV 
single-shot spin-echo EPI sequence with outer volume suppression (Morelli et al. , 2010) to assess 
microstructural changes of the whole spinal cord. Four measurements of 6 b=0 (T2-weighted) and 30 
500s/mm2 (diffusion-weighted) volumes were acquired, resulting in 144 images per participant and a 
nominal acquisition time of 6.17 minutes. The following parameters were applied: TR=350ms; 
TE=71ms; slice thickness=5mm (10% inter-slice gap); resolution=0.76×0.76mm2; FOV=133×30mm2; 
phase-oversampling=50%; 5/8 Partial-Fourier Imaging in phase-encoding direction; cardiac trigger 
delay=200ms; minimal time between triggers=1800ms. After acquisition, zero filling interpolation 
was used to double the in-plane resolution (0.38×0.38mm2). 
3.3.6 Image Processing 
3.3.6.1 Lesion segmentation 
Using the Jim 6.0 software (Xinapse systems, Aldwincle, UK), the lesion was segmented on the 
midsagittal T2-weighted images being visible as a high signal intensity area within the spinal cord as 
previously described (Huber et al. , 2017). Following parameters were quantified: 1) midsagittal 
anterior-posterior lesion width (=maximal anterior-posterior width of the lesion), 2) midsagittal 
rostrocaudal lesion length (=maximal caudocranial extent of the lesion), 3) total midsagittal lesion 
area, and 4) midsagittal thickness of midsagittal ventral and dorsal tissue bridges at the widest point 
of the lesion which was summed up to the total amount of midsagittal tissue bridges.  
3.3.6.2 Processing of high-resolution macrostructural data above the level of injury  
We used serial longitudinal registration (Ashburner and Ridgway, 2012) embedded within SPM 12 to 
average the five 3D MEDIC volumes, accounting for intra-subject motion. To further increase signal-
to-noise ratio, the average volume was resampled at a double slice thickness. We then used the Jim 
6.0 software to measure cross-sectional SCA of 3 slices. After marking the midpoint of the spinal cord 
manually in each slice, the SCA was calculated automatically using the semi-automatic 3D active-
surface model (Horsfield et al. , 2010). GMA, DCA, and VHA (approximately lamina VI-IX) and DHA 
(approximately lamina I-V) were extracted manually (Grabher et al. , 2017). WMA was calculated by 
subtracting the GMA from the SCA. The mean inter- and intra-observer reliability for these measures 
was previously shown (Morelli et al. , 2010, Grabher et al. , 2016). 
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3.3.6.3 Pre-processing and estimation of DTI data 
All processing of the DTI data was carried out using a modified version of the Matlab-based ACID 
toolbox optimized for the spinal cord. First, we reduced the in-plane FOV to 24×24mm2 to exclude 
much of the non-spinal cord tissue in each participant. Then, DTI volumes were slice-wise linearly 
registered with 3 degrees of freedom (translation in the frequency- and phase-encoding direction, 
scaling in the phase-encoding direction) to correct for intra-subject motion and eddy-current artifacts 
(Mohammadi et al. , 2010). A diffusion tensor was fitted using a robust tensor fitting algorithm that 
accounts for outlier volumes due to motion and physiological artifacts (Mohammadi et al. , 2010). 
Following DTI index maps were extracted: fractional anisotropy (FA), and mean, axial and radial 
diffusivity (MD, AD, RD). 
These DTI index maps were then spatially normalized to a self-constructed mean diffusivity template 
residing in the spinal MNI space (Fonov et al. , 2014). To further refine the accuracy of the 
registration, a manual slice-by-slice registration (in-plane translation and scaling) was performed. 
Finally, all DTI index maps were smoothed using a full-width at half maximum Gaussian kernel with 
0.5×0.5×5mm3. 
3.3.7 Statistical Analysis 
Statistical analysis of all macrostructural MRI data, neurophysiological and clinical data was 
performed using Stata13 (StataCorp LP, Texas, USA). The mean age was not statistically different 
between healthy controls and patients (Mann-Whitney U test: z=-1.61, p=0.10). All images were 
visually inspected for artifacts and the analysis was conducted on 3 slices from each modality at the 
same level.  
First, we assessed the morphometric differences in SCA, GMA, WMA, DCA, VHA and DHA between 
patients and healthy controls by means of ANCOVA, adjusted for age. For microstructural differences 
between patients and healthy controls, we used SPM12 for voxel-based analysis of the different DTI 
indices (FA, MD, AD, RD) by means of ANCOVA, adjusted for age. All statistical parametric maps were 
initially thresholded with a cluster defining threshold of p<0.01 (uncorrected) and clusters surpassing 
a cluster threshold of p<0.05 (family-wise error corrected) are reported. Next, we used linear 
regression analysis to investigate the relationship between changes at the lesion site (midsagittal 
lesion area, length and width, and size of midsagittal tissue bridges) and remote cord macro- and 
microstructural changes. We then determined associations between macrostructural (SCA, GMA, 
WMA, DCA, VHA and DHA) and microstructural (DTI indexes within lateral corticospinal tract, dorsal 
column and spinal lemniscus) parameters, and tract-specific clinical measures (motor, pin-prick, and 
light-touch score, GRASSP, SCIM) using linear regression models, adjusted for age and lesion area. 
Finally, we investigated associations between macro- and microstructural MRI indices and 
neurophysiological outcome measures using linear regression models, adjusted for age and lesion 
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area. Note, that only patients with both recordable electrophysiological potentials and available MRI 
data entered this regression analysis, resulting in a total number of 8 patients. For all microstructural 
associations, we extracted mean values of DTI indexes within anatomical region of interests (lateral 
corticospinal tract, dorsal column and spinal lemniscus (containing spinothalamic and spinoreticular 
tracts)) as embedded in the Spinal Cord Toolbox (De Leener et al. , 2017). The level of significance 
was set to p<0.05. 
3.4 Results 
3.4.1 Radiologic, clinical and neurophysiological characteristics 
Patients were scanned 6.7±7.8 years after injury. An area of hyper-intense signal was visible on the 
T2-weighted sagittal images in 16 patients [Fig. 5AB]; 13 patients showed hyper-intensities in their 
dorsal column, covering, on average, 41.4±21.0 % of the whole dorsal column and two patients 
showed hyper-intensities in the dorsolateral funiculus (e.g. corticospinal tract). The radiological level 
of injury (hyper-intense T2-weighted signal) covered the vertebral level C3-C5 in one patient, C3 in 
one patient, C4 in two patients, C4-C5 in one patient, C5 in two patients, C6 in two patients, C6-C7 in 
four patients and C7 in two patients. Two patients showed no signal alteration within the cord. The 
average lesion area was 45.4±66.6 mm2 with a lesion length of 11.3±9.4 mm and a lesion width of 
4.3±3.5 mm. In two patients, the lesion occupied the full cord area and no midsagittal tissue bridges 
could be identified. In the remaining 15 patients, the midsagittal tissue bridges had an average width 
of 2.9±1.9 mm. No MR abnormalities were identified in the control group. 
Two patients were motor and sensory complete, two patients were motor complete and sensory 
incomplete, and the remaining 13 patients were motor and sensory incomplete. The motor score 
[max. 100] was 68.1±30.4, the light-touch score was (mean ± SD) 66.3±32.7 [max. 112], and the pin-
prick score [max. 112] was 52.7±35.0. Manual dexterity was impaired as assessed by the GRASSP 
score, (149.8±66.3 [max. 232]) and functional independence was impaired as assessed by the SCIM 
score ([63.1±31.3 [max. 100]). Eight patients were able to walk independently [20/20 points in the 
WISCI score], two patients were dependent on walking aids [5/20 and 9/20 points in the WISCI score] 
and seven patients were not able to walk [0/20 points]. All data is summarized in Table 5. 
All patients had neurophysiological impairment of the spinothalamic tract, and a majority had 
impaired function of the dorsal column below the level of lesion as assessed by CHEPs and SSEPs, 
respectively. The mean (± SD) perception/pain thresholds as well as amplitudes and latencies of the 
recorded signals are shown in Table 6.   
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Figure 5: Macrostructural changes above the level of injury. Hyperintense regions most likely 
indicating A) retrograde degeneration in the corticospinal tract, and B) anterograde degeneration in 
the dorsal column. Arrows are indicating the corresponding locations. C) Differences between the 
cross-sectional white matter area, cross-sectional grey matter area, cross-sectional ventral horn area, 
and cross-sectional dorsal horn area in patients compared to healthy controls. 
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ID Gender Age 
[y] 
Years since 
injury 
Radiological 
level of injury 
AIS 
grade 
Neurological 
level of injury 
Motor 
score 
Light-touch 
score 
Pin-prick 
score 
SCIM score GRASSP 
score 
WISCI 
1 male 29 1.0 C4-C5 A C4 14 16 13 22 21 0 
2 female 40 7.0 C3-C5 A C4 7 71 12 19 43 0 
3 female 39 25.0 C6-C7 B C5 30 32 34 28 125 0 
4 male 50 25.1 C6-C7 B C7 46 62 26 63 188 5 
5 male 70 0.7 C5 C C2 46 48 34 19 71 0 
6 female 32 1.2 C6-C7 C C6 44 33 24 23 92 20 
7 male 51 4.3 NS D C1 82 90 57 100 130 20 
8 male 56 5.6 C4 D C2 88 56 26 40 151 0 
9 male 43 13.1 C7 D C2 76 55 55 74 225 0 
10 male 60 0.3 C3 D C3 78 60 60 67 NA 9 
11 male 50 7.6 C4 D C3 84 10 10 97 136 20 
12 male 48 1.8 NS D C4 100 112 107 100 232 20 
13 female 63 0.3 C5 D C6 85 109 99 70 172 20 
14 male 69 0.2 C6 D C6 99 109 99 87 206 20 
15 male 67 12.6 C6-C7 D C7 91 110 107 99 183 20 
16 male 27 4.7 C6 D C7 92 72 45 75 189 20 
17 male 33 3.0 C7 D C8 96 82 88 89 232 20 
Table 5: Clinical and epidemiological data for all patients included in the study.  
Abbreviations: AIS = American Spinal Injury Association Impairment Scale; GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension; NA = 
not available; NS = no signal alteration within myelon; SCIM = Spinal Cord Independence Measure; WISCI = Walking Index for Spinal Cord Injury 
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 C4 Dermatome  C6 Dermatome  C8 Dermatome  
CHEPs Left Right Left Right Left Right 
Heat perception  
threshold [°C] 
43.97 ± 3.26 
(15/15) 
44.94 ± 4.20 
(13/14) 
45.18 ± 5.69 
(11/15) 
41.86 ± 4.36 
(11/15) 
47.08 ± 3.82 
(10/14) 
45.27 ± 4.28 
(8/14) 
Pain threshold [°C] 50.12 ± 2.58 
(11/15) 
49.21 ± 3.53 
(10/14) 
49.56 ± 3.78 
(6/15) 
51.33 ± 2.75 
(10/15) 
49.50 ± 3.60 
(4/14) 
51.51 ± 2.12 
(7/14) 
Detectable signal 8/15 8/14 4/15 7/15 0/14 5/14 
Pathological signal 3/8 1/8 1/4 1/7 - 0/5 
N2 latency [ms] 409.12 ± 108.68 349.56 ± 78.45 357.38 ± 114.40 400.33 ± 63.15 - 352.88 ± 102.19 
P2 latency[ms] 506.63 ± 109.63 479.06 ± 90.75 461.38 ± 114.78 530.92 ± 45.90 - 466.13 ± 128.11 
N2P2 amplitude [µV] 39.28 ± 34.59 40.57 ± 48.16 33.21 ± 29.96 25.72 ± 20.05 - 30.45 ± 26.18 
SSEPs Left Right Left Right Left Right 
Electrical perception 
threshold [mA] 
4.26 ± 2.87 
(11/12) 
3.30 ± 1.94 
(12/12) 
6.49 ± 10.15 
(13/14) 
8.18 ± 13.35 
(12/14) 
7.28 ± 7.75 
(12/14) 
5.59 ± 4.52 
(11/14) 
Pain threshold [mA] 24.1 ± 12.02 
(11/12) 
26.24 ± 14.81 
(12/12) 
17.72 ± 6.56 
(12/14) 
17.63 ± 7.35 
(11/14) 
19.06 ± 12.60 
(11/14) 
15.7 ± 8.04 
(10/14) 
Detectable signal 10/12 11/12 11/14 9/14 9/14 9/14 
Pathological signal 1/10 0/11 1/11 0/9 2/9 1/9 
N1 latency [ms] 15.29 ± 3.07 15.78 ± 1.95 24.65 ± 2.23 23.92 ± 2.43 26.31 ± 3.20 26.08 ± 2.68 
P1 latency [ms]  21.57 ± 4.95 23.40 ± 3.10 29.71 ± 3.18 29.60 ± 2.69 31.07 ± 3.58 31.30 ± 2.87 
N1P1 amplitude [µV] 1.04 ± 1.49 1.22 ± 1.64 1.06 ± 0.62 1.33 ± 0.75 0.81 ± 0.47 1.08 ± 0.57 
Table 6: Neurophysiological data acquired in patients. Mean ± SD are shown. Numbers in brackets refer to the amount of patients with detectable 
threshold/signals over the total amount of measured patients.  
Abbreviations: CHEPs = contact heat evoked potentials; SSEPs = somatosensory evoked potentials 
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3.4.2 Pathophysiological changes in the cervical cord above the level of injury 
Compared to healthy controls, patients showed a decreased SCA of 20.2% (p<0.001, healthy controls: 
92.30±8.49mm2, patients: 73.71±20.04mm2). In patients, WMA was decreased by 16.9% (p=0.001, 
healthy controls: 75.34±8.06mm2, patients: 62.64±18.22 mm2), and GMA was decreased by 30.0% 
(p<0.001, healthy controls: 16.96±1.25mm2, patients: 11.93±2.73mm2). In the white matter, DCA was 
decreased by 21.4% (p<0.001, healthy controls: 23.73±2.99mm2, patients: 18.65±4.76 mm2). Within 
the grey matter, the bilateral VHA showed a 34.4% decrease in patients compared to healthy 
controls (left: p<0.001; healthy controls: 3.84±0.29mm2, patients: 2.56±0.62mm2; right: p<0.001, 
healthy controls: 3.95±0.40mm2, patients: 2.61±0.58mm2). In patients, the DHA was decreased 
bilaterally by 33.4% (left: p<0.001, healthy controls: 3.63±0.41 mm2, patients: 2.42±0.66mm2; right: 
p<0.001, healthy controls: 3.60±0.51mm2, patients: 2.37±0.66mm2) [Fig. 5C], and smaller DHA was 
associated with smaller DCA (p<0.001, R2=0.74, 95%CI (2.21 4.28)). 
Voxel-based analysis of the cervical cord revealed a 16.6% decrease in FA in the left dorsolateral 
funiculus (e.g. containing spinothalamic and lateral corticospinal tracts; p=0.003; localization (x, y, z): 
-4.2, -18.5, 26; z score=4.42; cluster extent=154), 14.9% decrease in the right dorsolateral funiculus 
(p=0.025; localization (x, y, z): 6, -18.5, 37; z score=4.34; cluster extent=85), and by 17.0% in the 
posterior funiculus (i.e. containing dorsal columns; p=0.004; localization (x, y, z): 0.7, -22.3, 37; z 
score=3.80; cluster extent=145) in patients compared to healthy controls. AD was also decreased in 
patients compared to healthy controls in the same regions, namely by 12.8% the left dorsolateral 
funiculus (p=0.014; localization (x, y, z): -3.1, -19.2, 26; z score=3.72; cluster extent=58), by 12.8% the 
right dorsolateral funiculus (p=0.002; localization (x, y, z): 4.1, -18.8, 26; z score: 4.70; cluster 
extent=94), and by 9.9% in the posterior funiculus (p=0.020; localization (x, y, z): 0.7, -19.2, 32; z 
score=3.69; cluster extent=52). RD increased by 31.8% in the dorsal column (p=0.022; localization (x, 
y, z): 0.3, -20.7, 37; z score=3.47; cluster extent=70) and by 34.0% in the left dorsolateral funiculus 
(p=0.023; localization (x, y, z): -5, -19.2, 32; z score=3.22; cluster extent=69) in patients compared to 
healthy controls. MD was not significantly different between patients and healthy controls [Fig. 6].  
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Figure 6: Microstructural changes above the level of injury. Voxel-wise analysis of microstructural changes above the level of injury in patients compared to 
healthy controls. The first row shows the spinal cord template and the second row shows the white matter atlas adapted from De Leener (2017). Note, the spatial 
overlap of the different DTI metrics showing that regions of decreased AD (e.g. axonal degeneration) but unaltered RD (e.g. no demyelination) lay mostly 
adjacent to the gray matter, where unmyelinated propriospinal neurons are located. 
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3.4.3 Relationship between lesion severity and remote tissue-specific 
neurodegeneration 
Greater lesion area and length were associated with greater SCA decrease above the level of injury 
(lesion area: p=0.048, R2=0.25, 95%CI: (-3.64, -0.23)1/mm2; lesion length: p=0.006, R2=0.42, 95%CI: (-
0.55, -0.11)1/mm2), independent of age. The width of total midsagittal tissue bridges was associated 
with less SCA decrease (p=0.007, R2=0.39, 95%CI: (0.02, 0.11)1/mm2). Greater lesion length was 
associated with smaller GMA (p=0.012, R2=0.40, 95%CI: (-3.74, -0.57)1/mm2), VHA (p=0.039, R2=0.29, 
95%CI: (-8.33, -0.25)1/mm2), and DHA (p=0.004, R2=0.49, 95%CI: (-8.36, -2.03)1/mm2) while 
midsagittal tissue bridges were positively associated with GMA (p=0.035, R2=0.28, 95%CI: (0.33, 
0.78)1/mm2) and DHA (p=0.011, R2=0.38, 95%CI: (0.26, 1.74)1/mm2) [Fig. 7A]. Greater lesion length 
and preserved midsagittal tissue bridges were associated with WMA (lesion length: p=0.014, R2=0.38, 
95%CI: (-0.61, -0.08)1/mm2; tissue bridges: p=0.011, R2=0.38, 95%CI: (0.02, 0.12)1/mm2) above the 
level of injury [Fig. 7B].  
 
Figure 7: Relationship between lesion severity and neurodegeneration above the level of injury. 
The magnitude of tissue damage at the lesion site is associated with the amount of 
neurodegeneration above the level of injury. Lesion length and midsagittal tissue bridges are 
associated with remote grey matter (A) and white matter (B) atrophy.  
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The width of total midsagittal tissue bridges was associated with DCA above the level of lesion 
(p=0.019, R2=0.29, 95%CI: (0.25, 2.39)1/mm2). Neither lesion size nor midsagittal tissue bridges were 
associated with microstructural changes above the level of lesion.   
3.4.4 Relationship between remote neurodegeneration and neurophysiological 
outcome  
The size of the cross-sectional area of the dorsal columns identified those patients with bilateral 
recordable SSEPs of the dermatomes C6 and C8 [Fig. 8]. This relationship was not evident for the 
WMA and CHEPs. Higher AD values within the dorsal column were associated with shorter SSEP N1P1 
latency at the C4 dermatome (p=0.0024, R2=0.83, 95%CI: (-.00007, -.00001)10-3*s2/mm2), corrected 
for age and lesion area. DTI metrics within the spinothalamic tracts were not associated with CHEPs 
recordings.  
 
Figure 8: Relationship between neurodegeneration above the level of injury and 
electrophysiological outcome. Patients were grouped into 3 cohorts: without, with unilateral or with 
bilateral recordable dermatomal SSEPs at the level C4, C6 and C8. Patients with recordable 
dermatomal SSEPs showed a tendency towards larger dorsal column area above the level of injury. 
Abbreviations: bSSEPs = bilateral somatosensory-evoked Potentials; uSSEPs = unilateral 
somatosensory-evoked potentials 
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3.4.5 Relationship between remote neurodegeneration and clinical outcome 
GMA was associated with motor score (p=0.007, R2=0.72, 95%CI: (1.77, 9.26) and pin-prick score 
(p=0.003, R2=0.58, 95%CI: (3.48, 13.90)), VHA area was associated with motor score (p=0.001, 
R2=0.78, 95%CI: (6.74, 21.93)), and DHA was associated with pin-prick score (p=0.004, R2=0.57, 
95%CI: (7.43, 31.52)) when corrected for lesion area and age [Fig. 9A]. 
To quantify tract-specific associations with appropriate clinical outcome, we used the extracted 
mean values of DTI indexes within the regions of interest (i.e. corticospinal tract, dorsal column and 
spinothalamic tract). FA and RD within corticospinal tract and the dorsal columns were associated 
with SCIM score (corticospinal tract: FA: p=0.002, R2=0.80, 95%CI: (105.82 361.55); RD: p=0.001, 
R2=0.83, 95%CI: (-169829.70 -60547.48); dorsal columns: FA: p=0.002, R2=0.80, 95%CI: (106.07 
341.42); RD: p=0.003, R2=0.79, 95%CI: (-216944.1 -60854.36)), independent of lesion extent and age 
[Fig. 9B]. AD within the dorsal columns was associated with GRASSP score, independent of lesion 
extent and age (p=0.30, R2=0.60, 95%CI: (40298.4 646999.7)). 
 
Figure 9: Relationship between neurodegeneration above the level of injury and clinical outcome. 
Associations between A) remote tract-specific macrostructural MRI parameters above the level of 
injury and clinical impairment, and B) remote tract-specific microstructural MRI indices above the 
level of injury and clinical impairment. 
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3.5 Discussion 
This study shows the in-vivo structure function relationship between the extent of tissue-specific 
cord pathology and neurophysiological and clinical impairment following traumatic SCI. Crucially, we 
show that the magnitude of tissue damage at the lesion epicenter is associated with the extent of 
neurodegeneration above the level of lesion; which, in turn, is associated with clinically relevant 
impairment and neurophysiological abnormalities. These findings allow us to investigate the extent 
of tissue-specific neurodegeneration above the level of injury, its relationship to neuronal tissue loss 
at the site of the lesion, and its effect on neurophysiological and clinical outcome. 
Tissue damage at the epicenter of a traumatic SCI results from both the direct effect of the traumatic 
insult, but also from damage to the vascular architecture and the ensuing ischemic effects on the 
neuronal and glial cell populations within the acute phase of injury (Schwab and Bartholdi, 1996). 
Remote from the epicenter of the lesion, secondary neurodegeneration within white (Crowe et al. , 
1997, Ward et al. , 2014) and grey matter (Huang et al. , 2007) follows with a time lag and is driven 
by a multiphasic response to cellular inflammation (Beck et al. , 2010). While the extent of secondary 
remote atrophy has been quantified in vivo after injury (Freund et al. , 2011a, Lundell et al. , 2011, 
Freund et al. , 2012ab), we provide evidence that changes within both grey and white matter 
contribute to cord atrophy above the level of injury. This is in agreement with spinal grey matter 
degeneration distant to the initial site of damage in multiple sclerosis patients (Calabrese et al. , 
2015) and experimental SCI (Pearse et al. , 2005). Although the relative decrease is larger within 
ventral and dorsal horns (i.e. grey matter), the absolute magnitude of change is larger within white 
matter, contributing more to the overall loss of SCA by 20.2%.  
We uncovered an in-vivo relationship between neuronal tissue loss (i.e. lesion severity) and remote 
tissue-specific cord pathology above the level of injury. Moreover, we show an interdependence of 
remote white and grey matter atrophy (i.e. DHA and DCA). Neurodegenerative changes within grey 
matter above the level of injury are not likely to be specific for any single pathological process, but 
rather are likely to represent a combination of different pathological mechanisms taking place after 
SCI. Possible mechanisms involve transsynaptic/transneuronal degeneration affecting the 
propriospinal systems (Yu et al. , 2016, Grumbles and Thomas, 2017) and motor neurons located in 
the proximity of the spinal injury (Filli et al. , 2015). Next to direct effects of neurodegenerative 
processes, reduction in muscle activity of the upper extremity could lead to reduction of neuronal 
activity above the level of injury which translates into shrinkage of the neurons soma size.  
Furthermore, demyelination of corticospinal projections to the dorsal horns (Lemon and Griffiths, 
2005), the expression of neurotrophic factors from non-neuronal cells around neighboring 
degenerating axons (Lemon and Griffiths, 2005), growth-factor dysregulation (Bareyre and Schwab, 
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2003), as well as vascular remodeling (Cao et al. , 2017) could contribute to grey matter pathology. 
As white matter damage is known to induce microglial activation altering glutamate signaling, this 
process is thought to be responsible for the dying back of axons and their parternal neurons (Matute 
et al. , 2007), which might be a shared underlying disease mechanism. Thus, next to anterograde and 
retrograde degeneration of white matter tracts (Buss et al. , 2005, Kerschensteiner et al. , 2005, 
Freund et al. , 2012b), the neuronal circuits within the spinal cord far above the level of injury 
undergo a temporary structured neurodegeneration (Ward et al. , 2014). 
Within the microstructure of the atrophied white matter, we found indications of both axonal 
degeneration and demyelination (Brennan et al. , 2013), represented by decreased FA and AD, and 
increased RD in the dorsolateral funiculus (e.g. containing the lateral corticospinal and spinothalamic 
tracts) and the posterior funiculus (e.g. containing the dorsal columns). Within the corticospinal tract 
and the dorsal column, leg function is represented most laterally, whereas arm function is located 
either medially (i.e. corticospinal tract) or centrally (i.e. dorsal column). Our observed changes cover 
the entire lateral corticospinal tract and the dorsal columns, indicating neurodegenerative processes 
affecting axons which convey information relating to leg and arm function. Spatially overlaying the 
different DTI metrics changes revealed that regions showing decreased AD (e.g. axonal 
degeneration), but unaltered RD (e.g. no demyelination), lay mostly adjacent to the gray matter 
border. This region contains the fasciculi proprii and contains mostly short, mainly unmyelinated 
propriospinal neurons (Flynn et al. , 2011). This underlies our hypothesis that SCI might lead to 
degeneration affecting interneurons within the spinal cord. 
Our findings complement previous studies in SCI patients (Cohen-Adad et al. , 2011, Kamble et al. , 
2011, Petersen et al. , 2012, Koskinen et al. , 2013) as it now locates these changes to grey and white 
matter rather than being non-specific in terms of location and tissue. Thus, our in vivo cord MRI 
measurements demonstrate a combination of structural and functional processes occurring over 
several segments above the level of injury affecting both grey and white matter and which is driven 
by lesion severity. 
We show that tract-specific micro- and macrostructural changes are associated with prolonged 
conduction of appropriate electrophysiological recordings. This association suggests a structure-
functional relationship, because the amount of neurodegeneration was directly associated with 
impairment of neurophysiological information flow. As the DTI signal is sensitive to altered diffusion 
properties occurring as a response to CNS damage (i.e. demyelination/ degeneration), and neuronal 
excitability is affected by morphometry of the axon and its myelin, it seems plausible that 
neurophysiological changes might be reflected in remote macro- and microstructural changes above 
the level of injury. Our findings complement previous findings showing that the topography and the 
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excitability of corticomotor projections were associated with cervical cord atrophy (Freund et al. , 
2011ab). 
Current assessments in SCI patients lack sensitivity to minimal changes in motor and sensory function 
(Ellaway et al. , 2011) as they cannot detect subtle changes due to remyelination and axonal 
regeneration. Neuroimaging biomarkers have the potential to track these subtle abnormalities as 
they are sensitive to microstructural changes (Huber et al. , 2015). In this study, the magnitude of 
both remote macro- and microstructural changes within grey and white matter was significantly 
associated with clinical impairment, independent of lesion extent. In particular, the extent of remote 
ventral horn atrophy was associated with motor impairment, whereas dorsal horn atrophy was 
associated with sensory disturbance. Microstructural tract-specific changes above the level of injury 
were related to measures of functional independence (i.e. SCIM) and strength, sensibility and 
prehension of the upper limbs (i.e. GRASSP). This suggests that high-resolution MRI sequences 
applied above the level of injury provide superior information on patient’s clinical status compared 
to standard clinical sequences at the lesion site. In addition, the latter findings are striking as they 
suggest that remote neurodegeneration within grey matter above the level of injury contributes, in 
addition to white matter pathology, to motor and sensory impairment. This multi-level interaction 
supports the view that SCI leads to a cascade of activity-dependent neurodegenerative changes 
affecting the entire spinal cord and brain (Freund et al. , 2016). Characterizing these secondary 
neurodegenerative events has the potential to provide insights into new therapeutic interventions in 
addition to providing opportunities for monitoring treatment effects in trials conducted in acute and 
chronic SCI patients.  
3.5.1 Limitations 
This study had several limitations. Although our cohorts did not show a significant age difference; the 
mean age was on average higher in the patients group, which could potentially affect the analysis. 
We therefore adjusted for age as a potential confounder of no interest in all analyses. Further, 
unbiased voxel-based morphometry of DTI indices in the spinal cord have just started emerging3 and 
the automated post-processing methods for spatial normalization of the spinal cord into common 
space are in their infancy. To increase the reliability of our analysis, we therefore manually corrected 
the spatial normalization to the template. 
3.6 Conclusion 
This study shows that the magnitude of dorsal and ventral horn and white matter structural changes 
above the level of injury are associated with appropriate clinical and neurophysiological impairment 
and are driven by the lesion severity. These findings suggest a combination of different pathological 
processes affecting both grey and white matter several segments above the level of injury, which are 
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clinically eloquent. Therefore, these neuroimaging biomarkers might serve as promising surrogate 
markers for future clinical trials supplementing (or complementing) clinical outcome measures. 
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4.1 Abstract 
Cervical neurodegenerative changes above the level of injury are evident following traumatic spinal 
cord injury (SCI), resulting in up to 30% atrophy of the cervical cord. This study investigates with 
Magnetic Resonance Spectroscopy (MRS) underlying metabolic changes in 18 SCI patients and 11 
controls that may subtend the development of atrophy. The amount of N-acetylaspartate (tNAA, cell 
integrity marker), myo-Inositol (mI, neuroinflammatory marker), choline (tCho, cell membrane 
marker), creatine (Cr, energy metabolism marker) and glutamate/glutamine (Glx, representing 
neurotransmission) was measured in the atrophied cervical cord above the level of injury. Regression 
analysis revealed relationships between metabolic changes in the atrophied cord, lesion severity, and 
clinical outcome. We found lesion-level dependent metabolic alterations related to chronic 
neuroinflammation, neurodegeneration and demyelination. Lesion severity and greater clinical 
impairment was linked to the amount of neuroinflammation. These metabolic alterations might be 
promising surrogate markers in therapy monitoring and clinical trials for SCI patients. 
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4.2 Introduction 
Spinal cord injury (SCI) results in most cases in permanent sensorimotor deficits, affecting 
permanently the quality of life. During the last years, many studies attempted to characterize and 
understand injury-induced remote neurodegeneration and reorganization along the neuraxis and 
their relationship to clinical outcomes (Freund et al. , 2011a, Chandra et al. , 2012, Grabher et al. , 
2015, Huber et al. , 2017b). This is of high clinical relevance as in-vivo neuroimaging biomarkers are 
able to assess volumetric as well as microstructural changes of the central nervous system and 
therefore might help to improve prediction of outcome and stratification of patients for future 
interventional trials (Huber et al. , 2015). 
At the cervical cord level C2, previous studies showed cord atrophy of up to 30% (Freund et al. , 
2011a), affecting both grey and white matter equally (Huber et al. , 2017a). Such changes are usually 
thought to represent neuronal degeneration and demyelination. However, as animal studies mainly 
focus on characterizing changes at the lesion site to identify possible repair strategies, little is known 
whether the environment and the function of preserved axons is also altered remote from the site of 
injury. Pre-clinical studies suggest that surviving cells might have reduced mitochondrial function 
(Cao et al. , 2013), altered membrane turnover (Arima et al. , 2014) and energy metabolism 
(Schwerdtfeger et al. , 2012), and changes in spinal excitatory synaptic transmission (Kim et al. , 
2011). In addition, there might be widespread changes such as chronic neuroinflammation (Qian et 
al. , 2010). It is still unknown, how these processes are altered in-vivo after human SCI above the 
level of injury, and whether these mechanisms might be underlying factors contributing to cervical 
spinal cord atrophy.  
To extend the analysis of metabolic processes in SCI and to obtain biochemical information non-
invasively and in-vivo, magnetic resonance spectroscopy (MRS) is the tool of choice. MRS allows for 
non-invasive assessment of morphological, microstructural and metabolic changes. However, the 
spinal cord is one of the most difficult areas within the central nervous system to acquire MRS data in 
terms of signal-to-noise ratio and magnetic field homogeneity due to its deep location and the 
heterogeneity of the surrounding tissue (Solanky and De Vita, 2014, Hock et al. , 2013b). The 
acquisition quality of spinal cord MRS recently improved (Hock et al. , 2013a, Hock et al. , 2013c) and 
allows detecting metabolites such as N-acetylaspartate (cell integrity marker), myo-Inositol (sensitive 
to neuroinflammatory changes), choline (marker of cell membrane turnover), creatine (indicator of 
energy metabolism), and glutamate/glutamine (representing neurotransmission). These metabolites 
have been investigated in the spinal cord of patients in different neurological diseases such as 
Multiple Sclerosis (Kendi et al. , 2004, Blamire et al. , 2007, Ciccarelli et al. , 2010, Ciccarelli et al. , 
2007, Marliani et al. , 2010, Bellenberg et al. , 2013, Abdel-Aziz et al. , 2015), amyotrophic lateral 
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sclerosis (Carew et al. , 2011), cervical spondylotic myelopathy (Holly et al. , 2009), and Friedreich’s 
ataxia (Henry et al. , 2014, Lenglet et al. , 2016). However, to best of our knowledge, MRS has not 
been applied in SCI patients yet, a disorder where immediately traumatic and secondary 
inflammatory processes are considered to impact the clinical outcome. 
In this study, we investigated metabolic alterations above the level of injury at the vertebral level C2, 
and assessed their relationship to spinal cord atrophy, lesion severity, and clinical impairment by 
using MRS. We hypothesize that 1) metabolic alterations relating to neuroinflammation and 
neurodegeneration, and changes in spinal excitatory synaptic transmission above the level of injury 
are evident in the severely atrophied cervical cord in chronic SCI patients; and 2) the amount of 
metabolic alterations is driven by lesion severity, and relates to the level of lesion, completeness of 
injury and clinical impairment. 
4.3 Materials and Methods 
4.3.1 Participants 
Inclusion criteria for SCI patients were 1) chronic traumatic injury (>1 year post injury), 2) no other 
neurological or mental disorders, 3) MRI compatible.  
The local Ethics Committee of Zurich approved the present study (KEK-ZH-No. 2014-610, PB_2016-
00126) which was in accordance with the Declaration of Helsinki. We recruited all participants for 
this study between March 2016 and January 2017. All participants were informed about the aim and 
procedure of the study prior to measurement and gave written informed consent.  
4.3.2 Experimental Design 
4.3.2.1 Clinical Assessments 
SCI patients underwent a comprehensive clinical protocol including a) the International Standards for 
Neurological Classification of Spinal Cord Injury (ISNCSCI) protocol for motor, light-touch and pin-
prick score (Kirshblum et al. , 2011) and b) the Spinal Cord Independence Measure (SCIM) to measure 
daily life independence (Itzkovich et al. , 2007). The ISNCSCI also provides the basis for the 
neurological classification of SCI, the American Spinal Injury Association (ASIA) Impairment Scale (AIS) 
classifying the functional completeness of the injury. In this classification, AIS A is referred to as a 
complete injury (i.e. no sensory or motor functions preserved in sacral segments), whereas AIS B, C 
or D is referred to as an incomplete injury. The neurological level of lesion is defined as the 
uppermost neurological intact segment. In addition, upper limb function of the tetraplegic patients 
was assessed using the Graded Redefined Assessment of Strength, Sensibility and Prehension 
(GRASSP) (Kalsi-Ryan et al. , 2012ab). All patients completed the full protocol. 
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4.3.2.2 MRI Protocol 
The study was performed on a 3T Philips scanner (Achieva, Release: 3.2.3, Philips Healthcare, Best, 
The Netherlands) using the 16 channel SENSE neurovascular coil (Philips Healthcare, Best, The 
Netherlands) to acquire spectra from the cervical cord above the level of injury (Fig. 10). The 
participants laid in the scanner in a head first supine position and the total scan duration was 
approximately 45 minutes. MR measurement sequences included a survey scan, anatomical T1 and T2 
weighted scans and spectroscopic measurements. 
At the C2 level, we used a T2 weighted image (TR: 3000ms, TE: 120ms, flip angle: 90°, in-plane 
resolution: 0.5mm x 0.5mm, slice thickness: 3.2mm) to place the spectroscopic volume of interest 
(VOI, dimensions: 6mm x 9 mm x 35mm, 1.9ml). We applied the metabolite cycling (MC) technique 
(Hock et al. , 2013c) in combination with inner volume saturation (IVS) (Edden et al. , 2006) and outer 
volume suppression (OVS) (Wilm et al. , 2007, Schulte et al. , 2007, Hock et al. , 2013b), and used a 
second-order projection-based shimming routine (Gruetter, 1993, Hock et al. , 2013a). We split the 
spectroscopic acquisition in measurement acquisition blocks of 128 or 256 signal averages and re-
adjusted the VOI based on an updated T2 image to minimize patient motion (TR: 2000-2500ms (heart 
beat triggered), TE: 30ms, number of signal averages (NSA): 512, spectral bandwidth: 2000Hz, 
readout duration: 512ms). 
At the lesion site, we used a standardized clinical protocol for all tetraplegic patients, which was 
previously acquired at a 1.5T (for two patients) or 3T (for seven patients) Siemens scanner (Siemens 
Healthcare, Erlangen, Germany). At the lesion epicenter, a sagittal T2-weighted image (for 1.5T: TR: 
4125ms, TE: 106ms, flip angle: 150°; for 3T: TR: 3500ms, TE: 84ms, flip angle: 160°) was acquired to 
assess lesion severity. 
4.3.3 MRI Post-Processing 
4.3.3.1 Post-Processing and quantification of spectroscopic data 
We reconstructed the spinal cord spectroscopic data from the scanner raw data using the  MRecon 
framework (GyroTools LLC, Zurich, Switzerland) carried out in MATLAB 2014b (MathWorks, Inc., 
Natick, MA, USA). We used a custom-build script to apply eddy current correction and frequency 
alignment, and to reconstruct the data from the non-water suppressed measurements series and to 
eventually merge all acquisition blocks for every participant as previously reported (Hock et al. , 
2013c). In addition, we applied truncation and zero filling in the time domain after 200ms before 
quantification. Metabolic concentration values were scaled to the internal creatine value, since 
absolute quantification by internal water referencing in the spinal cord is not reliable due to the 
pulsating surrounding CSF. We applied LCModel (Provencher, 1993) to the spectroscopic data of the 
spinal cord to quantify the metabolic ratios. A basis set for TE=30ms was used including simulated 
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basis set model data of N-Acetylaspartate (NAA), N-Acetyl-Aspartyl-Glutamate (NAAG), Glutamate 
(Glu), Glutamine (Gln), Glycerophosphocholine (GPC), Phosphocholine (PCh), Creatine(Cr), scyllo-
Inositol (sI) and myo-Inositol (mI). Due to strongly overlapping resonances lines, we combined the 
spectra of the following metabolites: NAA + NAAG = tNAA, GPC + PCh = tCho and Glu + Gln = Glx. The 
spectral range used covered in the fitting settings was 0.4 to 4.0 ppm. We aimed at preventing 
artificial cut-off effect introduced by a cut-off value of 20% (Kreis, 2016). Therefore, following the 
debate and the recommendation of the consensus discussion at the MRS workshop (Lake Constance, 
August 2016), metabolic ratios of metabolites were included in case the Cramer-Rao lower bounds 
(CRLB) were smaller than 100%. 
4.3.3.2 Post-Processing of MRI data above the level of injury 
The cross-sectional spinal cord area (SCA) above the level of injury was assessed in the T2 images 
using Jim 6.0 (Xinapse systems, Aldwincle, UK) in all participants. We determined the bottom of the 
C2 vertebra and determined the SCA in three consecutive slices at the C2 level. We first placed a 
region of interest in the middle of the cord. The SCA was then calculated automatically using an 
active-surface model (Horsfield et al. , 2010). In three participants, manual correction of the surface 
outline was necessary. 
4.3.3.3 Lesion segmentation 
In tetraplegic patients, the lesion severity was assessed on the midsagittal slice of the T2-weighted 
images using Jim 6.0 (Xinapse systems, Aldwincle, UK) as previously described (Huber et al. , 2017b). 
We quantified the midsagittal anterior-posterior lesion width (=maximal anterior-posterior width of 
the lesion), the midsagittal rostro-caudal lesion length (=maximal caudocranial extent of the lesion), 
total midsagittal lesion area, and the thickness of midsagittal ventral and dorsal tissue bridges at the 
widest point of the lesion which was summed up to the total amount of tissue bridges. An illustration 
of the tissue bridges is shown in Fig 1B by Huber et al. (Huber et al. , 2017b). 
4.3.4 Statistical analysis 
For statistical analysis we used the R software package (R Core Team, 2016) version 3.3.1 including 
the package ggplot2 (Wickham, 2009) for visualization. Data in the graphics show boxplot including 
the median and the quartiles.  
First, we assessed group differences for all metabolite concentration ratios at the spinal cord 
between SCI patients and healthy controls using a Kruskal–Wallis test followed by pairwise Mann–
Whitney U tests. We also investigated differences between para- and tetraplegic patients and further 
examined metabolite ratios that showed significant group differences between HC and all SCI 
patients. To investigate how the amount of cervical atrophy of all SCI patients is related to cervical 
chemical concentration changes, we performed Spearman’s rank correlation tests. Second, within 
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tetraplegic SCI patients, we assessed the relationship between the level of injury, lesion severity 
(lesion area, length and width, and tissue bridges) and cervical chemical concentration ratios using 
Spearman’s rank correlation tests. Last, we examined the relationship between metabolites 
concentration ratios and clinical outcome using Spearman’s rank correlation tests.  
The confidence interval is set to 95%. Age was included in the statistical model as a covariate of no 
interest to control for age dependency. 
4.4 Results 
4.4.1 Demographics 
We included nine patients with a paraplegic injury (injury below neurological level T1 of the spinal 
cord; mean age: 47.6±5.4 years), nine patients with a tetraplegic injury (above level T2; mean age: 
52.6±14.0 years), and 11 healthy controls (HC, mean age: 44.5±11.7 years) in the study without 
significant difference in age. All participants were male and the demographic data is summarized in 
Table 7.  
All patients completed the MRI examination and clinical assessment. The mean age at injury and the 
years since injury was 31.7± 12.8 and 15.9±10.0 for the paraplegic patients, and 40.7±13.0 and 11.9± 
10.0 for the tetraplegic patients, respectively. Para- and tetraplegic patients did neither significantly 
differ in age at injury (P=0.34) nor in years since injury (P=0.42) Eight patients were classified as 
functionally complete (American Spinal Injury Association Impairment Scale [AIS] A) and 10 as 
incomplete (AIS B-D; Table 7).   
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 ISNCSCI Outcome Measures 
ID 
 
Age at 
Injury 
Years since 
Injury 
AIS Level of 
Injury 
Motor 
Score 
Light-
Touch 
Pin-
Prick 
SCIM 
1 30 13 D C2 75 55 55 74 
2 51 6 D C2 86 56 26 48 
3 28 2 A C4 11 23 23 18 
4 31 2 A C4 22 31 20 28 
5 46 12 C C4 97 112 97 100 
6 60 4 D C4 89 79 64 100 
7 41 24 A C5 38 22 20 63 
8 24 31 B C5 31 68 68 64 
9 50 13 D C7 91 110 107 100 
10 44 10 A T2 50 39 41 58 
 11 19 27 A T4 50 71 72 73 
12 33 19 A T4 50 51 48 75 
13 14 25 B T4 50 78 78 66 
14 19 29 B T4 50 50 50 73 
15 26 20 A T5 50 48 48 68 
16 46 7 A T11 67 87 82 69 
17 48 2 D T12 100 94 82 98 
18 36 4 D L1 92 106 104 98 
Table 7: Clinical and Epidemiological Data for All Patients Included in the Study  
AIS=American Spinal Injury Association Impairment Scale, ISNCSCI= International Standards for 
Neurological Classification of Spinal Cord Injury, SCIM=Spinal Cord Independence Measure 
4.4.2 Quality of MRS measurements 
Representative spectra acquired in the spinal cord at level C2 are shown in Fig. 10. The spectroscopic 
voxel of interest placement is shown in A). Measured spectra and fitting results with separate 
metabolite components are shown in B) for a healthy control subject, a paraplegic and a tetraplegic 
patient. In every participant, 512 signal echo averages were included and no measurement block had 
to be excluded due to motion.  Valid concentration values could be determined for all metabolites in 
all participants with the exception of Glx. It could not be determined and zero was assumed in one 
healthy control and one paraplegic patient. No significant differences in the metabolite line width 
(full-width at half-maximum (FWHM) of the NAA peak) between healthy controls and SCI patients has 
been found (P=0.51). This indicates a homogenous magnetic field in the region of interest also in the 
case of patient with implants and therefore a methodological bias in the metabolic level is minimal.  
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Figure 10: Spectroscopic Voxel Localization and Representative Spectra. The placement of the 
spectroscopic voxel of interest is shown in A). A representative spectrum of a healthy volunteer, a 
paraplegic patient and a tetraplegic patients (underlying in grey) and the resulting fit (black) is shown 
in B). The metabolic components identified in the fit are shown below in red for Creatine (Cr), total 
NAA (tNAA), choline containing compounds (tCho), myo-Inositol (mI) and the combined Glutamate 
and Glutamine signal (Glx).  
 
4.4.3 Metabolic changes in the severely atrophied cervical cord 
In SCI patients, cross-sectional SCA at C2 was reduced by 17% when compared to controls (P<0.001), 
with more pronounced changes in tetraplegic patients (-25%, P<0.001) than in paraplegic patients  
(-10%, P=0.005).  
In terms of metabolic changes within this atrophied cord area, we found significantly lower tNAA/mI 
and tCho/mI ratios in SCI patients compared to controls (tNAA/mI: P=0.003; tCho/mI: P=0.043) [Fig. 
11AC]. This group difference was mainly driven by the tetraplegic patient group who significantly 
differed from the healthy control group (tNAA/mI: P=0.002; tCho/mI: P=0.033), whereas paraplegic 
patients only showed a trend towards lower ratios (tNAA/mI: P=0.056; tCho/mI: P=0.224) [Fig. 11BD]. 
Within patients, tetraplegic patients had lower tNAA/mI ratios compared to paraplegic patients 
(P=0.042), but no difference between patient subgroups was detected for tCho/mI (P=0.25). Patients 
with greater cord atrophy had lower levels of tNAA/mI (P=0.003) and showed the same trend for 
tCho/mI (P=0.094) [Fig. 12]. 
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Figure 11: Metabolic Ratios Group Differences. The group differences of tNAA/mI (A,B) and tCho/mI 
(C,D) are shown for healthy controls (HC) and spinal cord injury patients (SCI) (A,C) and for healthy 
controls (HC), paraplegic SCI (pSCI) and tetraplegic SCI (tSCI) (B,D). Significant differences are labelled 
and un-corrected P values are denoted. 
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Figure 12:Spinal Cord Atrophy and Metabolic Ratios. The cross-sectional spinal cord area at C2 is 
shown in Spinal Cord Injury (SCI) patients as relation to tNAA/mI (A) and tCho/mI (B). 
 
4.4.4 Relationship between lesion characteristics, metabolic changes at C2 level and 
clinical outcome 
Lesion level was positively associated with tNAA/mI (P=0.005) and showed the same trend for 
tCho/mI (P=0.062) [Fig. 13AC]. When only looking at complete patients (i.e. AIS A), significant 
associations between lesion level and both tNAA/mI (P=0.022) and tCho/mI (P=0.009) were found 
[Fig. 13BD]. Further, an increased tNAA/tCho ratio was associated with time since injury (P=0.009) 
[Fig. 14A], but did not differ between complete and incomplete patients (P=0.69) [Fig. 14B]. In 
tetraplegic patients, the size of midsagittal tissue bridges at the lesion site was positively correlated 
with tNAA/mI (P=0.006) as well as tCho/mI ratios (P=0.032) above the level of injury [Fig. 14CD]. 
The tNAA/mI ratio as well as Cho/mI ratio were positively associated to SCIM (tNAA/mI: P<0.001, 
R2=0.560; tCho/mI: P=0.002, R2=0.458) and pinprick score (tNAA/mI: P=0.009, R2=0.353; tCho/mI: 
P=0.004, R2=0.415) [Fig. 15ABCD]. In addition, lower levels of tCho/mI ratio was associated with 
lower light-touch (P=0.001, R2=0.529) and motor score (P=0.001, R2=0.531) [Fig. 15EF]. 
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Figure 13: Lesion proximity and Metabolic Ratios. The correlation of the neurological level of injury 
(C1 to T12) and the ratios of tNAA/mI (A,B) and tCho/mI (C,D) are shown. The patients are labelled 
according to their American Spinal Injury Association Impairment Scale (AIS) from A to D. All spinal 
cord injury patients are included in (A,C), whereas only patients diagnosed with complete injury (AIS 
A) are shown in (B,D). 
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Figure 14: Lesion Characteristics and Metabolic Ratios. The correlation between the time since 
injury and the tNAA/tCho ratio is shown in A. In B, the ratio tNAA/tCho is shown for complete (AIS A) 
vs. non-complete (AIS B, AIS C, AIS D and AIS E) spinal cord injury patients. The relation between the 
midsagittal tissue bridges size and the metabolic ratios of tNAA/mI (C) and tCho/mI (D) are shown for 
tetraplegic spinal cord injury patients (tSCI). 
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Figure 15: Metabolic Ratios and Outcome Measures. This figure shows the correlations of the 
metabolic ratios tNAA/mI (A,B) and tCho/mI (C,D,E,F) in spinal cord injury patients (SCI) to outcome 
measures including Spinal Cord Independence Measure (SCIM) (A,C), Pin-Prick (B,D), Motor (E) and 
Light-touch scores (F). 
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4.5 Discussion 
This study is the first to investigate underlying metabolic alterations in areas of spinal cord atrophy 
above the level of injury after SCI. Above the level of injury, we found altered metabolic ratios that 
positively correlated with the extent of atrophy and the sensorimotor outcome and were driven by 
lesion severity (i.e. level of lesion and extent of lesion). These findings may point to cellular and 
molecular factors underlying consecutive cervical cord atrophy after SCI, i.e. indication of 
neuroinflammation and deterioration of axonal metabolism, and how altered metabolism influences 
patient outcome. 
4.5.1 Metabolic changes in the severely atrophied cervical cord 
We show that tNAA/mI and tCho/mI are decreased in the atrophied cervical cord in SCI patients, with 
more pronounced changes in tetraplegic patients compared to paraplegic patients. Importantly, the 
more caudal the lesion level, the higher the ratios of tNAA/mI and tCho/mI, which reflects values 
being closer to healthy controls.  
Specifically, reductions of tNAA/mI and tCho/mI ratios can be either attributed to a decrease in N-
acetylaspartate and choline, or an increase in myo-Inositol, or both. N-acetylaspartate is synthesized 
in the mitochondria of neurons from aspartic acid and acetyl-coenzyme A (Truckenmiller et al. , 1985, 
Ariyannur et al. , 2010), and is predominantly present in neuronal cell bodies and axons, while 
synaptic elements and astrocytes are low in N-acetylaspartate (Nordengen et al. , 2015). In 
accordance, Manganas and colleagues (Manganas et al. , 2007) showed that the N-acetylaspartate 
amplitude measured with MRS primarily arises from N-acetylaspartate within neurons, whereas 
oligodendrocytes and astrocytes only contribute 5%, respectively 10%, to this signal. This suggests 
that decreased N-acetylaspartate reflects a combination of axonal/neuronal loss (Bjartmar et al. , 
2000) and reduced mitochondrial metabolism (Bates et al. , 1996). In addition, it was shown that N-
acetylaspartate could be released into the extracellular space and be taken up by oligodendrocytes, 
where N-acetylaspartate is degraded back to aspartate and acetate by aspartoacylase (Chakraborty 
et al. , 2001, Wang et al. , 2007, Moffett et al. , 2011). It was further suggested that acetate 
generated by this reaction is used to build lipids for maintaining myelination (Chakraborty et al. , 
2001). Therefore a reduction in N-acetylaspartate might also relate to demyelination, a mechanism 
also known in Canavan’s disease (Kaul et al. , 1993). In line, various MRS studies in 
neurodegenerative diseases like Multiple Sclerosis (Abdel-Aziz et al. , 2015, Ciccarelli et al. , 2010), 
amyotrophic lateral sclerosis (Carew et al. , 2011), and Friedreich’s ataxia (Lenglet et al. , 2016) 
showed reduced levels of N-acetylaspartate. 
On the other hand, myo-Inositol is also considered as a glial marker as it is primarily located within 
astrocytes and presumed to act as an osmolyte, maintaining glial cell volume (Strange et al. , 1994, 
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Isaacks et al. , 1994). Activated glial cells present large cell volumes and are therefore accompanied 
by increases in myo-Inositol. Supporting this, preclinical findings showed upregulation of astrocytes 
after SCI (Gwak et al. , 2017, Rust and Kaiser, 2017), indicating chronic neuroinflammation. 
Consistently, in patients with Multiple Sclerosis, where neuroinflammation plays a major role, myo-
Inositol levels (and their ratios) are elevated (Kirov et al. , 2013), also in patients with remitting 
relapsing Multiple Sclerosis without recent relapses (Bagory et al. , 2012). However, myo-Inositol is 
also a precursor of phosphatidylinositol, a minor component of the cell membrane (Holub, 1982). 
Inter alia, the phosphatidylinositol signaling pathway is capable of activating other proteins and 
thereby is capable of changing their catalytic activities (Cockcroft, 2012). Specifically, in spinal 
oligodendrocytes, glucosamine and mannose can be glycosidically bound to phosphatidylinositol. 
Such glycosyl-phosphatidylinositol is expressed at the node of ranvier and inhibits neurite outgrowth 
(Huang et al. , 2005).  Therefore, it seems likely that increases in myo-Inositol levels primarily indicate 
upregulation of astrocytes, indicating neuroinflammation, but might also hint to altered cell 
membrane properties inhibiting regeneration. 
Finally, total choline receives contribution from free choline, glycerophosphocholine and 
phosphocholine, which are precursors of phosphatidylcholine (Wang et al. , 2008, Lindner et al. , 
2017), used for cell membrane synthesis, as well as for the synthesis of the neurotransmitter 
acetylcholine (Wang et al. , 2008). Total choline is typically increased when there is an increased 
membrane turnover or when there is inflammation (Howe and Opstad, 2003). In Multiple Sclerosis 
for example, choline is typically increased in acute phases of demyelination as the degradation of 
myelin leads to the release of phosphatidylcholine (Richards, 1991). Chronic neuroinflammation and 
demyelination in SCI is expected to lead to increased myo-Inositol levels along with increased choline 
levels as choline is two to threefold higher in glial cells than in neurons (Brand et al. , 1993). 
However, in our cohort, choline behaves oppositely leading to the conclusion that two biological 
scenarios might account for the observed ratio changes: 1) tNAA levels are decreased and myo-
Inositol is increased indicating neurodegeneration, demyelination and chronic neuroinflammation, or 
2) tNAA and choline levels are decreased suggesting neurodegeneration and altered membrane 
metabolism. Animal studies investigating the choline concentration after SCI (Qian et al. , 2010) 
reported highly elevated levels of choline early after injury, and even tough choline levels declined 
over time, they were still elevated 56 days after injury. This suggests that following SCI, there is an 
initial high membrane turnover indicating cell membrane breakdown and/or demyelination, which 
levels off over time. Nevertheless, it seems plausible that once degeneration has terminated, the 
total amount of choline is reduced, as there are less viable neurons capable of undergoing 
membrane turnover. At which time after injury degenerative processes are actually reaching their 
plateau still remains a matter of debate (Huber et al. , 2015); however our study included chronic 
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patients, on average 13.9 years after injury. In addition, we need to consider that choline is not only 
part of the membrane metabolism, but also acts as a precursor of acetylcholine. Acetylcholine is an 
important neurotransmitter whose inhibition/ breakdown leads to paralysis (Plaud et al. , 2010), and 
conversely, after SCI choline receptors are decreased leading to a disturbed cholinergic metabolism 
(Chinthu et al. , 2017). Therefore reductions in choline levels indicate neurodegeneration with 
potentially both altered membrane and neurotransmitter metabolism. 
We therefore conclude that the observed lower ratios of tNAA/mI and tCho/mI in patients are driven 
by reduction in tNAA and choline and increases in myo-Inositol, primarily indicating 
neurodegeneration, demyelination and chronic neuroinflammation [Fig. 16].  
In addition to the observed metabolic changes within areas of cord atrophy, the tNAA/mI ratio was 
positively associated with the amount of cord atrophy. This indicates that patients with a smaller SCA 
do not only have more pronounced neurodegeneration, but also the structure within the cord is 
altered; namely patients with smaller cord areas have less densely packed neurons and/or more 
ongoing neuroinflammation. Postmortem studies of humans with  SCI suggest that damaged spinal 
neurons may be partly replaced by fibrous connective tissue and collagen (Norenberg et al. , 2004), 
which might account for this finding. As there is no functional benefit in this replacement, this 
reorganization represents an impediment to axonal re-growth (Berry, 1982). 
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Figure 16: Schematic representation of 
possible mechanisms involved in metabolic 
alterations in chronic SCI taking place 
above the level of injury.   
1. In healthy controls, choline is used for the 
synthesis of phosphatidylcholine, which is a 
part of the cell membrane of neurons, 
astrocytes and oligodendrocytes. In chronic 
SCI, there are less cells capable of 
undergoing membrane synthesis as neurons 
degenerate, which may lead to a reduction 
in free choline.  
2. In healthy controls, resident astrocytes 
are present in the central nervous system. 
Injury to the CNS might lead to attenuation 
of reactive gliosis, which is characterized by 
cell body swelling of astrocytes mediated by 
the osmolyte myo-Inositol. Reactive 
astrocytes are one feature of 
neuroinflammation. 
3. NAA is synthetized in the mitochondria of 
neurons and therefore reflects 
mitochondrial metabolism. In healthy 
controls, oligodendrocytes possess the 
ability to take up NAA and degrade it into 
aspartate and acetyl; the latter being used 
for the synthesis of the myelin sheet. After 
an SCI, there might be impaired 
mitochondrial metabolism and less neurons 
capable of synthesizing NAA (i.e. 
neurodegeneration), which may influence 
myelination as well. 
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4.5.2 Relationship between lesion characteristics, cervical metabolic changes and 
clinical outcome 
We show that the size of tissue bridges at the lesion site is positively associated with tNAA/mI as well 
as tCho/mI ratio. This suggests that smaller tissue bridges, indicating less spared tissue (Huber et al. , 
2017b), leads to a stronger decrease of N-acetylaspartate and larger increase in myo-Inositol above 
the level of injury. Thus, the larger the initial damage at the lesion site, the more axons above the 
level of injury undergo retro- and anterograde degeneration, and the more neuroinflammation is 
present. Interestingly, tNAA/tCho ratio increased significantly with time since injury. As atrophy is the 
end result of neurodegeneration, one would expect a decrease of both choline and N-acetylaspartate 
over time. It seems therefore likely that choline shows a relatively larger decrease compared to N-
acetylaspartate. This progressive degeneration and change in molecular content is of particular 
importance when new treatments are investigated, as treatments in SCI patients should ideally start 
as early as possible to prevent further structural damage.  
The tNAA/mI ratio as well as tCho/mI ratios were positively associated with sensory and motor 
scores, indicating that patients with lower N-acetylaspartate (and/or choline), and higher myo-
Inositol levels have worse outcomes. Previous studies showed that neurodegeneration above the 
level of injury, reflected in a decreased total SCA, involves both grey and white matter and is 
associated with worse clinical outcome (Freund et al. , 2011a, Freund et al. , 2012b, Huber et al. , 
2017b). In addition, higher myo-Inositol levels indicate the presence of reactive astrocytes, which 
produce chondroitin sulfate proteoglycans as well as keratins, which inhibit axonal regeneration 
(Silver and Miller, 2004).  
4.5.3 Limitations 
All the metabolic values are presented as ratios to other metabolites and not as absolute values with 
respect to the internal water (Gasparovic et al. , 2006). Although absolute quantification is possible in 
the brain and the brainstem referencing to the internal water signal (Zoelch et al. , 2017), this is not 
yet possible in the spinal cord, since the water reference scan in the spinal cord is affected by the 
surrounding cerebrospinal fluid due to partial volume effect and thus does not serve as a reliable and 
valid reference. Therefore, future studies should aim to quantify absolute metabolite concentrations. 
Our applied proton MRS is specific for metabolite changes mainly associated with the integrity and 
viability of neurons. Additional techniques, like Sodium or Phosphorus-31 MRS would be helpful for 
future studies to better understand ongoing mechanisms in neurodegeneration (e.g. access failure of 
action potentials) (Paling et al. , 2013, Solanky et al. , 2013) or to monitor changes in myelin 
phospholipids to follow changes in myelin structure (Husted et al. , 1994). 
Despite the fact that the technique applied to acquire spectra in the spinal cord is the first to correct 
for phase and frequency shift, it lacks the possibility of patient motion correction. We minimized the 
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effect by using tight fitting cushions to restrict the possible range of motion of the patient’s head and 
cord and we split the total number of signal echoes acquired in the spinal cord into measurement 
acquisition blocks of 128 or 256 averages and re-adjusted the VOI based on an updated T2 image. 
Spinal cord MRS is a mixed readout of both grey and white matter tissue. In vivo MRS does not yet 
allow for differentiation of intracellular and extracellular metabolite levels.  
4.6 Conclusion 
Our study describes for the first time metabolic alterations of the atrophied cervical spinal cord in 
chronic SCI patients using non-invasive magnetic resonance spectroscopy. We show that the 
metabolic environment within the cervical cord is altered after SCI indicating a combination of 
chronic neuroinflammation, demyelination and neurodegeneration. Patients with larger cord atrophy 
showed more pronounced metabolic alterations. Further, the amount of metabolic changes is driven 
by lesion severity and relates to clinical impairment. Such sensitive and valid biomarkers hold the 
potential to improve outcome prediction and patient stratification for future clinical trials and 
interventions. 
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5.1 Abstract 
Objective: Spinal cord injury (SCI) leads to wide-spread structural changes of the pyramidal, sensory 
and limbic system. Animal models suggest that the extrapyramidal system, like the basal ganglia, 
plays a crucial role in recovering sensorimotor function after spinal trauma. We therefore 
investigated the spatial and temporal evolution of structural and microstructural changes and their 
association to outcome after acute SCI. 
Methods: Surface morphology, myelin and iron changes of the basal ganglia (including thalamus, 
striatum and globus pallidus) were defined from 182 MRI datasets acquired in 17 SCI patients and 21 
healthy controls.  T1-weighted volumes, myelin-sensitive magnetization transfer saturation (MT) and 
longitudinal relaxation rate (R1), and iron-sensitive effective transverse relaxation rate (R2*=1/T2*) 
provided information on morphometry and microstructure. All participants were scanned at 
baseline, after 3, 6, 12, and 24 months; SCI patients were assessed with a comprehensive clinical 
protocol at the same time points. Using linear regression models, we investigated group difference in 
linear and non-linear trajectories of vertex-wise surface area, and underlying microstructural changes 
(i.e. myelin, iron). Basal ganglia changes at baseline were used to predict 24-month clinical outcome, 
adjusted for baseline clinical status. 
Results: Surface-based analysis revealed contractions of surface area over time in the motor 
thalamus within regions representing lower extremities, within the pulvinar nucleus and within the 
striatum in patients compared to controls. Expansions of surface area were observed in the 
sensorimotor thalamus representing upper extremities, and in the striatum. As morphometric 
changes progressed, myelin-sensitive parameters decreased in the motor thalamus, in the striatum 
and in the globus pallidus. In addition, patients showed decreases in iron levels within the left post-
commisural caudate over time. Increased surface area expansions at baseline within the motor 
caudate predicted 24-month lower extremity motor score.  
Conclusion: This study provides evidence for progressive extrapyramidal macro- and microstructural 
changes after SCI, indicating large scale, transneuronal remodeling of primarily unaffected brain 
regions. We found a striking somatotopic reorganization pattern with foot representative regions, 
whereas hand representative areas exhibited compensatory local surface area increases. This study 
provides unbiased, quantitative readouts of extrapyramidal changes relating to clinical readouts, 
which might serve as future biomarkers. 
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5.2 Introduction 
Spinal cord injury (SCI) is a devastating event, which in most cases, leads to permanent paralysis 
below the level of injury. Targeted neurorehabilitation can foster recovery of limb function but often 
only partial improvements in motor function can be achieved. Neuroimaging studies have recently 
revealed that a cascade of neurodegenerative changes after injury is early initiated affecting the 
pyramidal, sensory and limbic system (Freund et al. , 2012a, Freund et al. , 2013ab, Grabher et al. , 
2015).  Importantly, less neurodegenerative changes early after injury accounted for functional 
recovery; however, details of reorganization by the surviving networks are not fully understood. 
Moreover, next to the motor system, animal models suggest that the extrapyramidal system plays a 
role in recovering motor function after corticospinal tract injury (Lawrence and Kuypers, 1968, 
Belhaj-Saif and Cheney, 2000, Zaaimi et al. , 2012). However, in humans, there is sparse evidence for 
anatomical and functional significance of the extrapyramidal system (Lemon, 2008), or for its role in 
sensorimotor recovery after SCI. The extrapyramidal system contains the basal ganglia which consists 
of the caudate nucleus, the putamen (together refered as striatum), and the globus pallidus and is of 
high importance for sensorimotor tuning (Huston et al. , 1990). Studies indicate that SCI leads to a 
misbalance in the information flow between the basal ganglia, the thalamus (Cramer et al. , 2005) 
and the motor cortex (Min et al. , 2015), which could explain abnormal activation patterns in in 
pallido-thalamocortical loop and increased functional connectivity, respectively. Furthermore, an 
increased functional activation of the basal ganglia during passive toe movement early after injury 
was associated with increased neurological outcome (Jung et al. , 2011), suggesting that the basal 
ganglia might play a crucial role in sensorimotor recovery. 
To better understand the role of the basal ganglia in sensorimotor recovery from a SCI, we acquired 
longitudinal data including T1-weighted volumes, myelin-sensitive magnetization transfer saturation 
(MT ) and longitudinal relaxation rate (R1), and iron-sensitive effective transverse relaxation rate 
(R2*=1/T2*) in SCI patients and controls, providing information on morphometry and microstructure. 
This study aims to (1) track the temporal and spatial (in terms of shape) pattern of structural basal 
ganglia changes within the first 24 months after SCI with distinct trajectories using T1-weighted 
volumes, (2) characterize associated microstructural changes like alterations in myelin and iron using 
MT, R1, and R2*, and (3) relate observed basal ganglia changes at 1-month post injury to appropriate 
24-month clinical outcome. For analysis of the sensorimotor system, usually volume or tensor-based 
approaches are used (Ashburner and Friston, 2000, Ashburner and Ridgway, 2012), alongside with 
standard imaging segmentation methods with whose the basal ganglia cannot be accurately 
assessed. We therefore applied a recently developed shape analysis technique (Chakravarty et al. , 
2013, Pipitone et al. , 2014) whose atlas is based on manually segmented serial histological data 
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(Chakravarty et al. , 2006); capable of segmenting thalamus, striatum, and globus pallidus fully 
automatically and unbiased. Such analyses hold the potential not only to complement traditional 
volumetric analysis, but might be even more sensitive in the detection of trauma-induced subcortical 
structural changes. To characterize structural trajectories of surface area and microstructural 
parameters, we modelled the MRI measures in terms of linear rate of change (reflecting 
degeneration/ plasticity) and non-linear changes in the rate (reflecting acceleration/ deceleration). 
Linear regression models were used for prediction of outcome. 
5.3 Materials and Methods 
5.3.1 Subjects 
17 patients with SCI and 21 healthy controls were recruited at the Balgrist University Hospital and 
from neighborhood between July 2010 and July 2016. All patients suffered from a subacute SCI (<3 
months) without brain injury, and all participants had no pre-existing neurological, mental or medical 
disorders affecting functional outcome, were older than 18 years, and had no contraindications to 
MRI. 
All participants underwent a comprehensive MRI protocol. In total, 182 appointments were 
conducted from 38 participants (21 healthy controls, 17 SCI patients) at baseline and at 3, 6, 12 and 
24 months. Follow-ups were performed successfully in 82.4%, 100%, 100% and 76.5% of the patients, 
respectively in 100%m 100%, 95.2% and 100% of the controls. At the same time points, patients were 
also clinical assessed including 1) International Standards for Neurological Classification of Spinal 
Cord Injury (ISNCSCI) protocol for motor, light-touch and pin-prick score (Kirshblum et al. , 2011), and 
2) the Spinal Cord Independence Measure (SCIM) to measure daily life independence (Itzkovich et al. 
, 2007).  
The study protocol was in accordance with the Declaration of Helsinki and was approved by the local 
ethics committee of Zurich (EK-2010-0271). All participants provided written informed consent 
before participation.  
5.3.2 Image acquisition 
Participants were scanned with a 3T Magnetom Verio or Skyra Fit MRI scanner (Siemens Healthcare, 
Erlangen, Germany) operated with a 16-channel radiofrequency receive head and neck coil and 
radiofrequency body transmit coil. To obtain high reproducibility and minimize motion artefacts, 
participants were carefully positioned in supine position and were asked to wear a stiff neck (Laerdal 
Medicals, Stavanger, Norway). 
At each time point, the MRI measurement consisted of two protocols: (1) an optimized 3 dimensional 
high-resolution T1-weighted Magnetization Prepared Rapid Acquisition Gradient-Echo (MPRAGE) 
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sequence (Tardif et al. , 2009) used to segment the basal ganglia structures, and (2) a multi-
parameter mapping (MPM) protocol based on multiecho 3D fast low angle shot (FLASH) sequence 
(Helms and Dechent, 2009, Draganski et al. , 2011) to extract underlying microstructural parameters. 
For the T1-weighted MPRAGE sequence, 176 sagittal partitions were acquired with a resolution of 
1mm isotropic within a nominal scan time of 9.04min (field of view (FOV) = 224x256mm2, repetition 
time (TR) = 2420ms, echo time (TE) = 4.18ms , inversion time = 960ms, flip angle (FA)= 9°, readout 
bandwidth = 150 Hz/pixel.  
The MPM protocol consisted of 3 volumes with different contrast-weights with 176 sagittal partitions 
and 1mm isotropic resolution scanned within a nominal time of 23min (FOV = 240 x 256mm2, 
readout bandwidth = 480Hz/pixel). The 3 different contrast-weighted volumes included a T1-
weighted image (TR = 25ms, FA = 23°), a proton density (PD)-weighted image (TR = 25ms, FA = 4°), 
and a magnetization transfer (MT)-weighted image (TR = 37ms, FA = 9°). For all MPM images, 
alternating gradient echoes were acquired at seven equidistant echo time points between 2.46ms 
and 17.22ms, whereas for T1-weighted and PD-weighted images one additional echo at 19.68ms was 
acquired. MT weighting was achieved by applying an off-resonance RF pulse prior to nonselective 
excitation. Parallel imaging with a speed-up factor of 2 was used in the phase-encoding (anterior–
posterior) direction using a generalized auto-calibration partially parallel acquisition algorithm 
(GRAPPA) to reduce the overall acquisition time. 
5.3.3 Image analysis 
5.3.3.1 Segmentation of basal ganglia based on T1-weighted MPRAGE images 
Thalamus, striatum, and globus pallidus were automatically identified using a newly developed 
segmentation algorithm known as the MAGeT brain algorithm (Chakravarty et al. , 2013, Pipitone et 
al. , 2014), which is based on serial histological data (Chakravarty et al. , 2006). In contrast to 
automated model-based segmentation approaches, where usually a single rater identifies an 
anatomical structure on a template which then serves as a label being co-registered to a specific 
subject’s unique neuroanatomy (Chakravarty et al. , 2009a, Chakravarty et al. , 2009b), MAGeT brain 
uses a multi-atlas-based strategy while still relying on a single well-defined template. This strategy 
overcomes the limitations of model-based segmentation, namely reduced accuracy induced by errors 
in the transformation estimation, incompatible neuroanatomical differences between the 
neuroanatomy of the template and the subject, and resampling errors after the application of the 
transformation to the labels. MAGeT brain algorithm uses a single atlas containing the thalamus, 
striatum, and globus pallidus based on the average of 27 MRIs of the same individual (Holmes et al. , 
1998). This atlas is first registered to a representative subset of the dataset (21 subjects) using 
nonlinear transformations (Chakravarty et al. , 2008, 2009ab). This set of subjects now serves as a set 
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of templates and all other subjects are now warped to these templates using non-linear registration, 
resulting in 21 candidate segmentations for each subject. Using a voxel-wise majority vote (Collins 
and Pruessner, 2010), the 21 candidate labels are fused to output the final segmentation. All 
segmented images were manually checked by two authors (RP, EH) to ensure high segmentation 
quality. After quality checking the segmentation, one baseline scan of one healthy control was 
excluded. This results in a total number of MPRAGE scans analyzed of 20/17 (controls/ patients) at 
baseline, 21/14 at 3-month, 21/17 at 6-month, 20/17 at 12-month and 21/13 at 24-month. 
5.3.3.2 Surface area calculation 
A surface-based methodology originally proposed by Lerch et al. (2008) was modified to benefit from 
the multiple nonlinear deformation fields, created during the image segmentation process, that map 
each subject to the original atlas. First, the shape of each structure was estimated by applying the 
marching cube algorithm (Lorensen and Cline, 1987) to the input atlas of each subject, which was 
then morphologically smoothed using the AMIRA software package (Visage Imaging; San Diego, CA, 
USA). The resulting surfaces consist of about 3000 per thalamus, 6300 vertices per striatum, and 
1200 per globus pallidus. Second, transformations from the 21 candidate segmentations were 
averaged within each subject and then across the template library to reduce noise (Frey et al. , 2011).  
This procedure also results in 21 possible surface segmentations, which are subsequently merged for 
each subject and time point, resulting in a new surface representation for each basal ganglia 
structure for each subject and time point.  Surfaces are merged by identifying the median location of 
each vertex in all 21 possible surfaces. Then, for each vertex, a third of the surface of each 
connecting triangle is assigned to the vertex surface area. A surface-base diffusion-smoothing kernel 
was then applied (5 mm and 3 mm for the thalamus/ striatum and globus pallidus, respectively). This 
provides surface-area values (Raznahan et al. , 2014) parallel to the normal, offering measures of 
surface contraction and expansion. 
5.3.3.3 Microstructural analysis 
MT-weighted, PD-weighted, and T1-weighted FLASH volumes were used to calculated quantitative 
MT, R1, and R2* maps as described previously (Helms and Dechent, 2009, Draganski et al. , 2011, 
Weiskopf et al. , 2011). R1 maps were corrected for radiofrequency transmit field in homogeneities 
with UNICORT (Weiskopf et al. , 2011). For each subject and time point, MT, R1, and R2* maps were 
coregistered to their respective T1-weighted image using a 6 parameter registration with a 
normalized mutual information cost function (https://github.com/CobraLab/minc-toolkit-
extras/blob/master/bestlinreg_g). After coregistration, segmentations of the thalamus, striatum, and 
globus pallidus (including the subnuclei) obtained from MAGeT Brain were used as a binary mask to 
extract mean values of MT, R1, and R2* for each subject and timepoint. The first subjects and 
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patients included in this study did not receive the MPM protocol. After quality checking, data was 
excluded from 1 healthy control at 3-month, and of 2 patients at baseline, and of 1 patient at 12-
month resulting in a total number of scans analyzed of 17/12 (patients/controls) at baseline, 17/11 at 
3-month, 18/16 at 6-month, 17/17 at 12-month, and 18/13 at 24-month. 
5.3.4 Statistics 
R software package (R Core Team, 2016) was used for all statistical analysis. Clinical measures and 
vertex-wise shape measures were analyzed using mixed-model regression as it permits the inclusion 
of multiple measurements per person at different time points and at irregular intervals between 
measurements (Pinheiro and Bates, 2000). We first compared rates of change of these measures 
between patients and healthy controls by including a group × time (reflecting degeneration 
/plasticity) and a group x squared time (reflecting acceleration/ deceleration) interaction in the 
regression model. For clinical measures, time was modelled on a log scale to account for non-linear 
recovery patterns. Age and sex terms were included to accommodate potential confounding effects. 
To identify in which specific nuclei group differences are observed, we superimposed a 
cytoarchtiectonic atlas for the thalamus (Chakravarty et al. , 2006, Chakravarty et al. , 2008) on our 
thalamic template. Second, in those structures that showed group differences in surface area over 
time, we explored for underlying differences in microstructure (MT, R1, R2*) using the same models. 
Last, associations between early shape structure at 1-month and clinical outcome at 24-month were 
investigated using linear regression models adjusted for age and gender. As baseline clinical scores 
are known to have an important influence on the primary outcome, we further adjusted significant 
models for appropriate clinical baseline scores. All vertex-wise analyses were corrected for multiple 
comparisons using the false discovery rate (FDR) at 10% (Genovese et al. , 2002).  
5.4 Results 
5.4.1 Demographics 
We included a total of 17 SCI patients (43.8±19.9 years, 14 male) and 21 healthy controls (33.8±9.8 
years; 13 male); they did not significantly differ in age compared to the controls (p<0.05). The 
baseline scan was acquired 1.4±0.5 months after injury, respectively at 3.5±1.5, 7.1 ± 1.9, 13.3±3.1 
and 28.7±5.1 months after injury for the 3-, 6-, 12- and 24-month scan. Eight patients were 
tetraplegic and 9 patients were paraplegic. All clinical data of patients is summarized in Table 8. 
Over the 2 years, patients recovered by 2.76 points per log month on their lower extremity motor 
score (p=0.001, 95%CI: (1.07 4.45)), by 0.91 point per log month on their upper extremity motor 
score (p=0.046, 95%CI: (0.02 1.80)), and by 7.89 points per log month on their SCIM score (p<0.001, 
95CI: (5.03 10.75)). Light-touch and pin-prick score remained unchanged over time (p=0.152, 
p=0.790).  
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ID Age at 
injury 
Injury 
type 
Initial Site of 
Impairment  
(motor/sensor
y) 
INSCSCI upper 
extremity motor score  
(Baseline/ 24-months) 
INSCSCI lower 
extremity motor score 
(Baseline/ 24-months) 
INSCSCI light-touch 
score 
(Baseline/ 24-
months) 
INSCSCI pin-prick 
score 
(Baseline/ 24-
months) 
SCIM score 
(Baseline/ 24-
months) 
1 18 Fall C5/ C4 19/ 22 0/ 0 24/ 30 27/ 32 4/ 22 
2 23 Fall C7/ C6 42/ 48 0/ 23 69/ 70 38/ 33 23/ 70 
3 68 Fall T10/ T10 50/ 50 2/ 31 78/ 74 75/ 65 41/ 46 
4 44 Fall T12/ T12 50/ 50 39/ 45 107/ 106 109/ 98 84/ 100 
5 42 Fall T11/ T11 23/ 26 0/ 0 27/ 21 20/ 17 18/ 41 
6 71 Fall C7/ C8 36/ 48 16/ 42 85/ 66 36/ 25 17/ 43 
7 20 MVA C5/ C5 21/ 21 0/ 0 21/ 45 19/ 18 4/ 39 
8 30 MVA C7/ C8 47/ 47 0/ 0 64/ 72 35/ 30 38/ 40 
9 52 Fall T9 / T9 50/ 50 48/ 49 95/ 94 89/ 90 84/ 100 
10 42 MVA C5/ C4 41/36 46/ 48 104/ 99 104/ 96 99/ 100 
11 29 Fall T11/ T11 50/ 50 10/ 12 86/ 76 88/ 69 52/ 68 
12 71 ischemia T1/ T10 50/ 50 43/ 50 88/93 72/ 67 47/ 69 
13 71 CSM T1/ T4 50/ 50 43/ 50 83/ 112 81/ 112 56/ 97 
14 73 ischemia T1/ T11 50/ 50 0/ 0 75/ 71 77/ 72 28/ 36 
15 31 SA C4/ C5 20/ 26 0/ 0 22/ 31 19/ 20 13/ 25 
16 28 SA C4/ C3 15/ 10 0/ 0 14/ 23 14/ 23 16/ 20 
17 32 SA T1/ T4 50/ 50 9/ 50 79/ 112 58/ 77 40/ 96 
Table 8: Clinical and epidemiological data for all patients included in the study.  
Abbreviations: AIS = American Spinal Injury Association Impairment Scale; GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension; NA = 
not available; NS = no signal alteration within myelon; SA = Swimming Accident; SCIM = Spinal Cord Independence Measure; WISCI = Walking Index for Spinal Cord 
Injury 
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5.4.2 Time course of vertex-level surface area changes 
The surface area analysis demonstrated linear changes over time in patients compared to controls in 
the thalamus and striatum, but not in the globus pallidus.  
Specifically, both thalami showed surface expansion in patients compared to controls over time 
within the superior parts of the ventral anterior nuclei (VAN), and surface contractions within its 
inferior parts (Fig. 17). In the left thalamus, these changes were levelling-off over time (i.e. negative/ 
positive quadratic term) (Fig. 18). In the superior parts of the ventral lateral nuclei (VLN), both 
thalami showed linear surface expansions in patients compared to controls over time. In addition, 
the left thalamus showed surface contraction in patients compared to controls within the inferior 
parts of the VLN. Both thalami showed surface expansions within the posterior part of the ventral 
posterior nuclei (VPN). The right thalamus also showed contractions within the anterior part of the 
VPN. Both changes within the right VPN were levelling-off over time. Left and right pulvinar nuclei 
showed linear surface contractions in patients compared to controls, in particular within lateral and 
the medial pulvinar. 
Figure 17: Linear shape differences within the thalamus estimated as significant surface area 
contractions and expansions. All surface area contractions (representing degeneration) are 
represented in blue color, and all surface area expansions (reflecting compensatory plasticity) are 
shown in red color. Compared to controls, patients showed contractions of surface area within the 
inferior part of the ventral anterior and ventral lateral nuclei (motor nuclei) and within the pulvinar 
nuclei over the first 24 month after SCI. Surface area expansions were evident in the superior parts of 
the ventral anterior and ventral lateral nuclei (motor nuclei), as well as within the ventral posterior 
nuclei (sensory nuclei). 
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Figure 18: Quadratic shape differences within the thalamus estimated as significant surface area 
contractions and expansions. All surface area contractions are represented in blue color, and all 
surface area expansions are shown in red color (both reflecting levelling-off of linear changes). 
Compared to controls, patients showed levelling-off of surface area contractions within the left 
ventral anterior nucleus and within the right ventral lateral nucleus. Surface area expansions levelled-
off bilaterally within the ventral anterior nuclei and within the left ventral posterior nucleus. 
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In the striatum, patients showed bilateral surface area contractions and expansions over time in the 
caudate and the putamen compared to controls. Specifically, bilateral contractions were evident 
medially within the central to posterior part of the caudate (Fig. 19A), which levelled-off over time in 
patients compared to controls (Fig. 20). Bilateral expansions of surface area were observed in the 
inferior part of the anterior caudate (Fig. 19B), also bilaterally levelling-off over time, and in the 
inferior parts of the ventral caudate (i.e. nucleus accumbens; Fig. 19C), which showed a levelling-off 
over time at the left side only. Unilateral contraction of surface area was evident in the left lateral 
part of the anterior caudate (Fig. 19D). Within the putamen, bilateral contractions of surface area 
were observed in the medial central (Fig. 19E) as well as the lateral anterior putamen (Fig. 19F). The 
surface area of the right lateral anterior putamen showed a levelling-off over time in patients 
compared to controls. In addition, surface area contractions were observed in the left medial 
posterior (Fig. 19G), left medial anterior (Fig. 19H) and left lateral superior posterior putamen (Fig 
19I). Expansions in surface area were detected within the left medial anterior (Fig. 19J) and lateral 
anterior putamen (Fig 19K). Expansions within the left anterior putamen levelled-off over time in 
patients compared to controls. 
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Figure 19: Linear shape differences within the striatum estimated as significant surface area 
contractions and expansions. All surface area contractions (representing degeneration) are 
represented in blue color, and all surface area expansions (reflecting compensatory plasticity) are 
shown in red color. Compared to controls, patients showed contractions of surface area within the 
putamen, and the caudate, in particular in regions involved in sensorimotor and emotion processing, 
and in cognitive function over the first 24 month after SCI. Surface area expansions were evident in 
regions involved in cognition, emotion and reward processing. Please note that the atlas on the right 
shows the somatotopy of the striatum, based on a review of functional MRI studies (Arsalidou, 2013). 
Labels therefore represent approximate regions of corresponding functions. 
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Figure 20: Quadratic shape differences within the striatum estimated as significant surface area 
contractions and expansions. All surface area contractions are represented in blue color, and all 
surface area expansions are shown in red color (both reflecting levelling-off of linear changes). 
Compared to controls, patients showed levelling-off of surface area contractions within regions 
involved in sensorimotor and emotion processing over the first 24 month after SCI. Surface area 
expansions levelled-off in regions involved in cognition, emotion and reward. Please note that the 
atlas on the right shows the somatotopy of the striatum, based on a review of functional MRI studies 
(Arsalidou, 2013). Labels therefore represent approximate regions of corresponding functions. 
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5.4.3 Time course of microstructural changes 
Within the thalamus, the left VAN (patients decrease by 6.527s-1/month [95% CI: (-11.526 -1.527)] 
more than controls, p=0.011), the left (patients decrease by 6.054 -1/month [95% CI: (-11.018 -1.089)] 
more than controls, p=0.017) and right VLN (patients decrease by 5.156s -1/month [95% CI: (-9.760 -
0.552)] more than controls, p=0.028), and the left VPN (patients decrease by 5.185 s-1/month [95%CI: 
(-10.214 -0.157)] more than controls, p=0.043) showed progressive decreases of myelin-sensitive R1, 
which levelled-off over time in all structures except the VPN (left VAN: 0.193 s-1/month2, 95%CI: 
(0.032 0.354), p=0.019; left VLN: 0.173 s-1/month2, 95%CI: (0.0131 0.333), p=0.034; right VLN: 0.159 s-
1/month2, 95%CI: (0.011 0.307), p=0.036).  
In the striatum, we observed a greater rate of linear decrease of myelin-sensitive MT in the left 
(patients decrease by 0.020-1/month [95% CI: (-0.039 -0.001)] more than controls, p=0.047) and right 
ventral striatum (patients decrease by 0.017s-1/month [95% CI: (-0.033 -0.001)] more than controls, 
p=0.037), and in the left pre-comissural caudate (patients decrease 0.020s-1/month [95% CI: (0.038 -
0.003)] more than controls, p=0.021) in patients compared to controls. In addition, myelin-sensitive 
R1 decreased within the left pre-commisural caudate (patients decrease by 4.598s-1 per month [95% 
CI: (-8.887 -0.308)] more than controls, p=0.036), and levelled-off over time (0.164 s-1/month2, 
95%CI: (0.025 0.303), p=0.021). The left post-comissural caudate showed greater rate of linear 
decreases in iron-sensitive R2* in patients compared to control (patients decrease by 0.001s-1/month 
[95% CI: (-0.001 -0.001)] more than controls, p=0.034). 
Patients had a significantly greater rate of linear change of myelin-sensitive R1 in the left (patients 
decrease by 5.570s-1/month [95% CI: -10.728 -0.411] more than controls, p=0.034) and right globus 
pallidus (patients decrease by -5.674s-1 per month [95% CI: -10.763 -0.585] more than controls, 
p=0.029), which levelled-off over time (left:  0.178 s-1 /month2, 95%CI:  0.013 0.343, p=0.034; right: 
0.187s-1/month2, 95%CI: 0.024 0.350, p=0.024).  
5.4.4 Relationship of 1-month macro- and microstructural parameters and outcome 
Significant relationships between local surface area of the basal ganglia at 1-month and 24-month 
clinical outcome were observed in the left and right striatum. Increased surface area expansions 
within the central caudate and the lateral central-posterior putamen at 1-month were associated 
with better lower extremity motor score at 24-months. This relationship persisted even when 
corrected for 1-month lower extremity motor score (Fig. 21A). 
Higher iron-sensitive R2* levels within the left and right pulvinar nuclei were associated with lower 
24-month pin-prick score (left: p=0.036, R2=0.57, 95%CI: (-8946.01 -385.67); right: p=0.02, R2=0.58, 
95%CI: (-11298.95 -776.50)) (Fig. 21B). When adjusted for baseline clinical score, this relationship did 
not sustain. 
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Figure 21: Relationship between 1-month structural and microstructural parameters and outcome. 
A) Local morphological features of the striatum (motor region) at 1-month post injury predicted 24-
month lower extremity motor score, adjusted for age, gender and appropriate baseline clinical score. 
Red blobs indicate surface area expansions (reflecting compensatory plasticity) – patients with 
increased surface area at 1-month presented better 24-month lower extremity motor score. B) 
Higher R2* values at 1-month, indicating higher iron levels, predicted 24-month pin-prick score. 
When corrected for appropriate baseline score, this association did not persist. 
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5.6 Discussion 
In this study, patients showed a distinct pattern of structural changes in the extrapyramidal system 
comprising the thalamus, striatum and globus pallidus within the first 2 years after SCI. Over time, we 
observed both surface contractions and extensions, along with underlying changes in microstructural 
parameters indicative of demyelination and iron changes. At 1-month such changes within the motor 
caudate were predictive of 24-month lower extremity motor score, even when adjusted for clinical 
baseline score. 
5.6.1 Time course of surface area and microstructural changes 
Previous studies have described anatomical and functional changes within the thalamus after SCI 
(Pattany et al. , 2002, Grabher et al. , 2015, Jutzeler et al. , 2016). We provide new evidence by 
showing which sub-regions of the latter structures are most affected.  Specifically, patients showed 
bilateral surface area expansions over time in the superior aspects of the VAN, VLN and VPN 
compared to controls, and surface area contractions in the inferior parts of the VAN and the VLN, 
paralleled by decreases in myelin-sensitive R1. The VAN and the VLN are two nuclei of the motor 
thalamus, with the VAN mainly receiving input from the globus pallidus and projecting to the 
premotor cortex, and the VLN receiving afferents from the substantia nigra, globus pallidus and the 
cerebellum and projecting to both primary motor cortex and premotor cortex (Nambu, 2011). The 
VPN on the other hand, is the thalamic principal somatosensory nucleus receiving input from the 
lemniscus medialis (transmitting light touch, vibration, and proprioception) and from the 
spinothalamic tract (transmitting pain and heat sensation), and projecting to the premotor cortex. As 
within the primary motor and sensory cortices, the sensorimotor thalamic nuclei are also organized 
somatotopically (Nambu, 2011) with distal muscles being represented dorsal to those for proximal 
limb portions; and more cranial representations were found more anterior (Asanuma and 
Hunsperger, 1975, Strick, 1976, Asanuma et al. , 1983, Vitek et al. , 1994, Schmid et al. , 2016). As the 
sensorimotor thalamus is well conserved across vertebrates, it is likely that the somatotopy is also 
conserved in humans (Bosch-Bouju et al. , 2013). We therefore interpret our observed contractions 
of surface area in the motor thalamus as local changes within the distal parts of the limbs, in 
particular in leg areas, and  our observed surface area expansion within the sensorimotor thalamus 
as changes within proximal part of the limbs, in particular in hand areas. Based on animal studies, 
possible mechanisms for local volume decreases (i.e. surface area contractions) might include 
changes in the amount of neurons induced by trans-synaptic degeneration, neuronal death, 
demyelination, synaptic pruning, or changes in the amount of glial cells (Hains et al. , 2003, Kim et al. 
, 2006). On the other hand, axonal sprouting and activity-dependent plasticity (Lee et al. , 2004) 
might account for volume increases (i.e. surface area expansions). In particular, compensatory use of 
the upper limbs might drive expansion of cortical M1 hand area into output-deprived leg area (Ghosh 
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et al. , 2010) as a consequence of the rewiring of axotomized hind limb neurons onto cervical motor 
circuits (Ghosh et al. , 2010); the same mechanism might also be reflected in the basal ganglia. As 
such observed surface area changes are not specific to any single pathological process, R1 
complement such readouts as they are reflective of demyelination (Lutti et al. , 2014), increases in 
proton density (Gelman et al. , 2001, Rooney et al. , 2007, Harkins et al., 2015), or decreases in lipid 
content indicative of degeneration (Stanisz et al. , 2005).  Overall, demyelinating processes seem to 
be present within the sensorimotor nuclei of the thalamus. 
In addition to sensorimotor nuclei in the thalamus, the lateral and medial pulvinar nuclei showed 
surface area contraction over time. They are involved in visual attention regulation, and also link 
visual stimuli with contex- specific motor responses (Petersen et al. , 1987). Furthermore, the medial 
pulvinar also integrates multimodal sensory inputs with limbic influence and coordinates such 
sensory input with its corresponding motor response (Cappe et al. , 2009). As most SCI patients have 
motor and sensory deficits, it seems likely that the coordination between these two modalities is also 
altered. In addition, both animals and humans show altered visual activity and connectivity between 
the visual cortex and other regions after SCI, (Hawasli et al. , 2018), maybe because they rely 
stronger on their visual input in order to coordinate limb movements 
Similarly, in the striatum, we observed surface area contractions in patients compared to controls in 
regions involved in cognition, sensorimotor and emotional processing and surface area expansions 
were observed in regions involved in cognition, emotion and reward processing (Arsalidou et al. , 
2013). These changes were paralleled by decreases in myelin-sensitive R1 and MT (Helms et al. , 
2008, Helms and Dechent, 2009). Interestingly, we observed bilateral surface area contraction within 
thin the medial and lateral dorsal part of the motor putamen, and as the putamen consists of two 
sets of somatotopic representation (Tokuno et al. , 1999), this indicates loss of afferents from both 
the primary motor cortex and the supplementary motor area. This is in line with previous studies, 
showing that both of these structures show altered function and structure (Bruehlmeier et al. , 1998, 
Wrigley et al. , 2009a, Freund et al. , 2013ab, Hou et al. , 2014, Jutzeler et al. , 2016). In addition, 
whereas most studies show elevated iron levels in neurodegenerative diseases (Andersen et al. , 
2014), we found decreased R2* in the left post-comissural caudate over time in patients compared 
to controls. R2* maps (=1/T2*) are linearly correlated with tissue iron concentration (Yao et al. , 
2009). Interestingly, this is the region processing sensorimotor function and showing most prominent 
surface area contractions. In healthy controls, iron enters the brain via the blood system bound to 
transferrin and is afterwards presumably taken up by oligodendrocytes and to a less extend by 
pericytes (Gerber and Connor, 1989) to prevent the environment of the toxic effect of iron and its 
generated free radicals. In neurodegenerative disorders, it is thought that glial cells are not able to 
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fully take up iron and therefore iron accumulation appears within disease-specific regions affected by 
neurodegeneration (Andersen et al. , 2014). Possible mechanism for our observed changes might 
involve chronic neuroinflammation, which is characterized by the invasion of astrocytes and 
microglia. It was previously shown that iron uptake persists in the central nervous system even in the 
absence of normal oligodendrocytes and myelin, with astrocytes and microglia sequestering iron via 
phagocytosis (Connor and Menzies, 1990). 
Last, the globus pallidus did not exhibit any surface area changes in patients over time, but we 
observed decreases in myelin-sensitive R1 in the absence of macrostructural changes pointing at the 
increased sensitivity of MPM protocols. 
5.6.2 Relationship of 1-month macro- and microstructural parameters and outcome 
In the present study, we revealed that at 1-month, surface area expansions within the motor 
striatum were predictive of 24-month lower extremity motor score and R2* within the pulvinar 
nuclei predicted 24-month pinprick score. Previous studies showed that volume changes within the 
first 12 months after injury within the right internal capsule, which also encompasses the 
corticospinal tract, were associated with total motor score at 12-months (Freund et al. , 2013a). In 
addition, volume changes within the corticospinal tract (at the level of the medullary pyramid) and 
the pons, as well as MT changes within the sensorimotor cortex within the first 6 month after injury 
were predictive of 24-month lower extremity motor outcome (Ziegler et al. , 2018). Changes of R2* 
within the first 6-month in the right cerebellum and ACC were predictive of 24-month pin-prick score 
(Ziegler et al. , 2018).  
It might appear rather surprising at first, that the basal ganglia predict outcome earlier than the 
primary motor cortex and the corticospinal tract, as the latter are directly involved in execution of 
movements, whereas the basal ganglia are rather orchestrating and fine-tuning motor commands. 
However, the mechanisms of reorganization might be fundamentally different. After SCI, the motor 
system undergoes degenerative changes in grey and white matter, relating to neuronal 
degeneration, demyelination, shrinkage of somata of pyramidal neurons (Wannier et al. , 2005) and 
apoptotic cell death in a proportion of axotomized cortical motor neurons (Hains et al. , 2003). 
Characterizing the temporal evolution of Wallerian degeneration and distinguishing this effect from 
other mechanisms (e.g. volume changes associated with changes glia cells) is challenging in humans 
and has so far not fully been characterized. In animals, degenerative changes within the primary 
motor cortex have been observed within the first weeks after injury (Hains et al. , 2003, Kato et al. , 
1997). However, as the distance from lesion to cortical areas is much smaller than in humans and 
MRI methods are less sensitive than histological analysis, it seems rationale that this process cannot 
be observed at the earliest stages after human injury. In addition, clinical motor scores solely 
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measures strength of different muscles, but the primary motor cortex represents movement, defined 
as coordinated motions about joints, rather than single muscle strength. We speculate that this 
might be reasons, that early markers within the motor system are not predictive of long-term clinical 
outcome. 
Within the basal ganglia, early surface area expansions within motor regions of the striatum 
predicted lower extremity motor score. In contrast to the motor system, this speaks for 
compensatory plasticity – a phenomena also known in Multiple sclerosis (Hier and Wang, 2007) and 
Parkinson’s disease (Worker et al. , 2014). After SCI, the transection of corticospinal axons causes a 
decrease of target-derived trophic support of the cell bodies, which leads to a decreased regional 
blood flow along with decreased activation in the motor cortex in the early phase after injury (Cermik 
et al. ,2006; Jurkiewicz et al. , 2007), accompanied by increased activation in associated sensorimotor 
regions. Specifically, increased intra-hemispheric functional interaction within the primary motor 
cortex, premotor cortex, SMA, thalamus and cerebellum was observed (Hou et al. , 2014). In line, 
Min et al. (2015) showed increased function connectivity between the secondary somatosensory 
cortex  and the basal ganglia, suggesting that the basal ganglia affects movement by gating sensory 
inputs in motor areas (Lidsky et al. , 1985). In functional imaging studies in monkeys, an increased 
activity of the ventral striatum was shown during a reach- and grasp task in association with the 
primary motor cortex (M1) when the animals were recovering from an incomplete SCI (Nishimura et 
al. , 2007, Nishimura et al. , 2011); the amount of activity being associated with the  extent of 
recovery. Pharmacologically inactivating the ventral striatum early after injury led to a reduced 
activity in the sensorimotor cortex which was accompanied by a diminished recovery of the 
dexterous finger movements during rehabilitation (Sawada et al. , 2015). This suggests that the 
striatum plays a direct role in finger movement control. We therefore speculate that early structural 
changes within the motor striatum may reflect activity-dependent plasticity, leading to increased 
functional activity helping to compensate for the motor dysfunction. Our data suggests that 
establishing novel structural substrates (e.g. axonal sprouting, myelination) within the 
extrapyramidal system helps in recovery after SCI. 
5.6.3 Limitation 
This study had a number of limitations. First, the applied MPM protocol, consisting of MT, R1 and R2* 
measures, are sensitive to demyelination, degeneration and iron content, but not specific to them as 
they are indirect markers of such processes. Therefore, we cannot certainly identify the exact 
underlying pathological process. Second, although we identified the gross location of changes within 
the striatum and the globus pallidus, we currently lack a histology-based atlas of the striatum and the 
globus pallidus. Second, although our groups did not significantly differ in age or gender; the mean 
age was on average higher and there were less women in the patients group, which could potentially 
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affect the analysis. We therefore adjusted for age and gender as potential confounders of no interest 
in all analyses. Last, in future studies we hope to better understand underlying mechanisms driving 
basal ganglia changes by investigating the relationship of structural changes between motor and 
sensory cortex, their associated regions, and the basal ganglia. Such studies of structural connectome 
will help to better understand the structure and function of complex brain networks and their role 
after SCI. 
5.7 Conclusion 
In summary, this study provides evidence for progressive extrapyramidal macro- and microstructural 
changes after SCI, indicating large scale, transneuronal complex remodeling of primarily unaffected 
brain regions. We observed surface area contractions and expansion in the thalamus and the 
striatum, with a remarkable somatotopic reorganization pattern with its sensorimotor regions, along 
with microstructural changes. In particular, foot representative regions showing sign of 
degeneration, demyelination and/or neuroinflammation, whereas hand representative areas 
exhibited local surface area increases, indicative of ongoing compensatory mechanism (axonal 
sprouting and activity-dependent plasticity).  Importantly, increased compensatory reorganization 
within the motor caudate at 1-month were predictive of 24-month lower extremity motor score, 
adjusted for baseline clinical status. This study therefore provides unbiased, quantitative readouts of 
nuclei-specific changes relating to clinical readouts, which might serve as future biomarkers. 
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reviewed the manuscript. 
6.1 Abstract 
Purpose of review: This review will highlight the latest findings from neuroimaging studies that track 
structural and functional changes within the central nervous system at both the brain and spinal cord 
levels following acute human spinal cord injury (SCI). The putative, underlying biological mechanisms 
of structural change (e.g. degradation of neural tissue) rostral to the lesion site will be discussed in 
relation to animal models of SCI and their potential value in clinical studies of human SCI.  
Recent findings: Recent prospective studies in human acute SCI have begun to reveal the time-
course, spatial distribution and extent of structural changes following an acute SCI and their relation 
to functional outcome. Adaptive changes in sensory and motor pathways above the level of the 
lesion have prognostic value and complement clinical readouts.  
Summary: The introduction of sensitive neuroimaging biomarkers will be an essential step forward in 
the implementation of interventional trials in which proof-of-concept is currently limited to clinical 
readouts, but more responsive measures are required to improve the sensitivity of clinical trials.  
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6.2 Introduction 
Key points 
 Innovative new multimodal MR protocols allow for the quantification of trauma-induced white 
and gray matter changes in the spinal cord and the brain above the level of SCI.  
 Longitudinal studies in both animals and humans are key to understand the course of structural 
and functional changes from the acute to the chronic stage of SCI, as well as the prediction of 
early structural changes and their relation to clinical outcomes. 
 Translation between experimental animal models of SCI and clinical (human) SCI will be essential 
to provide information about the comparability of these models and their ability to distinguish 
specific disease stages such as how to define the transition from acute to chronic SCI, the 
dynamic stages of secondary axonal and/or myelin degeneration and training or treatment-
induced effects of repair and neural plasticity. 
 
Spinal cord injury (SCI) is a devastating life event affecting mostly the young (mean age at injury: 33 
years) and is 3.8 times more prevalent in men than in women (Wyndaele and Wyndaele, 2006). 
Worldwide, about 23 cases per million occur annually (Cripps et al. , 2011) with tetraplegia slightly 
more common than paraplegia (Wyndaele and Wyndaele, 2006). In the majority of instances, 
patients are left with profound and persistent functional impairments such as immediate paralysis, 
sensory disturbance and the emergence of neuropathic pain at or below the level of injury as a 
secondary complication (Siddall and Loeser, 2001, Siddall et al. , 2004). A main reason for the limited 
degree of recovery following SCI relates to failure of the interrupted nerve fiber tracts to regenerate 
across the lesion site in the adult central nervous system (CNS) of mammals and humans (Schwab, 
2004). Important impediments that form the basis of this phenomenon are proteins expressed in 
CNS myelin (e.g. Nogo-A), which inhibit neurite growth, and the formation of a glial scar that contains 
extracellular matrix molecules such as chondroitin sulphate proteoglycans (Kwok et al. , 2014). Apart 
from the failure to regenerate, plastic ‘hardware’ changes in the adult CNS of mammals and humans 
are restricted. Experimental treatments against these impediments have resulted in first-in-man 
phase-I trials for human SCI including anti-Nogo-A antibody treatments (Starkey and Schwab, 2012), 
stem cell transplantation (HuCNS-SC: NCT01321333 identified in ClinicalTrials.gov) and drug 
administration (Riluzole: NCT00876889 identified in ClinicalTrials.gov; Minocycline: identified as 
NCT00559494 in ClinicalTrials.gov; for a review, see Nagoshi and Fehling, 2015). Although much has 
been learned from these trials, they suffer from a lack of adequate outcome assessments and 
sensitive biomarkers with the potential to stratify the highly diverse patients into homogenous 
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cohorts and validate the efficacy of drugs (Tanadini et al. , 2014, Velstra et al. , 2014). To enable 
efficient translation, these interventions require biomarkers that can be used as surrogate makers of 
safety and efficacy of agents in a timely and economical manner (Cadotte and Fehlings, 2013). 
This review addresses the structural and functional plasticity (i.e. secondary, rostral and degenerative 
structural changes) in both the spinal cord and the brain after SCI against the background of current 
advances in the field, their relation to clinical outcomes as well as challenges and future avenues in 
clinical SCI research.  
6.3 Human spinal cord injury: non-invasive tracking of trauma-induced 
changes 
Conventional magnetic resonance imaging (MRI) remains the gold standard for identifying the 
localization and the extent of an SCI (Dietz and Curt, 2006, Fehlings et al. , 2011) but does not allow 
for the quantification of trauma-induced disruption to the microstructure of the spinal cord and 
supraspinal changes. Novel quantitative MRI protocols of the spinal cord and brain have the potential 
to measure neural changes at the microstructural level. This is because the degree of myelination, 
iron content and neuronal microstructure are reflected in MR relaxation times, magnetization 
transfer and diffusion-weighted images which can be measured at high resolution (Mohammadi et al. 
, 2013b, Callaghan et al. , 2014, Mohammadi et al. , 2014). These novel quantitative MR methods 
include multiparametric mapping (Draganski et al. , 2011, Weiskopf et al. , 2011, Dick et al. , 2012, 
Weiskopf et al. , 2013, Lutti et al. , 2014) and diffusion tensor imaging (Le Bihan et al. , 2012) next to 
volumetric measures (i.e. voxel-based morphometry (Ashburner, 2009) and voxel-based cortical 
thickness (Hutton et al. ,2009). 
6.3.1 Structural changes 
By means of computational anatomy, trauma-induced structural changes have been revealed across 
the entire neuroaxis. In chronic SCI patients, cervical cross-sectional cord area, rostral to the site of 
injury, was reduced by up to 30% and white matter integrity within the corticospinal tracts altered 
(Cohen-Adad et al. , 2011, Freund et al. , 2011a, Petersen et al. , 2012). Further upstream, structural 
changes in terms of volume and microstructure within the white matter of the pyramids and internal 
capsule paralleled those of the spinal cord (Freund et al. , 2012a). At the cortical level, the primary 
sensorimotor cortices were atrophied (Jurkiewicz et al. , 2006, Wrigley et al. , 2009a, Freund et al. , 
2011a). The question of the temporal evolution and spatial specificity of these atrophic changes was 
addressed in a recent longitudinal study in acute SCI patients ((Freund et al. , 2013a),; see Fig. 22). 
Extensive upstream structural changes appeared already within the first months after injury as 
reflected by a decrease in cervical spinal cord area (see Fig. 22AB), white matter volume of the 
corticospinal tracts at the level of internal capsule and right cerebral peduncle and gray matter 
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volume in M1 (see Fig. 22CD). Importantly, clinically eloquent relationships between structural spinal 
and brain changes of the sensorimotor system have been demonstrated. Specifically, the amount of 
motor and sensory disability, as assessed by the international standards for the neurological 
classification of SPI protocol (Kirshblum et al. , 2011), was directly associated with the degree of 
spinal (Cohen-Adad et al. , 2011, Lundell et al. , 2011, Freund et al. , 2012b) and brain atrophy 
(Jurkiewicz et al. , 2006, Freund et al. , 2011b). Moreover, a decrease in the left-right diameter of the 
cervical cord area correlated with the motor score and the anterior-posterior diameter with the 
sensory score (Lundell et al. , 2011), indicating tract-specific atrophy. These clinically eloquent 
structural changes along the neuroaxis are suggestive of axonal degeneration and demyelination of 
the corticospinal tracts and the volume reduction at the cortical level reflect soma shrinkage of 
injured corticomotor neurons (Lemon, 2008). 
Figure 22: (a)/(b) Progressive structural changes of the acute injured spinal cord. (a) Representative 
example of a healthy control (spinal cord area highlighted in blue) and a chronic SCI patient (spinal 
cord area highlighted in red). (b) Change in cross-sectional spinal cord area differed significantly 
between patients and controls. Error bars show the standard errors of the scan intervals (horizontal) 
and of the percentage change in cross-sectional spinal cord area (vertical). (c)/(d) Longitudinal 
changes in local brain volume as revealed by tensor-based morphometry. (c) Statistical parametric 
map including the cranial corticospinal tract and the bilateral sensorimotor cortex (uncorrected 
P<0_001, shown for descriptive purposes). Regions of volume changes are highlighted in blue (gray 
matter) and red (white matter). (d) Changes in white matter volume in the corticospinal tracts, at the 
level of the left internal capsule, in patients and healthy controls over time. Error bars show the 
standard errors of the scan intervals (horizontal) and of the percentage change in spinal cord area 
(vertical). Adapted from Freund et al. , 2013.  
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6.3.2 Functional changes 
Next to trauma-induced structural changes, brain (neural) activity in SCI – revealed by functional MRI 
– has shown motor task-related activation in the primary motor cortex (M1) and associated cortical 
motor areas in the subacute phase of SCI (Jurkiewicz et al. , 2007). In the transition from acute to 
chronic SCI, the area of M1 activation increased, whereas associated sensorimotor areas (e.g. 
supplementary motor areas) showed a progressive decrease in activation (Jurkiewicz et al. , 2007). 
Studies in chronic SCI patients indicate that the deafferented M1 regions remain hyperexcitable 
during motor stimulation (Freund et al. , 2013b). Loss of motor input was shown to induce an 
expansion of the M1 hand area of paraplegic and tetraplegic patients into the output-deprived M1 
leg area (Bruehlmeier et al. , 1998, Curt et al. , 2002, Freund et al. ,2011a). However, whether these 
changes translate into functional output is questionable as stimulations of corticomotor neurons by 
transcranial magnetic stimulation (TMS) above the M1 leg area did not elicit hand/arm muscle 
activation (Freund et al. , 2011b).  
Interestingly, a recent study showed in incomplete paraplegics patients that performance 
improvements through intensive virtual reality augmented coordination and balance training of foot 
and leg movements were directly linked to local volume increases in cortical and subcortical areas 
associated with learning and motor performance (Villiger et al. , 2015). 
Brain reorganization may not only be related to functional recovery, but could also be associated 
with sensory disturbances as there is increasing evidence relating thalamic and cortical changes to 
the generation and/or maintenance of neuropathic pain below the level of injury (Wrigley et al. , 
2009b, Gustin et al. , 2012). Functional and structural alteration in terms of decreased activity in the 
atrophied thalamus (Jurkiewicz et al. , 2006), as well as decreased cortical activity in frontal areas and 
possibly increased subcortical activity have been related to pain (Jensen et al. , 2013, Yoon et al. , 
2013, Moxon et al. , 2014, Vuckovic et al. , 2014; for a review, see Pascoal-Faria et al. , 2014).  
Although the underlying mechanisms are uncertain, Qiu et al. (2014) described that repetitive TMS 
treatment over M1 leads to a substantial pain relief in a patient who suffered from deafferentation 
pain for more than 20 years. Interestingly, glucose metabolism was significantly reduced at the 
contralateral anterior cingulate cortex, insula and caudate nucleus after treatment, which might 
indicate some type of short-term plasticity induction (Qiu et al. , 2014). As treatment over M1 was 
also shown to be effective for other chronic pain states (Lechaufeur et al. , 2008, Leung et al. , 2009, 
Galhardoni et al. , 2014) this treatment might be promising for future clinical applications. However, 
double-blinded studies with larger sample sizes are needed to understand the functional changes at 
brain level and their effect on pain (Nardone et al. , 2014).  
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6.3.4 Summary 
In conclusion, these new findings from neuroimaging studies in human SCI indicate progressive long-
distance fiber degeneration along the sensorimotor system, structural cortical reorganization with a 
typical temporal and spatial course and a close relationship between the degree of structural and 
functional changes to clinical measures of impairment and outcome. 
6.4 Animal models of spinal cord injury: Invasive tracking of trauma-
induced changes 
Although neuroimaging outcome measures can track trauma-induced structural changes and 
functional reorganization in human SCI, they cannot reveal the biological processes underlying these 
changes (i.e. degeneration/demyelination vs. regeneration/remyelination and cortical 
reorganization). The pathological processes underlying these changes are not fully resolved, but in 
principal underlying mechanisms of spinal cord damage and regeneration/repair are assumed to be 
rather similar between animal models of SCI and human SCI (Edgerton and Roy, 2002). Both are 
characterized by remote axonal damage and demyelination of white matter tracts (Buss and Schwab, 
2003), the evolution of the lesion area (i.e. cyst formation) (Miyanji et al. , 2007), cortical 
reorganization (Freund et al. , 2013a) and the inherent low capacity of repair (Cregg et al. , 2014). In 
particular, rodent and primate models of SCI have demonstrated progressive axonal anterograde and 
retrograde degeneration of spinal pathways with subsequent neuronal changes at multiple levels 
(Beaud et al. , 2012, Nardone et al. , 2013, Nielson et al. , 2014).  
When investigating acute stages of SCI, not only the spinal cord circuitries react immediately to the 
injury (Yague et al. , 2011), but also cortical reorganization occurs as early as hours after thoracic 
hemisection in responses to electrical stimuli to the intact forepaw (Yague et al. , 2011, Sydekum et 
al. , 2014), previously only shown in chronic SCI rodents (Aguilar et al. , 2010, Dutta et al. ,2014). This 
enlargement of cortical S1 area appeared as early as 3 days after injury (Humanes-Valera et al. , 
2013, Sydekum et al. , 2014), and 7 days after injury the performance of tested animals was 
proportional to the reorganization at 1 day after injury (Sydekum et al. , 2014) (see Fig. 23, Yague et 
al. , 2011). In accordance, resting-state functional MRI showed alterations in spontaneous neuronal 
activity in several brain regions in monkeys (Rao et al. , 2014) as well as in rats (Yague et al. , 2011) 
with a thoracic hemisection. These observations might further help to understand the 
pathophysiological mechanisms behind these changes.   
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Figure 23: (a) Individual task-related brain activity maps within the forelimb representations for 
intact animals and SCI animals over time. BOLD-fMRI maps of forelimb representations in the 
sensory-motor cortex, intact and after injury for six individual rats monitored. Maps (upper: red, 
lower: blue) are displayed at uniform intensity levels and semitransparent to visualize overlaps. Maps 
are displayed for the 1.6mA (intact, 1, 3, 7 days postinjury) stimulation strength. In the coordinate 
space, x-axis denotes lateral distance from the midline (in mm) and y-axis: distance from bregma (in 
mm). (b)/(c) Effects on spinal cord injury (thoracic level T8) on skilled forelimb function. (b) Success 
rate quantified as percentage of correct steps among all of the attempted steps while crossing the 
horizontal ladder as a function of the number of steps required for a fixed distance. Symbols 
represent values measured as baseline (blue squares), 1 (open squares) and 7 days following SCI (red 
squares). (c) Success rate in forelimb use at day 7 as a function of change in activation area as derived 
from BOLD fMRI signal on day 1 (open squares) and days 3 (red squares with orange filling) with 
respect to baseline values. The correlation coefficients are indicated in the figure. Adapted from 
(Yague et al. , 2011). 
  
Literature Review 
 
Tracking structural changes in spinal cord and brain after SCI 118 
Furthermore, recent longitudinal studies showed that disintegration of the spinal cord spreads 
rostrally and caudally with a tendency to reduced spinal cord diameters 12 weeks after injury as 
shown in Fig. 24 (Rao et al. , 2013, Rao et al. , 2014), as in human SCI (Freund et al. , 2011a, Lundell et 
al. , 2011). In addition, cortical reorganization of S1 increased over time and correlated with the 
rostral, anterio-posterior diameter of the spinal cord indicating that a more severe SCI leads to 
greater cortical reorganization. This is in line with Yang et al. (2014) who showed that not only the 
severity of injury correlated with the extent of early cortical plasticity in the sensory cortices, but also 
to the severity of late behavioral deficits. The investigation of cortical activation after electrical 
forepaw stimulation represents one reliable method for tracking the cortical reorganization. As 
somatosensory evoked potentials (SSEPs) are already routinely used in patients, Bazley et al. (2014) 
showed that SSEPs are able to detect significant enhancements in activation of forelimb sensory 
pathways in rats with SCI at the thorax level, indicating that this method might also be useful for 
assessing treatments that modulate plasticity after SCI. Moreover, Sydekum et al. (2014) showed a 
significant latency difference at the ipsilateral S1 cortex on day 7. This might predict, at least in rats, 
the time at which the brain undergoes the most adaptions which might be a promising time window 
for therapeutic strategies such as rehabilitation (Bazley et al. , 2014).  
 
Figure 24: (a)/(b) Progressive structural changes of the injured spinal cord. (a) Representative 
example of a healthy nonhuman primate (spinal cord area highlighted in blue) at thoracic level. (b) 
MRI of the injured region in a nonhuman primate model of spinal cord injury (thoracic level T7_T9). 
Cross-sectional rostral spinal cord area (highlighted in red) assessed 2 cm above the lesion at 12 
weeks after SCI. (c)/(d) Correlations among the rostral transverse (TD) and anteriorposterior 
diameter (AD) of the spinal cord at different time points after lesion. The y-axis in each diagram 
indicates the measured diameter of the spinal cord at different locations, and the x-axis is the time 
point. The correlation coefficients areindicated in the figure. Adapted from (Rao et al. , 2014).  
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6.5 Conclusion 
At present, neuroimaging biomarkers are still not used routinely in human SCI to assess the efficacy 
of interventions (physical therapies or drugs) and how they relate to compensatory neuronal 
processes at the spinal cord and brain level. The proposed neuroimaging biomarkers have shown 
their potential to provide novel insights specifically wherein clinical measures might be insensitive to 
reveal subtle changes of spinal cord and brain function. However, these subtle changes ultimately 
may become valued as a proof-of-concept in which an amplification of the effectiveness eventually 
may translate into clinically meaningful changes of functional outcomes. The establishment of 
quantifiable and specific surrogate markers in animal models and human SCI will be essential to 
inform about the comparability of these models in the sense of disease stage (what indicate the 
transition from an acute to a chronic SCI, what stages of chronic SCI can be distinguished), extent of 
axonal/myelin damage and effects of repair/neural plasticity. Ultimately, quantitative and functional 
MRI in longitudinal multicenter assessments in acute SCI are required that measure central spinal 
and brain sequels simultaneously (Kong et al. , 2014) and their impact on cortical reorganization as 
SCI patients recover. This should allow the identification of the most sensitive imaging markers and 
their applicability in clinical trials.  
6.5.1 Future directions 
From a clinical perspective, the relationships between the extent of the spinal cord lesion, the 
amount of cortical reorganization and the recovery of behavior need to be further investigated in 
serial studies (Wu et al. , 2015). Animal models will help us understand not only the influence and 
ensuing consequences of different lesions, but also which neuroimaging outcome measures have 
predictive value. The continuous developments in the rapidly evolving field of spinal cord MRI at high 
resolution will help in detecting and understanding the structural changes below, within and above a 
SCI. Novel, improved MRI sequences and automated image processing methods (Finsterbusch et al. , 
2012, Mohammadi et al. , 2012, Finsterbusch et al. , 2013, Fonov et al. , 2014) have shown the 
potential to accurately distinguish (separate) gray and white matter at the spinal level and assess 
spinal activation patterns (Sprenger et al. , 2012). These advances will help us to better define the 
lesion level, extent of the injury and tracts affected.  
Current work in our laboratory is focusing on improving the MR sequences and postprocessing 
pipelines. The primary aim will be to extend our existing brain image segmentation approach to use 
atlas data from both head and neck (Fonov et al. , 2014). This would allow clinicians to better assess 
MRI data of patients with SCI and patients with neurological diseases involving the spinal cord. 
Moreover, anatomical MRI scans of the head and neck, collected at multiple time points following a 
spinal incidence such as trauma, allow longitudinal changes in terms of both rates of change (i.e. 
velocity) and its acceleration or deceleration (e.g. atrophy rates and possible recovery) to be 
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determined more accurately via longitudinal image registration procedures (Ashburner and Ridgway, 
2012).  
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7 General discussion 
The overall objective of this thesis was to increase our understanding of trauma-induced structural 
changes at different levels of the neuraxis and their relationship to clinical outcome. Within each of 
the specific studies conducted within this thesis, we hoped to gain novel insights into degenerative 
mechanisms leading to, or manifesting in sensorimotor impairments, as well as understanding 
compensatory mechanisms during the course of clinical recovery. With this obtained knowledge, we 
hope to contribute to the development of biomarkers within the SCI field to 1) improve patient 
selection and stratification into homogenous subgroups for therapeutical interventions and clinical 
trials, and 2) identify biomarkers which can potentially be used as surrogate markers to improve 
safety and efficacy determination in early stages of new intervention and clinical trials. 
In this thesis, we used a combination of conventional (T1-/T2-weighted images at spinal cord and 
brain) and advanced imaging modalities (MEDIC, DWI, MRS, quantitative MRI), together with 
different clinical methods (neurological and neurophysiological assessments, questionnaires). The 
imaging modalities were analyzed with different post-processing techniques (spinal DTI, spinal VBM, 
different segmentation techniques, fitting of spectroscopy data in frequency domain, vertex-wise 
surface area analysis). This enabled us to comprehensively investigate different mechanisms 
occurring after traumatic SCI. In particular, we assessed the temporal and spatial pattern of 
macrostructural changes at the lesion site (chapter 2), investigated remote macro- and 
microstructural changes (chapter 3), as well as remote cellular and molecular alterations (chapter 4) 
at the cervical cord above the level of lesion, and evaluated the temporal pattern and spatial extent 
of macro- and microstructural changes within the extrapyramidal system after acute SCI (chapter 5). 
As the findings of each individual study have been discussed within the specific sections, this general 
discussion serves as a summary of how each study increases our understanding of trauma-induced 
structural changes and their ability to serve as a future neuroimaging biomarker. Findings are 
discussed in conjunction to each other and set in relation to relevant literature. First, structural 
changes at the lesion site, remote structural changes above the level of lesion and potential 
mechanisms of such changes will be briefly discussed. Next, associations of structural changes with 
clinical outcome will be explained, and their potential as a biomarker set into context of current 
clinical trials. After outlining the limitations and the conclusion, next steps towards improving our 
understanding of structural changes and the development of neuroimaging biomarkers will be 
discussed. 
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7.1 Structural changes at the site of trauma 
As MRI is the gold standard to determine the extent of intramedullary changes at the injury site and 
damage of adjacent structures (e.g. bones), it is usually acquired within the first 48 hours after injury. 
Therefore, several groups investigated the predictive ability of such acute MRI parameters. In 
particular, neuroimaging assessments of the acutely injured spinal cord have identified relationships 
between macro-structural intramedullary changes (e.g. extent of hemorrhage (Boldin et al. , 2006), 
lesion length (Arabi et al. , 2011, Arabi et al. , 2012, Le et al. , 2015), maximal spinal canal 
compromise/compression (Miyanji et al. , 2007) and clinical impairment at admission (Miyanji et al. , 
2007, Flanders et al. , 1999, Furlan et al. , 2011) or early discharge (Mabray et al. , 2016). Although 
the lesion measures possess information about the extent and location of primary and secondary 
damage, regenerative treatments aiming at the repair of the injured spinal cord will likely depend on 
tissue bridges as it provides a bridge (or conduit) for axonal regeneration and or sprouting (Freund et 
al. , 2006, Krishna et al. , 2014). 
In this thesis (chapter 2), we investigated the dynamics of midsagittal tissue bridges at the lesion site 
and observed that at 1-month post injury, the lesion was well demarcated and allowed for reliable 
identification of ventral and dorsal tissue brides and their temporal evolution. In particular, the size 
of total tissue bridges remained stable within the first year after injury, was paralleled by recordable 
electrophysiological information flow and predictive of clinical outcome at 12-month. 
In chronic SCI, the lesion cavity is surrounded by a rim of spared fibers (Bunge et al. , 1993, Hill et al. , 
2001). As SCI can lead to necrosis at the lesion site, the lesion cavity often contains multilocular 
cavities which are separated by glial trabeculae, and surrounded by astrocytic fibers and collagenous 
scar tissue (Bunge et al. , 1993, Scholtes et al. , 2006). Interestingly, in the majority of functionally 
complete patients, tissue bridges were evident at the lesion site, a phenomenon also described as 
discomplete (Kakulas, 1999). In addition, in incomplete SCI, demyelination is also present in intact 
fibers adjacent to the lesion epicenter (Guest et al , 2005). It was therefore debated, whether the size 
of tissue bridges actually is able to represent the clinical status of a patient. However, we show, that 
at 1-month post injury, complete patients have much smaller tissue bridges than incomplete 
patients, and that the size of the tissue bridges is predictive of functional outcome. 
This is the first prospective longitudinal study characterizing the spatial and temporal evolution of 
MRI parameters specific of macrostructural-anatomical changes occurring at the lesion site and 
linking those to clinical outcome in cervical SCI patients. The sensitivity to change and accuracy for 
clinical outcome shows the potential of these neuroimaging biomarkers to be used in clinical routine 
and clinical trials in both acute and chronic SCI.   
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7.2 Large-scale remodeling above the level of lesion 
Plasticity of the CNS is a concept that arose first when long-term potentiation as a form of synaptic 
plasticity was shown to modulate learning (Raisman, 1969, Teyler and DiScenna, 1987, Bliss and 
Collingridge, 1993). Before that, researchers regarded the brain as being developed within a critical 
period in natal and prenatal phase (Pascual-Leone et al. , 2005). This ability of the brain to constantly 
adapt the environments need is of high relevance in daily life, but also important when the fragile 
CNS gets damaged. As regeneration is very limited in the adult CNS (Ba and Bonhoeffer, 1994), next 
to functional compensation (Alstermark  et al. , 1987), CNS plasticity might compensate for loss of 
function by regenerative axonal growth and sprouting (Weidner et al. , 2001), myelin repair 
(McDonald and Belegu, 2006) , synaptic strengthening (Cooke and Bliss, 2006) and the use of detour 
pathways (Courtine et al. , 2008, Filli et al. , 2014) (see also chapter 1.5). In healthy subjects, 
Draganski et al. (2004) first showed that brain plasticity can be captured not only by functional MRI 
but also by structural MRI. Soon, the idea arose within the neuroscience community that, 
degenerative and maladaptive processes after CNS injury, in addition to neuronal mechanisms of 
repair could also potentially be captured by using MRI. One example of CNS injury is traumatic SCI. 
Specifically, understanding the sequence of structural changes after SCI and their relationship to 
outcome by means of MRI, might serve as a solution for the pressing need for in-vivo biomarkers in 
the field, helping to develop evidence-based rehabilitation strategies (Freund et al. , 2013a, Huber et 
al. , 2015). 
In SCI, one of these first ideas included the observation that directly damaged corticospinal axons 
degenerate and lead to shrinkage and partially apoptosis of the appropriate cell body in layer IV due 
to loss of trophic support (Kalil & Schneider, 1975). Although many studies have confirmed apoptosis 
and shrinkage of appropriate cell bodies in response to corticospinal tract damage (McBride et al. , 
1989, Hains et al. , 2003, Tang et al. , 2004), there is also a body of evidence that is contradictory with 
this result (Barron et al. , 1988, Nielson et al. ,2010), possibly resulting from differences in 
methodologies (e.g. time of injury, injury location) (Oudega and Perez, 2012). Nevertheless, such 
changes might translate into volume changes at the spinal cord, and possibly also within appropriate 
brain regions (e.g. primary motor cortex), trackable by means of MRI.  
At the spinal level, first studies using structural MRI remote from the lesion site showed decreases in 
SCA (Freund et al. , 2011a) above the level of injury, along with indicators of demyelination and 
altered white matter integrity (Cohen-Adad et al. , 2011, Petersen et al. , 2012).   
Within this thesis (chapter 3), we extended this knowledge and showed that not only white matter 
atrophies and undergoes demyelination and neurodegeneration, but also grey matter changes 
contribute to the overall observed remote spinal atrophy. As changes within the grey matter were 
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associated with lesion severity and the clinical status of the patient, this is suggestive of trans-
synaptic neurodegeneration of neuronal circuits within the spinal cord far above the level of injury. 
Indeed, different preclinical studies show reorganization of intraspinal circuits (Bareyre et al. , 2004, 
Vavrek et al. , 2006, Courtine et al. , 2008). Similar effects have also been observed in patients with 
cervical spondylotic myelopathy (Grabher et al. , 2016, Grabher et al. , 2017), whose cord became 
progressively compressed, mainly caused by chronic cervical disc degeneration (Crandall and 
Batzdorf, 1966).  
In a next step (chapter 4), we investigated underlying cellular and molecular changes in areas of 
atrophy above the level of lesion and found metabolic alterations related to neurodegeneration and 
demyelination, which were driven by lesion severity, supporting our findings from chapter 3. In 
addition, we found indicators of chronic neuroinflammation, which were associated with greater 
clinical impairment. After initial damage to the cord, there is an initial inflammatory response 
originating in the cord, primarily by activation of microglia. Microglia produce cytokines, like L-1β, 
TNF-α, proteases, and other cytotoxic factors (Nesic et al. , 2001). As spinal cord trauma leads to 
degeneration and demyelination of injured axons as well as glial apoptosis, a secondary 
inflammatory response follows (Dumont et al. , 2001). This neuroinflammatory response is poorly 
understood and can persist months to years after the initial trauma (Norenberg et al. , 2004, Fleming 
et al. , 2006, Felix et al. , 2012). However, inflammatory responses are complex as they exert both 
beneficial (plasticity enhancing) and detrimental (glial- and neurodegenerative) effects (Schwab, 
2014). For example, animal studies showed that even 180 days after injury, inflammation persists. 
However, blocking the late C5a-mediated inflammatory response (>14 days post injury) leads to 
reduced locomotor recovery, suggesting a multiphasic response with the late component possibly 
serving as reparative function (Beck et al. , 2010). On the other hand, selective inhibition of 
transcription factors nuclear factor kB of astrocytes leads to an improvement in recovery (Brambilla 
et al. , 2005). Such persisting inflammatory responses are not a unique feature of SCI – several acute 
and chronic brain diseases show persisting brain inflammatory responses (Lyman et al. , 2014) which 
might arise from an increased metabolic demand of the CNS when undergoing increased plastic 
changes (Xanthos and Sandkuehler, 2014). Such responses may also become maladaptive - in 
humans studies, there is evidence of inflammatory brain changes after SCI related to pain (Pattany et 
al. , 2002, Widerström-Noga et al. , 2013), but also to cognitive decline (Wu et al. , 2014). 
Understanding the temporal cascade of spinal neuroinflammatory responses as described in chapter 
4, and their relationship to structural changes (i.e. ventral and dorsal horn changes, microstructural 
changes) as described in chapter 3, the emergence of neuropathic pain and cognitive function will 
enhance our understanding of SCI pathophysiology. 
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At the cortical level, previous studies showed that the brain exhibited volumetric decreases, 
paralleled by demyelination within the corticospinal tract and in the primary motor cortex (Wrigley et 
al. , 2008, Freund et al. , 2011ab, Freund et al. , 2013a, Ziegler et al. , 2018), and in sensory and limbic 
system (Jurkiewicz et al. , 2006, Hou et al. , 2014, Grabher et al. , 2015). The extent of such structural 
changes was also related to the occurrence and amount of neuropathic pain within the motor and 
sensory system (Gustin et al. , 2009, Wrigley et al. , 2009b, Yoon et al. , 2013, Jutzeler et al. , 2016). In 
addition, our last study (chapter 5) shows progressive morphometric somatotopic changes (increases 
and decreases of surface area) within the basal ganglia, paralleld by decreases in myelin-sensitive 
paramters. Even tough it remains controversial, under which circumstances directly injured 
corticospinal neurons lead to atrophy of cell bodies within the motor cortex (Oudega and Perez, 
2012), we show clear evidence that even networks not being directly injured undergo structural 
changes after SCI. Brain networks are topologically organized and consist of different interconnected 
elements, which transfer information between each other (Bulmore and Sporns, 2012). In terms of 
structure, this topological organization is critically related the function of each element (Barbarasi et 
al. , 2004, Li et al. , 2004). From this perspective, it seems reasonable that damage to one element of 
this integrated network will lead to alterations in connected elements. Studying the brain as an 
integrated, hierarchical network (Bullmore and Sporns, 2009) might therefore be a new powerful 
tool for better understanding brain function and structure, and its alterations after damage to the 
CNS in both human and animal studies. 
Taken together, SCI does not only result in changes at the primary lesion site (chapter 2) and in 
reduced white matter integrity of main sensorimotor tracts (chapter 3), we also found spinal grey 
matter changes (chapter 3) and an altered biochemical environment (chapter 4) above the level of 
lesion, as well as cortical reorganization of primarily unaffected brain regions (chapter 5), indicating 
that SCI leads to a large scale, transneuronal remodeling and wide-spread structural changes 
throughout the CNS. 
7.3 Potential of these neuroimaging biomarkers to serve as surrogate 
markers 
In this thesis, we showed that several of our applied MR sequences exhibited localized trauma-
induced changes which were predictive of clinical outcome. These biomarkers might serve as future 
surrogate markers in interventional studies and clinical trials. Such surrogate markers have the 
potential to identify potential responders to a certain treatment, and determine safety and efficacy 
of new treatments in early phases of clinical trials, which will result in reduced developmental, but 
also ease socioeconomical costs (see also chapter 1.6). 
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At the lesion site, we revealed that as early as 1-month after injury, the lesion extent but also the size 
of tissue bridges were predictive of 12-month sensory and motor scores, as well as of daily-life 
independence (chapter 2). These associations were not specific to sensory or motor scores, but 
rather represented the overall damage, respectively preservation, of function as an approximation of 
the amount of spared fibers. In preclinical models, there is evidence that tissue bridges are actually 
responsive to treatment and represent the sensorimotor status of the animal. In particular, the 
amount of tissue sparing at the lesion center was associated with locomotor recovery in rats with 
cord contusion (Basso et al. , 1996). When comparing two groups of mice receiving different type of 
treatments, Boato et al. (2013) showed that worsened outcome is associated with an increase in 
lesion width along with a reduced number of spared corticospinal tract fibers. In line, Calderon-
Vallejo et al. (2015) showed that pharmacological treatment can increase the number and caliber of 
nerve axons which leads to significant higher spared tissues. For treatments aiming at the repair of 
the lesion site, MR biomarkers could help to reproduce preclinical findings and possibly identify 
efficacy of treatment in a timely manner prior to functional improvements. At the moment, several 
such clinical trials are conducted in subacute (Schwann cells: NCT01739023 identified in clinical-
trials.gov, Collagen scaffolds: NCT02510365 identified in clinical-trials.gov, HuCNS-SC: NCT01321333 
identified in clinical-trials.gov) and chronic patients (Schwann cells: NCT02354625 identified in 
clinical-trials.gov, Scaffolds seeded with stem cells: NCT02688049 identified in clinical-trials.gov), 
which potentially could profit from these established measures. In particular tissue bridges’ 
responsiveness to treatment will be evaluated within a phase II clinical trial of Anti-Nogo A antibody, 
a multi-center investigator initiated clinical trial with the Balgrist University Hospital as the lead 
center. 
In the atrophied cervical cord above the level of lesion, molecular levels of NAA/mI and Cho/mI ratios 
were associated with daily-life independence and sensorimotor scores (chapter 4). This indicates that 
patients with lower N-acetylaspartate and choline, indicative of neuronal degeneration (Bjartmar et 
al. , 2000) and reduced mitochondrial metabolism (Bates et al. , 1996) and higher myo-Inositol levels, 
suggestive of neuroinflammation (Rust and Kaiser, 2017), have worse outcomes. Although MRS 
measurements are sensitive and specific to absolute concentrations of certain molecules, none of 
these molecules are involved in a single biological process, making the underlying cause for change 
conjecturable. However, as we showed that spinal MRS is sensitive to detect trauma-induced 
changes, such measures might help to detect subtle changes early in pathological processes. In 
particular, taken the example of neurodegeneration, which results in the breakdown of the cell 
membrane, this leads to an immediate increase of choline, detectable by MRS.  Volumetric changes 
attributed to neurodegeneration are likely to arise only after the removal of cell debris, which allows 
the detection of this process only at a later time when using morphometric measures. Future studies 
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need to assess whether MRS actually holds the potential to detect trauma-induced changes earlier 
than morphometric measures. As novel therapeutical approaches will most likely have best efficacy 
when applied earliest after injury, biomarkers able to timely predict outcome of the patients are 
urgently needed in order to detect treatment effects. Within the last years, a variety of new 
interventions have been investigated in very acute SCI patients, who could benefit from such early 
surrogate markers (e.g. Neuro-spinal scaffolds: NCT02138110 identified in clinical-trials.gov, Anti-
Nogo-A (ATI355): NCT00406016 identified in clinical-trials.gov, Magnesium-Chloride infusion 
(AC105): NCT01750684 identified in clinical-trials.gov, Riluzole: NCT01597518 identified in clinical-
trials.gov). 
In contrast to the measures from study 1 and 3 (chapter 2/4), our study 2 and 4 (chapter 3/5) 
showed specific associations of structural changes above the level of injury with outcome. In 
particular, at the cervical cord, dorsal horn atrophy and microstructural changes within the dorsal 
column were associated with sensory outcome, while the size of ventral horns was associated with 
motor outcome (chapter 3). Within the basal ganglia, we found that at 1-month after injury, surface 
area changes within the motor caudate were predictive of 24-month lower extremity motor score 
(chapter 5). As a next step, future studies should longitudinally assess the temporal evolution of such 
measures and identify the earliest time point for prediction to validate their potential as a surrogate 
marker. 
7.4 Limitation and Considerations 
Strengths and limitations of each study were discussed in the specific chapters separately. Here, 
general limitations and considerations of this thesis are discussed.  
All studies were conducted prospectively and included a control group when required. This allowed 
us to carefully select patients and healthy subjects, minimizes effects not related to the variables of 
interest and enabled interpretation about the magnitude of our observed effects. In study 2-4 
(chapter 3-5), structural MRI sequences with high resolution were acquired, which have the potential 
to detect subtle and small changes. The knowledge gained within this thesis complements previous 
findings and brings us another step closer towards the development of in-vivo MRI bio- and 
surrogate markers within the SCI field. 
One limitation of this study is that most of our readouts from the different imaging modalities show 
rather high inter-subject variability. This might be partially due to influencing factors which were not 
all properly controlled in this study, like lesion level, extent of lesion, time since injury, genetics, and 
neuroanatomical differences leading to subtle differences in registration and normalization 
procedures. However, we controlled for age in all of the studies, as previous studies have shown an 
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age-dependent decline in axonal growth after CNS injury, limiting the potential of repair in the 
elderly SCI population (Geoffroy et al. , 2016). For predicting functional outcome after SCI, it is 
important that the experimental and biologic variability in the quantified metabolite is smaller than 
their changes caused by the injury (Öz et al. , 2014). For future (multi-center) studies, it is therefore 
of particular importance to show robustness of MR biomarkers (Raunig, 2015). In particular, 
reproducibility and reliability need to be assessed for all measures, and eventually improved. In 
particular, measures of R2* and T1-weighted images show rather low reproducibility between sites 
(coefficient of variation > 15%) (Weiskopf et al., 2013), which highlights the need for prospective 
studies to improve the reproducibility of MR imaging-derived metrics. 
Next, our studies 2 and 3 (chapter 3 and 4) were cross-sectional studies, which does not allow for 
understanding the temporal relationship between cervical structural changes and outcome. As 
measures of the cervical cord above the level of injury hold the potential to serve as surrogate 
markers, longitudinal studies are warranted to close this gap of knowledge. 
A further limitation of this thesis involves the fact that all of our applied MR measures are not 
specific not any biological process (e.g. demyelination, neurodegeneration or inflammation). 
Morphometric measures (e.g. surface area analysis, VBM, TBM, cortical thickness) allow detecting 
morphological differences (i.e. volume and surface area) between patients and controls, and tracking 
them over time. However, they are not specific to any pathological processes occurring after SCI like 
atrophy, demyelination, or changes in the amount or shape of different cell types. Although 
quantitative MRI is sensitive, and MRS is sensitive and specific for molecular changes, they remain 
indirect markers of demyelination and neurodegeneration. Nevertheless, in our studies we show that 
these MR measures are indeed sensitive to trauma-induced changes. 
7.5 Concluding remarks 
The present thesis extensively investigated trauma-induced structural changes at and above the level 
of injury after SCI by applying standard and advanced imaging and post-processing techniques and 
associating them with neurological and neurophysiological outcome of the patient. Previous studies 
showed cervical atrophy and cortical changes within the sensorimotor and limbic system occurring 
after SCI. We now characterized changes at the lesion site and showed degeneration and 
demyelination in directly injured white matter tracts above the level of injury. In addition, primarily 
unaffected spinal and brain regions like the dorsal and ventral horns above the level of lesion or the 
basal ganglia system, also undergo structural and microstructural changes and are predictive of 
outcome. We conclude that SCI does not only lead to structural changes of directly affected 
networks, but also results in large scale, transneuronal reorganization. In addition, our findings 
indicate that chronic neuroinflammation might be present after SCI, relating or contributing to 
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ongoing degenerative changes within the CNS, and therefore also possibly being associated to clinical 
outcome. In conclusion, quantitatively analyzed conventional as well as innovative multimodal MR 
protocols allowed for the quantification of trauma-induced changes. The present findings deepen our 
understanding of spinal and supraspinal structural changes occurring after SCI and highlight their 
potential to serve as a future surrogate marker. 
7.6 Future directions 
7.6.1 The role of tissue bridges and their responsiveness to treatment 
The assessment of tissue bridges might be in particular important for all clinical trial investigating 
treatments aiming at repair at the lesion site (e.g. scaffold implanation, stem cell treatment, Anti-
Nogo-A antibody infusion). Before assessing the responsiveness of tissue bridges in future clinical 
trials, it is important to understand whether preserved dorsal (i.e. representing the dorsal column) 
and ventral (i.e. representing the anterior corticospinal tract) midsagittal tissue bridges encode tract-
specific electrophysiological properties and whether they are specific in predicting appropriate 
functional outcome. This will enhance our understanding of the specificity and sensitivity of tissue 
bridges. 
Next, as most clinical trials in SCI patients are including paraplegic patients in their Phase I due to 
safety reasons, an extension of our established measurements from tetraplegic patients to paraplegic 
patients is highly needed. Generally, injury morphology (e.g. compression, burst, rotation, 
translation, flexion, hyperextension) differs between tetra- and paraplegic patients as the cervical 
cord is much more vulnerable to hyper-/hypoflexion injuries. Therefore, the spatial extent and the 
evolution of lesions in paraplegic patients might fundamentally differ in SCI patients, which should be 
investigated in future studies. Once developed, measures of tissue bridges could be applied within 
clinical trials in both tetra- and paraplegic patients. 
7.6.2 Disentangle structural correlates of neuropathic pain from neurodegenerative 
changes 
We showed that SCI leads to widespread changes at and above the level of injury (chapter 2-5). 
However, as a large proportion of SCI patients (>80%) develop chronic pain refractory to treatment 
(Siddall et al. , 1999, Siddall et al. , 2003, Cruz-Almeida et al. , 2005, Finnerup et al. , 2014), it is 
important to disentangle causes and effects of persisting pain from neurodegenerative changes. 
Previous studies suggest, that patients with neuropathic pain show a less pronounced somatotopic 
reorganization in the brain (Jutzeler et al. , 2015), and less pronounced atrophy in the spinal cord 
(Jutzeler et al. , 2015), but the process of pain development remains incompletely understood.  
In patients suffering from chronic pain, but not of SCI, increases in cortical thickness within the 
primary somatosensory cortex were detected and consistent across different etiologies (Kayris et al. , 
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2015, DaSilva et al. , 2008). In line, preclinical neuropathic pain models showed that localized S1 
astrocyte activation in the early phase of developing pain (Kim et al. , 2017) led to increased dendritic 
spine turnover of the pyramidal cells present in the layer V (Kim and Nabekura 2011) and increased 
spine motility (Kim and Moalem-Taylor, 2011), suggesting that astrocytes are a key trigger for S1 
synaptic rewiring (Kim et al. , 2017), resulting in S1 hyperexcitability. This in turn might affect also a 
variety of other regions connected to S1 like the ACC, thalamus and the insula, prefrontal cortex – 
regions which are also known to be altered after SCI. 
 
For our SCI population, patients suffering from neuropathic pain might exhibit different mechanisms 
in parallel, which possibly compete against each other. On the one hand, damage to the 
sensorimotor tracts leads to pronounced atrophy and microstructural changes of the somatosensory 
cortex. However, when developing pain, mechanism seem to exist which also lead to the opposite 
effect within the same regions. Whether these mechanisms exist in parallel, are a consequence of 
each other, or are competing against each other, leading to the development of neuropathic pain, 
needs to be investigated. In particular, we need to understand causes and effects of neuropathic 
pain, and how this is translated into structural and microstructural changes as measurable by means 
of MRI. Longitudinal MRI studies in concordance with neurophysiological recording targeting the 
somatosensory system are needed to link hyperexcitability states to structural changes. Given the 
fact that early structural changes leading to neuropathic pain in preclinical models, it is of high 
importance that such measures (e.g. functional and structural MRI) are applied as close to the injury 
as possible with close follow-ups in the acute and sub-acute phase. 
 
7.6.3 The role of neuroinflammation in recovering from a spinal cord injury  
We investigated cellular and molecular changes within the atrophied cervical cord above the level of 
injury using MRS (chapter 4) in chronic SCI patients, and found indicators of neuroinflammation. The 
amount of neuroinflammation was related to lesion severity and outcome. To further investigate 
neuroinflammation after SCI, we need to better understand whether neuroinflammation is globally 
present throughout the whole CNS, or whether it affects certain regions with the CNS. Future studies 
should characterize the temporal and spatial evolution of neuroinflammatory markers. In particular, 
as the neuroimflammatory response consist of a variety of altered processes, combining different 
imaging methods might be in particular beneficial. Such techniques include MRS to track levels of 
myo-Inositol (an osmolyte regulating astrocyte cell volume), contrast-enhanced MRI using 
gadolinium to study blood-brain-barrier alterations (Rebeles et al. , 2006), and dynamic contrast-
enhanced MRI with appropriate modeling techniques to study cerebral blood flow and blood-brain-
barrier permeability (Heye et al. , 2014). It is important to note however, that pain should also be 
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carefully tracked, as pain itself might also be associated with inflammatory responses in a variety of 
brain regions (Widerström-Noga et al. , 2015). 
7.6.4 The role of neuroinflammation after spinal cord injury and the risk of developing 
dementia 
Several human studies showed persisting signs of neuroinflammation after CNS injury, including ours 
(chapter 4). Apart from the role of neuroinflammation in recovery after CNS damage, increased risk 
of dementia after traumatic brain injury possibly mediated by neuroinflammation has lately received 
widespread attention (Faden et al. , 2016). Huang et al. , (2017) recently conducted a large 
epidemiological study and reported that patients with SCI are at higher risk of dementia than age- 
and sex-matched controls. In line, chronic neuroinflammation is present in mice with SCI and results 
in impaired neurogenesis within the dentate gyrus of the hippocampus (Wu et al. , 2016) along with 
decreased BDNF levels (Felix et al. , 2012, Gommez-Pinilla et al. , 2012), depending on initial lesion 
severity. These mice also showed cognitive impairments in a variety of tests including spatial 
navigation, object recognition and memory function (Wu et al. , 2016). To date, structural changes of 
the hippocampus after SCI have not been considered yet. Future studies should address if and when 
structural changes within the hippocampus occur after human SCI. In particular, morphometric and 
microstructural changes of hippocampal subfields, as recently provided by Chakravarty et al. (2013), 
are of particular interest, as well as their relationship to late cognitive outcome. 
7.6.5 Understanding trauma-induced changes in spinal and cortical networks  
It has not been that long ago, as the brain organization was considered to consist of different cell 
types, whereof neurons form a complicated structural network (y Cajal, 1995, Swanson, 2012). As 
understanding the network organization within the brain in healthy controls is a challenge per se, the 
Human Connectome Project (HCP) was launched in 2010 with a total of 38.5 million spent over five 
years to identify and map networks (connectome), shedding light on functional and structural 
connectivity. This body of research, along with recent advances in graph theory of brain networks 
(Bullmore and Sporns, 2009) will facilitate the understanding in network changes after SCI. So far, our 
group focused on understanding structural changes within specific regions of the brain or within 
several regions belonging to a network (e.g. basal ganglia), and their relationship to lesion severity 
using simple correlation analysis. It would be of particular interest to unravel the temporal sequence 
of structural changes, their relationship to each other and to changes at the lesion site. By such 
means, we could also disentangle primary effects induced by the lesion itself (e.g. degeneration of 
damaged tracts) from secondary effects not directly related to the lesion (e.g. changes emotional 
status).  
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7.6.6 Translational research: Improving transfer from bench to bedside and from 
bedside back to bench 
An important step towards clinically reliable bio- and surrogate markers is the development of 
comparable methods between animal and human SCI to identify correlations between MRI metrics 
and pathophysiological processes. Recent studies have already started to assess relationships 
between DTI (Kozlowski et al. , 2008, Kelley et al. , 2014), myelin water imaging (Kozlowski et al. , 
2014), magnetization transfer (Wang et al. , 2015, Wang et al. , 2016), susceptibility-weighted 
imaging (Wang et al. , 2011) and clinical histological parameters in several animal models of SCI. 
Most of such MRI studies in animals have focused on changes of the lesion site rather than remote 
changes above the level of injury. However, novel imaging measures are more prone for metal 
artefacts caused by instrumentation in the spine, making the application of quantitative MR 
protocols at the lesion site in humans challenging. Therefore, future animal studies should focus on 
longitudinal characterization of comparable quantitative MR parameters above the level of injury, 
assess their predictive ability for clinical outcome, and their relationship to histological changes.  
7.6.7 Towards the development of surrogate markers: Next steps 
As highlighted in the introduction (chapter 1.6.3), after having found biomarker candidates which 
provide clinically relevant information about the actual or future status of the patient, we need to 
validate the biomarker’s effectiveness or utility as a surrogate endpoint before we can clinically apply 
it.  
Within this thesis, a prospective, longitudinal training study was conducted, investigating training-
induced structural changes after SCI. To date, the only effective treatment leading to a limited extent 
of functional recovery is by means of intensive neurorehabilitation. We therefore designed an 
interventional study, where we investigated whether intensive feedback-guided sensorimotor 
training is reflected by structural changes in learning associated brain areas and /or can induce 
rebound effects within areas of atrophy in chronic SCI patients. For this aim, during the last 3 years, 
18 controls (age: 37.5 ±12.5 years) and 17 incomplete SCI patients (age: 46.1 ± 15.6 years), divided 
into two equal subgroups for lower and upper limb training, received feedback-guided training 
during 4 weeks (4 x 30 minutes per week). A further control group consisting of 9 healthy controls 
(age: 41.1 ± 12.2 years), not receiving training, was additionally included. Participants were assessed 
weekly and at 84 day follow-up. For those having received the training, improvements and retention 
in training success, attentional networks, lower extremities reaction and movement time, and 3D gait 
analysis were assessed next to a comprehensive neurological examination (Fig. 25). Computational 
morphometry will assess structural correlates (volumetric and myelin changes) of performance 
improvements in the spinal cord and brain using repeat MRI (n=5 scans per subject).  
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We are optimistic, that our novel neuroimaging measures of dynamic structural central changes in 
response to training hold significant potential to elucidate neuronal changes associated with learning 
vs. clinical recovery. We are optimistic that the sensitive and accurate MRI biomarkers so developed 
can be applied as surrogate endpoints in clinical trials and to personalize the care of patients with 
SCI. 
 
Figure 25: Training and assessment paradigm 
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9 List of Abbreviations 
AD axonal diffusivity 
AH abductor hallucis 
AIS American Spinal Injury Association Impairment Scale 
ASIA American Spinal Injury Association 
CHEPs contact heat evoked potentials 
CNS central nervous system 
COV coefficient of variation 
Cr creatine 
CSGP chondroitin sulphate proteoglycans 
DCA cross-sectional dorsal column area 
DHA cross-sectional dorsal horn area 
DTI diffusion tensor imaging 
DWI diffusion-weighted imaging 
FA fractional anisotropy 
FLASH fast low angle shot 
FOV field of view 
GMA cross-sectional grey matter area 
GRASSP Graded Redefined Assessment of Strength, Sensibility and Prehension 
ISNCSCI International Standards for Neurological Classification of Spinal Cord Injury 
LEMS lower extremity motor score 
MEDIC multiple echo data image combination 
mI myo-Inositol 
MD mean diffusivity 
MEPs motor evoked potentials 
MPM multi-parameter mapping 
MRI magnetic resonance imaging 
MRS magnetic resonance spectroscopy 
MT magnetization transfer 
PD proton density 
RD radial diffusivity 
R1  longitudinal relaxation rate 
R2* effective transverse relaxation rate 
ROI region of interest 
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SCA cross-sectional spinal cord area 
SCI spinal cord injury 
SCIM spinal cord independence measure 
SEPs/ SSEPs somatosensory evoked potentials 
TA tibialis anterior 
TMS transcranial magnetic stimulation 
TNF-α tumor necrosis factor alpha  
tNAA total N-acetyl-aspartate and N-acetyl-aspartate-glutamate 
tCho phosphocholine and glycerophosphocholine 
UEMS upper extremity motor score 
VAN ventral anterior nucleus 
VHA cross-sectional ventral horn area 
VLN ventral lateral nucleus 
VOI voxel of Interest 
VPN ventral posterior nucleus 
WISCI Walking Index for Spinal Cord Injury 
WMA cross-sectional white matter area 
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